首页 » 细胞株Cell Lines 53-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 53-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV53
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.

电话:400-800-2947 工作QQ:1843439339 (微信同号)

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心


http://www.biovector.net


ID   MDAH 2774

AC   CVCL_0420

SY   MDAH-2774; MDAH2774; 2774; #2774; OV-2774; OV-CA-2774; SK-2774

DR   BTO; BTO:0003942

DR   MCCL; MCC:0000317

DR   ATCC; CRL-10303

DR   BCRJ; 0163

DR   Cosmic; 724881

DR   Cosmic; 844345

DR   Cosmic; 875291

DR   Cosmic; 897431

DR   Cosmic; 923109

DR   Cosmic; 1044237

DR   Cosmic; 1113282

DR   Cosmic; 1524360

DR   Cosmic; 1708386

DR   Cosmic; 1709262

DR   Cosmic; 2186588

RX   PubMed=719612;

RX   PubMed=6582512;

RX   PubMed=11314036;

RX   PubMed=15153938;

RX   PubMed=19288585;

RX   PubMed=22328975;

RX   PubMed=22710073;

RX   PubMed=25230021;

RX   PubMed=27235858;

WW   http://www.addexbio.com/productdetail?pid=57

CC   Part of: OCCP ovarian cancer cell line panel.

CC   Omics: Deep proteome analysis.

ST   Source(s): ATCC; PubMed=25230021

ST   Amelogenin: X

ST   CSF1PO: 10,14 (ATCC)

ST   CSF1PO: 10,11 (PubMed=25230021)

ST   D13S317: 8,9,12 (ATCC)

ST   D13S317: 8,9 (PubMed=25230021)

ST   D16S539: 10,11,12,14 (ATCC)

ST   D16S539: 10,11,12 (PubMed=25230021)

ST   D18S51: 14,15

ST   D21S11: 30,31

ST   D3S1358: 16,18

ST   D5S818: 10,12,13 (ATCC)

ST   D5S818: 10,11,12 (PubMed=25230021)

ST   D7S820: 8,9.3,10.1,11 (ATCC)

ST   D7S820: 10,11,12 (PubMed=25230021)

ST   D8S1179: 14

ST   FGA: 24,25

ST   Penta D: 13,14

ST   Penta E: 13,14

ST   TH01: 6,8

ST   TPOX: 8,11 (ATCC)

ST   TPOX: 8 (PubMed=25230021)

ST   vWA: 14,16,19,21 (ATCC)

ST   vWA: 15,19 (PubMed=25230021)

DI   NCIt; C7979; Ovarian endometrioid adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MDAH041

AC   CVCL_E212

RX   PubMed=2000218;

RX   PubMed=2253239;

RX   PubMed=7667317;

DI   NCIt; C3476; Li-Fraumeni syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MDAH087

AC   CVCL_E213

SY   MDAH 087

RX   PubMed=2000218;

RX   PubMed=2253239;

DI   NCIt; C3476; Li-Fraumeni syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MDAH172

AC   CVCL_E214

RX   PubMed=2253239;

DI   NCIt; C3476; Li-Fraumeni syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MDAH174

AC   CVCL_E215

RX   PubMed=2253239;

DI   NCIt; C3476; Li-Fraumeni syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MDAY-D2

AC   CVCL_S411

DR   ChEMBL-Cells; CHEMBL3308420

DR   ChEMBL-Targets; CHEMBL614337

RX   PubMed=6591445;

RX   PubMed=6929020;

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MDBK

AC   CVCL_0421

SY   MDBK (NBL-1); NBL-1; Madin-Darby Bovine Kidney; Madin Darby Bovine Kidney

DR   BTO; BTO:0000836

DR   CLO; CLO_0007642

DR   CLO; CLO_0007643

DR   CLO; CLO_0050865

DR   MCCL; MCC:0000318

DR   CLDB; cl3412

DR   CLDB; cl3413

DR   CLDB; cl3414

DR   CLDB; cl3415

DR   CLDB; cl3416

DR   ATCC; CCL-22

DR   ATCC; CRL-6071

DR   BCRC; 60126

DR   BCRJ; 0167

DR   CCLV; CCLV-RIE 0084

DR   CCLV; CCLV-RIE 0261

DR   CCRID; 3111C0001CCC000288

DR   CCRID; 3111C0002000000076

DR   CCRID; 3131C0001000400007

DR   CCRID; 3153C0001000000033

DR   CLS; 600396/p848_MDBK_(NBL-1)

DR   DSMZ; ACC-174

DR   ECACC; 90050801

DR   IFO; IFO50014

DR   IZSLER; BS CL 63

DR   JCRB; JCRB9028

DR   KCB; KCB 90031YJ

DR   KCLB; 10022

DR   Lonza; 925

DR   NCBI_Iran; C500

DR   RCB; RCB0180

RX   PubMed=5587551;

RX   PubMed=5988125;

RX   PubMed=13567776;

RX   PubMed=19941903;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MDBK

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-133.html

WW   http://microscopyu.com/moviegallery/livecellimaging/mdbk/index.html

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Doubling time: ~35 hours (DSMZ).

CC   Discontinued: ATCC; CRL-6071; true.

OX   NCBI_TaxID=9913; ! Bos taurus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDBK clone 955-1

AC   CVCL_DD20

RX   PubMed=5988125;

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_0421 ! MDBK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDBK clone 958-9

AC   CVCL_DD21

RX   PubMed=5988125;

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_0421 ! MDBK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDBK-Bu100

AC   CVCL_4541

SY   MDBK(BU 100); MDBK(BU100)

DR   CLO; CLO_0007644

DR   CLDB; cl5228

DR   IZSLER; BS CL 118

RX   PubMed=2824831;

CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_0421 ! MDBK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDBK-NST

AC   CVCL_E073

DR   CLO; CLO_0050864

DR   RCB; RCB1859

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_0421 ! MDBK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDBK-PES

AC   CVCL_0I74

DR   CCLV; CCLV-RIE 0154

RX   PubMed=25565633;

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_0421 ! MDBK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDBK.P3

AC   CVCL_3021

DR   JCRB; JCRB0716

OX   NCBI_TaxID=9913; ! Bos taurus

HI   CVCL_0421 ! MDBK

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDCC-3867K

AC   CVCL_6E15

SY   3867K

RX   PubMed=26612074;

CC   Group: Bird cell line.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-AL1

AC   CVCL_T748

SY   AL1

RX   PubMed=7390658;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-AL2

AC   CVCL_U116

SY   AL2

RX   PubMed=7390658;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-AL3

AC   CVCL_U117

SY   AL3

RX   PubMed=7390658;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-BMCL2-1C10

AC   CVCL_T649

RX   CelloPub=CLPUB00078;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-BMCL2-1C2

AC   CVCL_T650

RX   CelloPub=CLPUB00078;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-BMCL2-20C1

AC   CVCL_T651

RX   CelloPub=CLPUB00078;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-BP1

AC   CVCL_T645

SY   JMV-YS-1

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-BP2

AC   CVCL_T646

SY   JMV-YS-2

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-BP3

AC   CVCL_T647

SY   JMV-YS-3

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-BP4

AC   CVCL_T648

SY   JMV-YS-4

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-HP10

AC   CVCL_T607

SY   HP10

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP11

AC   CVCL_T608

SY   HP11

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP12

AC   CVCL_T609

SY   HP12

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP13

AC   CVCL_T610

SY   HP13

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP14

AC   CVCL_T611

SY   HP14

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP15

AC   CVCL_T612

SY   HP15

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP16

AC   CVCL_T613

SY   HP16

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP17

AC   CVCL_T614

SY   HP17

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP18

AC   CVCL_T615

SY   HP18

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP19

AC   CVCL_T616

SY   HP19

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-HP20

AC   CVCL_T617

SY   HP20

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP21

AC   CVCL_T618

SY   HP21

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP22

AC   CVCL_T619

SY   HP22

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP23

AC   CVCL_T620

SY   HP23

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP24

AC   CVCL_T621

SY   HP24

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-HP25

AC   CVCL_T622

SY   HP25

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP26

AC   CVCL_T623

SY   HP26

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP27

AC   CVCL_T624

SY   HP27

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-HP28

AC   CVCL_T625

SY   HP28

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP29

AC   CVCL_T626

SY   HP29

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP3

AC   CVCL_T600

SY   HP3

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP30

AC   CVCL_T627

SY   HP30

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP31

AC   CVCL_T628

SY   HP31

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-HP4

AC   CVCL_T601

SY   HP4

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP5

AC   CVCL_T602

SY   HP5

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP6

AC   CVCL_T603

SY   HP6

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP7

AC   CVCL_T604

SY   HP7

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP8

AC   CVCL_T605

SY   HP8

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-HP9

AC   CVCL_T606

SY   HP9

RX   PubMed=7199514;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-JM-1

AC   CVCL_T448

SY   JM-1

RX   PubMed=208974;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-JMV-1

AC   CVCL_T449

SY   JMV-1

DR   ATCC; CRL-9093

RX   Patent=EP0244760A2;

RX   PubMed=208974;

RX   PubMed=18670936;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

CC   Discontinued: ATCC; CRL-9093; probable.

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-JP1

AC   CVCL_8459

SY   JP-1; JP1; MOGA-1

RX   PubMed=231432;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-JP2

AC   CVCL_8460

SY   JP-2; JP2; MOGA-2

RX   PubMed=231432;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-LS1

AC   CVCL_H687

SY   LS1; MKT-1

RX   PubMed=209622;

RX   PubMed=225531;

RX   PubMed=6251256;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

CA   Cancer cell line

//

ID   MDCC-MOB1

AC   CVCL_8456

SY   MDCC-MOB-1; MOB-1; MOB1

RX   PubMed=69431;

RX   PubMed=180968;

RX   PubMed=4596339;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-MOB2

AC   CVCL_8457

SY   MDCC-MOB-2; MOB-2; MOB2

RX   PubMed=69431;

RX   PubMed=180968;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-MOB3

AC   CVCL_8458

SY   MDCC-MOB-3; MOB-3; MOB3

RX   PubMed=69431;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-MSB1

AC   CVCL_4542

SY   MDCC MSB1; MDCC-MSB-1; MSB-1; MSB1

DR   CLO; CLO_0007645

DR   EFO; EFO_0002659

DR   CLDB; cl5229

DR   CLS; 601413/p659_MDCC-MSB1

DR   IZSLER; BS TCL 7

RX   PubMed=69431;

RX   PubMed=163334;

RX   PubMed=180968;

RX   PubMed=18766641;

WW   http://www.rccc.cytspb.rssi.ru/ecellbank/animal/amdcc.htm

CC   Group: Bird cell line.

CC   Doubling time: 8-10 hours (PubMed=163334).

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-MSB1-33C

AC   CVCL_T660

RX   PubMed=6628902;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

HI   CVCL_4542 ! MDCC-MSB1

SX   Female

CA   Cancer cell line

//

ID   MDCC-MSB1-41C

AC   CVCL_T661

RX   PubMed=6628902;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

HI   CVCL_4542 ! MDCC-MSB1

SX   Female

CA   Cancer cell line

//

ID   MDCC-MSB1-Clo. 18

AC   CVCL_T662

SY   MDCC-MSB1-CLO

RX   PubMed=6090745;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

HI   CVCL_4542 ! MDCC-MSB1

SX   Female

CA   Cancer cell line

//

ID   MDCC-PA5

AC   CVCL_T629

SY   PA5

RX   PubMed=2433209;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-PA9

AC   CVCL_T630

SY   PA9

RX   PubMed=2433209;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-RP1

AC   CVCL_T461

SY   MDCC-RP-1; MDCC-RP 1; RP-1; RP1; RPL1; RPL-1

RX   PubMed=190995;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-RP2

AC   CVCL_T462

SY   MCL-R2; RP-2; RP2

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-RP22

AC   CVCL_T652

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-RP23

AC   CVCL_T653

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-RP24

AC   CVCL_T654

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-RP25

AC   CVCL_T655

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-RP26

AC   CVCL_T656

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-RP27

AC   CVCL_T657

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-RP28

AC   CVCL_T658

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-RP29

AC   CVCL_T659

RX   PubMed=6314315;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Male

CA   Cancer cell line

//

ID   MDCC-RP4

AC   CVCL_T463

SY   MDCC-RP-4; RP-4; RP4

RX   PubMed=6326737;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Cancer cell line

//

ID   MDCC-TV1

AC   CVCL_R816

SY   TV-1; TV1

RX   PubMed=226481;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 11636; Reticuloendotheliosis virus (REV) [Strain T].

CC   Breed/subspecies: White Leghorn SPAFAS.

OX   NCBI_TaxID=9031; ! Gallus gallus

SX   Female

CA   Transformed cell line

//

ID   MDCK

AC   CVCL_0422

SY   MDCK (NBL-2); NBL-2; Madin-Darby Canine Kidney; Madin Darby Canine Kidney

DR   BTO; BTO:0000837

DR   CLO; CLO_0007646

DR   CLO; CLO_0007647

DR   CLO; CLO_0050861

DR   MCCL; MCC:0000319

DR   CLDB; cl3417

DR   CLDB; cl3418

DR   CLDB; cl3419

DR   CLDB; cl3420

DR   CLDB; cl3421

DR   CLDB; cl3422

DR   CLDB; cl3423

DR   CLDB; cl3424

DR   CLDB; cl3425

DR   ATCC; CCL-34

DR   ATCC; CRL-6253

DR   BCRC; 60004

DR   BCRJ; 0168

DR   CCLV; CCLV-RIE 0083

DR   CCRID; 3111C0001CCC000078

DR   CCRID; 3111C0002000000045

DR   CCRID; 3131C0001000400014

DR   CCRID; 3131C0001000400024

DR   CCRID; 3142C0001000000012

DR   CCRID; 3142C0001000000149

DR   ChEMBL-Cells; CHEMBL3308370

DR   ChEMBL-Targets; CHEMBL614068

DR   CLS; 602280/p823_MDCK_(NBL-2)

DR   ECACC; 02050101

DR   ECACC; 84121903

DR   ECACC; 85011435

DR   IFO; IFO50071

DR   IZSLER; BS CL 64

DR   JCRB; JCRB9029

DR   KCB; KCB 2006105YJ

DR   KCLB; 10034

DR   Lonza; 153

DR   NCBI_Iran; C426

DR   MeSH; D061985

DR   RCB; RCB0995

DR   TOKU-E; 2403

DR   TOKU-E; 3636

DR   Wikidata; Q28335011

RX   PubMed=5918973;

RX   PubMed=19941903;

RX   PubMed=21819694;

RX   PubMed=21982418;

RX   PubMed=24058646;

RX   PubMed=25903999;

WW   http://www.atcc.org/support/faqs/5889f/Morphology%20of%20ATCC%20CCL34%20MDCK-444.aspx

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mdck/mdckcells.html

WW   http://en.vircell.com/products/mdck-cell-line/

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-89.html

CC   Group: Vaccine production cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Caution: There seems to be two distinct cell lines which were assigned NCBI_Iran catalog number C426.

CC   Discontinued: ATCC; CRL-6253; true.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK 33016

AC   CVCL_2A36

SY   MDCK-33016

RX   Patent=US6455298;

RX   PubMed=18485545;

CC   Group: Vaccine production cell line.

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-2219.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK 33016-PF

AC   CVCL_2A37

SY   MDCK 33016 PF; MDCK 33016PF; MDCK-33016PF; MDCK subline 33016-PF

RX   PubMed=20071567;

CC   Group: Vaccine production cell line.

CC   Biotechnology: Used for the production of the influenza vaccine Optaflu.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_2A36 ! MDCK 33016

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK 9B9-1B1

AC   CVCL_DF69

DR   ATCC; PTA-7909

RX   Patent=US8846032;

CC   Group: Vaccine production cell line.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK 9B9-1E4

AC   CVCL_DF70

DR   ATCC; PTA-7910

RX   Patent=US8846032;

RX   PubMed=20307595;

RX   PubMed=22902973;

CC   Group: Vaccine production cell line.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK Sky1023

AC   CVCL_AP67

RX   Patent=US9447383;

CC   Group: Vaccine production cell line.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK Sky10234

AC   CVCL_AP68

RX   Patent=US9447383;

CC   Group: Vaccine production cell line.

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3114.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK Sky3851

AC   CVCL_AP69

RX   Patent=US9447383;

CC   Group: Vaccine production cell line.

CC   Registration: International Depositary Authority, Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); ACC-3113.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK Tet-Off

AC   CVCL_V359

WW   http://www.clontech.com/US/Products/Inducible_Systems/Tetracycline-Inducible_Expression/Tet-Off_Cell_Lines

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-AD

AC   CVCL_K177

DR   CLO; CLO_0050862

DR   RCB; RCB2611

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-B-702

AC   CVCL_AP66

SY   B-702

RX   Patent=US6825036;

CC   Group: Vaccine production cell line.

CC   Registration: International Depositary Authority, Japanese National Institute of Bioscience and Human-Technology, Agency of Industrial Science and Technology; FERM BP-7449.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-C11

AC   CVCL_AP70

RX   PubMed=7790388;

RX   PubMed=7971172;

RX   PubMed=11211115;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-C7

AC   CVCL_0423

DR   MCCL; MCC:0000320

DR   Lonza; 688

RX   PubMed=7790388;

RX   PubMed=7971172;

RX   PubMed=10864013;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-chAbcb1

AC   CVCL_DF31

RX   PubMed=27234533;

CC   Transfected with: UniProtKB; F1NKW0; Chicken ABCB1.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-E [Korea]

AC   CVCL_AQ31

SY   MDCK-epithelial-like

RX   CelloPub=CLPUB00313;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-E [Taiwan]

AC   CVCL_Y089

DR   BCRC; 60567

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-F

AC   CVCL_AP75

SY   MDCK-fibroblast-like

RX   CelloPub=CLPUB00313;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-I

AC   CVCL_0592

SY   MDCK I; MDCK1; MDCK-1

DR   BTO; BTO:0004606

DR   CLO; CLO_0007649

DR   ECACC; 00062106

RX   PubMed=21982418;

RX   PubMed=24975811;

CC   Group: Vaccine production cell line.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-II

AC   CVCL_0424

SY   MDCK II; MDCKII; MDCK2; MDCK-2

DR   BTO; BTO:0004607

DR   MCCL; MCC:0000321

DR   CCLV; CCLV-RIE 1061

DR   ChEMBL-Cells; CHEMBL3308862

DR   ECACC; 00062107

DR   Lonza; 811

RX   PubMed=19941903;

RX   PubMed=21982418;

RX   PubMed=24975811;

CC   Group: Vaccine production cell line.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-MDR1

AC   CVCL_S586

SY   MDCK MDR1; MDCKII-MRP1; MDCKII-MDR1; MDCKII x ABCB1-Neo

DR   BTO; BTO:0005423

RX   PubMed=9426231;

RX   PubMed=12134945;

RX   PubMed=16749865;

WW   http://www.creativecell.hu/cell-line_rtu_abc.html

CC   Transfected with: HGNC; 40; ABCB1.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0424 ! MDCK-II

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-MRP2

AC   CVCL_X022

SY   MDCKII-MRP2; MDCKII-MOAT17

RX   PubMed=9525973;

RX   PubMed=12134946;

CC   Transfected with: HGNC; 53; ABCC2.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0424 ! MDCK-II

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-S

AC   CVCL_IQ72

DR   ATCC; PTA-6500

RX   Patent=US7670837;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-SF101

AC   CVCL_IQ73

SY   MDCK-SF 101

DR   ATCC; PTA-6501

RX   Patent=US7670837;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-SF102

AC   CVCL_IQ74

SY   MDCK-SF 102

DR   ATCC; PTA-6502

RX   Patent=US7670837;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-SF103

AC   CVCL_IQ75

SY   MDCK-SF 103

DR   ATCC; PTA-6503

RX   Patent=US7670837;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK-SIAT1

AC   CVCL_Z936

DR   ECACC; 05071502

RX   PubMed=12857911;

WW   http://en.vircell.com/products/mdck-siat1-cell-line/

CC   Transfected with: HGNC; 10860; ST6GAL1.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK.1

AC   CVCL_B033

DR   ATCC; CRL-2935

DR   BCRJ; 0169

RX   PubMed=21982418;

WW   http://www.atcc.org/support/faqs/5bd5e/MDCK%20Cells%20Clonal%20Deriviatives-744.aspx

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK.2

AC   CVCL_B034

DR   ATCC; CRL-2936

DR   BCRJ; 0170

RX   PubMed=21982418;

WW   http://www.atcc.org/support/faqs/5bd5e/MDCK%20Cells%20Clonal%20Deriviatives-744.aspx

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK.5F1

AC   CVCL_DE56

SY   BV-5F1; BV5F1

DR   ATCC; CRL-12042

RX   Patent=US20080254067;

RX   PubMed=10494965;

CC   Group: Vaccine production cell line.

CC   Discontinued: ATCC; CRL-12042; probable.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK.P3

AC   CVCL_2586

DR   JCRB; JCRB0717

RX   PubMed=21982418;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCK/60

AC   CVCL_K241

SY   MDCK 60

DR   BCRJ; 0171

RX   PubMed=10738110;

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0422 ! MDCK

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCKII-MRP2/UGT1A1

AC   CVCL_9U72

SY   MDCKII-UGT1A1/MRP2

RX   PubMed=26833852;

CC   Transfected with: HGNC; 53; ABCC2.

CC   Transfected with: HGNC; 12530; UGT1A1.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_X022 ! MDCK-MRP2

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDCKts.src

AC   CVCL_GZ12

SY   MDCKts.src, cl2; ts-src MDCK clone ts-31-2

DR   TOKU-E; 4072

RX   PubMed=8425900;

CC   Transfected with: UniProtKB; P00524; Avian leukosis virus RSA v-Src.

CC   Breed/subspecies: Cocker Spaniel.

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

HI   CVCL_0592 ! MDCK-I

SX   Female

CA   Spontaneously immortalized cell line

//

ID   mDD1

AC   CVCL_9T74

SY   mouse Ductus Deferens 1

RX   PubMed=11850199;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mDD2

AC   CVCL_9T75

SY   mouse Ductus Deferens 2

RX   PubMed=11850199;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   MDEC-07114

AC   CVCL_IM31

RX   CelloPub=CLPUB00364;

CC   Group: Insect cell line.

CC   Doubling time: 44 hours (CelloPub=CLPUB00364).

OX   NCBI_TaxID=7370; ! Musca domestica

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MDG2.1

AC   CVCL_6685

RX   PubMed=8143903;

RX   PubMed=15541573;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9823; ! Sus scrofa

SX   Female

CA   Transformed cell line

//

ID   MDGK

AC   CVCL_U237

SY   MDG.K; Madin-Darby Goat Kidney

DR   ATCC; CRL-6280

RX   PubMed=5587551;

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6280; true.

OX   NCBI_TaxID=9925; ! Capra hircus

CA   Spontaneously immortalized cell line

//

ID   MDM2-RNB

AC   CVCL_D272

DR   IFO; IFO50490

RX   PubMed=8895524;

CC   Transfected with: HGNC; 6973; MDM2.

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_D273 ! RNB

CA   Transformed cell line

//

ID   MDN

AC   CVCL_HX07

RX   PubMed=10583232;

RX   PubMed=16956823;

RX   PubMed=21173094;

CC   Characteristics: IL6 dependent.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDOK

AC   CVCL_2587

SY   Madin-Darby Ovine Kidney

DR   CLO; CLO_0007650

DR   CLDB; cl3427

DR   ATCC; CRL-1633

DR   BCRJ; 0172

DR   IZSLER; BS CL 65

RX   PubMed=5587551;

RX   PubMed=13567776;

WW   http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/mdok/mdokcells.html

CC   Discontinued: IZSLER; BS CL 65; probable.

OX   NCBI_TaxID=9940; ! Ovis aries

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MDPC-23

AC   CVCL_0E50

SY   MDPC 23

DR   ATCC; CRL-2537

RX   PubMed=9862224;

RX   PubMed=22770625;

CC   Discontinued: ATCC; CRL-2537; true.

CC   Breed/subspecies: CD-1.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MDR3

AC   CVCL_Z836

DR   DGRC; 8

RX   PubMed=432755;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z838 ! Kc-HP

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MDS

AC   CVCL_L807

DR   BioSample; SAMN03151806

RX   PubMed=1438250;

RX   PubMed=12592342;

RX   PubMed=19344951;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (PubMed=12592342, PubMed=19344951, PubMed=20143388).

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0065 ! Jurkat

SX   Male

CA   Cancer cell line

//

ID   MDS1r(17)-1 iPSC

AC   CVCL_DF95

SY   MDS1 iPSC clone 1

DR   GEO; GSM1274193

RX   PubMed=24413397;

DI   NCIt; C124852; Miller-Dieker syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5U19 ! GM06047

SX   Male

CA   Induced pluripotent stem cell

//

ID   MDS1r(17)-2 iPSC

AC   CVCL_DF96

SY   MDS1 iPSC clone 2

DR   GEO; GSM1274194

RX   PubMed=24413397;

DI   NCIt; C124852; Miller-Dieker syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5U19 ! GM06047

SX   Male

CA   Induced pluripotent stem cell

//

ID   MDS2-1 iPSC

AC   CVCL_DF97

SY   MDS2 iPSC clone 1

DR   GEO; GSM1274195

RX   PubMed=24413397;

DI   NCIt; C124852; Miller-Dieker syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5U20 ! GM06097

SX   Female

CA   Induced pluripotent stem cell

//

ID   MDS2-2 iPSC

AC   CVCL_DF98

DR   GEO; GSM1274196

RX   PubMed=24413397;

DI   NCIt; C124852; Miller-Dieker syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5U20 ! GM06097

SX   Female

CA   Induced pluripotent stem cell

//

ID   MDS3-1 iPSC

AC   CVCL_DF99

SY   MDS3 iPSC clone 1

RX   PubMed=24413397;

DI   NCIt; C124852; Miller-Dieker syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5U22 ! GM09208

SX   Male

CA   Induced pluripotent stem cell

//

ID   MDS3-2 iPSC

AC   CVCL_DG00

RX   PubMed=24413397;

DI   NCIt; C124852; Miller-Dieker syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5U22 ! GM09208

SX   Male

CA   Induced pluripotent stem cell

//

ID   MDS92

AC   CVCL_A647

DR   Cosmic; 690409

DR   Cosmic; 1465958

RX   PubMed=7947263;

RX   PubMed=8547120;

RX   PubMed=19344951;

DI   NCIt; C3247; Myelodysplastic syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MDST8

AC   CVCL_2588

SY   T8

DR   EFO; EFO_0006644

DR   BioSample; SAMN03473139

DR   CCLE; MDST8_LARGE_INTESTINE

DR   Cosmic; 1995502

DR   Cosmic-CLP; 1240173

DR   ECACC; 99011801

DR   GDSC; 1240173

DR   GEO; GSM206524

DR   GEO; GSM827347

DR   GEO; GSM887303

DR   GEO; GSM888378

DR   GEO; GSM1448122

DR   GEO; GSM1670088

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 10,11

ST   D16S539: 11

ST   D18S51: 16,19.3

ST   D19S433: 12,14,15

ST   D21S11: 28,31

ST   D2S1338: 23

ST   D3S1358: 16,17

ST   D5S818: 10

ST   D7S820: 8,10 (Cosmic-CLP; ECACC)

ST   D7S820: 10 (PubMed=25877200)

ST   D8S1179: 11,14

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 7,13

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 15,20

DI   NCIt; C4910; Colon carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MDTC-CU44

AC   CVCL_T663

SY   CU44

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-CU45

AC   CVCL_T664

SY   CU45

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-CU46

AC   CVCL_T665

SY   CU46

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-HP114-1

AC   CVCL_T666

SY   HP114-1

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_T667 ! MDTC-HP114-2

SX   Female

CA   Cancer cell line

//

ID   MDTC-HP114-2

AC   CVCL_T667

SY   HP114-2

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_T666 ! MDTC-HP114-1

SX   Female

CA   Cancer cell line

//

ID   MDTC-HP115

AC   CVCL_T668

SY   HP115

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-HP116

AC   CVCL_T669

SY   HP116

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-HP117

AC   CVCL_T670

SY   HP117

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-HP118

AC   CVCL_T671

SY   HP118

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-HP119

AC   CVCL_T672

SY   HP119

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-HP121

AC   CVCL_T673

SY   HP121

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-HP122

AC   CVCL_T674

SY   HP122

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-HP41-1

AC   CVCL_T675

SY   HP41-1

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_T676 ! MDTC-HP41-2

SX   Male

CA   Cancer cell line

//

ID   MDTC-HP41-2

AC   CVCL_T676

SY   HP41-2

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_T675 ! MDTC-HP41-1

SX   Male

CA   Cancer cell line

//

ID   MDTC-HP48-3

AC   CVCL_T677

SY   HP48-3

RX   PubMed=18766837;

RX   PubMed=18766641;

CC   Group: Bird cell line.

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP16

AC   CVCL_N505

SY   RP16; RP-16

RX   PubMed=6277804;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_N506 ! MDTC-RP17

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP17

AC   CVCL_N506

SY   RP17; RP-17

RX   PubMed=6277804;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_N505 ! MDTC-RP16

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP18

AC   CVCL_N507

SY   RP18; RP-18

RX   PubMed=6277804;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_2589 ! MDTC-RP19

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP19

AC   CVCL_2589

SY   MDTC RP 19; RP19; RP-19

DR   CLO; CLO_0007651

DR   CLO; CLO_0007652

DR   CLDB; cl3428

DR   ATCC; CRL-8135

DR   IZSLER; BS TCL 39

RX   Patent=US4388298;

RX   PubMed=6277804;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

OI   CVCL_N507 ! MDTC-RP18

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP30

AC   CVCL_T450

SY   RP30

RX   PubMed=2848484;

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP31

AC   CVCL_T451

SY   RP31

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

CA   Cancer cell line

//

ID   MDTC-RP32

AC   CVCL_T452

SY   RP32

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP34

AC   CVCL_T453

SY   RP34

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

CA   Cancer cell line

//

ID   MDTC-RP35

AC   CVCL_T454

SY   RP35

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

CA   Cancer cell line

//

ID   MDTC-RP36

AC   CVCL_T455

SY   RP36

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-RP37

AC   CVCL_T456

SY   RP37

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-RP38

AC   CVCL_T457

SY   RP38

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP39

AC   CVCL_T458

SY   RP39

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Male

CA   Cancer cell line

//

ID   MDTC-RP40

AC   CVCL_T459

SY   RP40

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTC-RP41

AC   CVCL_T460

SY   RP41

RX   PubMed=18766641;

CC   Group: Bird cell line.

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9103; ! Meleagris gallopavo

SX   Female

CA   Cancer cell line

//

ID   MDTF

AC   CVCL_J394

SY   Mus Dunni Tail Fibroblast

RX   PubMed=6092693;

RX   PubMed=8510216;

OX   NCBI_TaxID=254704; ! Mus terricolor

CA   Finite cell line

//

ID   MDV OU2.1

AC   CVCL_Y591

SY   OU2.1

RX   Patent=US5866117;

RX   PubMed=8553556;

RX   PubMed=9126245;

CC   Group: Bird cell line.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

OX   NCBI_TaxID=9031; ! Gallus gallus

HI   CVCL_Y589 ! CHCC-OU2

CA   Transformed cell line

//

ID   MDV OU2.2

AC   CVCL_Y590

SY   MDVOU2.2; OU2.2

DR   ATCC; CRL-11985

RX   Patent=US5866117;

RX   PubMed=8553556;

RX   PubMed=9126245;

CC   Group: Bird cell line.

CC   Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).

CC   Transformant: NCBI_TaxID; 10390; Gallid herpesvirus 2 (Marek's disease virus).

CC   Discontinued: ATCC; CRL-11985; probable.

OX   NCBI_TaxID=9031; ! Gallus gallus

HI   CVCL_Y589 ! CHCC-OU2

CA   Transformed cell line

//

ID   MDW1

AC   CVCL_S412

SY   Mdw1

RX   PubMed=6935454;

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S411 ! MDAY-D2

CA   Cancer cell line

//

ID   MDW3

AC   CVCL_S413

SY   Mdw3

RX   PubMed=6935454;

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S411 ! MDAY-D2

CA   Cancer cell line

//

ID   MDW4

AC   CVCL_S414

RX   PubMed=3858579;

RX   PubMed=6935454;

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S411 ! MDAY-D2

CA   Cancer cell line

//

ID   MDW5

AC   CVCL_S415

RX   PubMed=6935454;

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21602; Mouse lymphoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S411 ! MDAY-D2

CA   Cancer cell line

//

ID   ME [Human melanoma]

AC   CVCL_C666

RX   PubMed=11287286;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ME [Mouse]

AC   CVCL_4986

DR   CLO; CLO_0007653

DR   ATCC; CRL-6371

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6371; true.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Undefined cell line type

//

ID   ME [Mouse teratocarcinoma]

AC   CVCL_5T97

RX   PubMed=2098280;

CC   Breed/subspecies: C3H/J.

DI   NCIt; C129859; Mouse teratocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_3554 ! NE

CA   Cancer cell line

//

ID   ME 1

AC   CVCL_4987

DR   CLO; CLO_0007654

DR   ATCC; HB-119

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   ME 195

AC   CVCL_J840

SY   ME195

DR   CLO; CLO_0007658

DR   ATCC; HB-8431

RX   Patent=US4666845;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   ME 46

AC   CVCL_J842

DR   ATCC; HB-8430

RX   Patent=US4666845;

CC   Discontinued: ATCC; HB-8430; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   Me Jon

AC   CVCL_3746

DR   CLO; CLO_0007655

DR   ATCC; CRL-1288

DI   NCIt; C26837; Osteogenesis imperfecta

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Me Kam

AC   CVCL_U673

SY   XP15BE

DR   ATCC; CRL-1279

CC   Discontinued: ATCC; CRL-1279; true.

DI   NCIt; C3452; Xeroderma pigmentosum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Me Lor

AC   CVCL_U786

DR   ATCC; CRL-1368

DR   BioSample; SAMN03471359

CC   Discontinued: ATCC; CRL-1368; true.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 7.3,11

ST   D13S317: 8,10

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C34568; Ehlers-Danlos syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Me Mon

AC   CVCL_3747

DR   CLO; CLO_0007656

DR   ATCC; CRL-1342

DI   NCIt; C34568; Ehlers-Danlos syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Me Rey

AC   CVCL_U787

DR   ATCC; CRL-1346

CC   Discontinued: ATCC; CRL-1346; true.

DI   NCIt; C2887; Ataxia telangiectasia syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   Me We

AC   CVCL_U677

DR   ATCC; CRL-1194

CC   Discontinued: ATCC; CRL-1194; true.

DI   NCIt; C34568; Ehlers-Danlos syndrome

DI   NCIt; C85036; Pseudoxanthoma elasticum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   ME-1 [Human leukemia]

AC   CVCL_2110

SY   ME1

DR   EFO; EFO_0006645

DR   BioSample; SAMN03472157

DR   CCLE; ME1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 787450

DR   Cosmic; 975268

DR   Cosmic; 999732

DR   Cosmic; 1281326

DR   Cosmic; 1524833

DR   Cosmic; 2131544

DR   Cosmic; 2306217

DR   Cosmic-CLP; 1330942

DR   DSMZ; ACC-537

DR   GDSC; 1330942

DR   GEO; GSM236788

DR   GEO; GSM236824

DR   GEO; GSM887304

DR   GEO; GSM888379

DR   GEO; GSM1374666

DR   GEO; GSM1670089

DR   Lonza; 157

RX   PubMed=2070080;

RX   PubMed=15843827;

RX   PubMed=16523483;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~3-5 days (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,11

ST   D16S539: 12

ST   D18S51: 16,23

ST   D21S11: 29

ST   D3S1358: 14,16

ST   D5S818: 9,11

ST   D7S820: 10,11

ST   D8S1179: 11,14

ST   FGA: 21,25

ST   Penta D: 9

ST   Penta E: 5,11

ST   TH01: 9

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ME-1 [Human myeloma]

AC   CVCL_M535

RX   CelloPub=CLPUB00079;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me-116

AC   CVCL_C598

DR   ESTDAB; ESTDAB-122

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 11,12

ST   D3S1358: 15,17

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   FGA: 21,22

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,20

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ME-180

AC   CVCL_1401

SY   Me-180; ME 180; ME180

DR   CLO; CLO_0007657

DR   CLO; CLO_0050924

DR   EFO; EFO_0006646

DR   CLDB; cl3429

DR   ATCC; HTB-33

DR   ATCC; CRL-7932

DR   BioSample; SAMN03471125

DR   BioSample; SAMN03472007

DR   BioSample; SAMN03472511

DR   BioSample; SAMN03473047

DR   ChEMBL-Cells; CHEMBL3308114

DR   ChEMBL-Targets; CHEMBL1075499

DR   Cosmic; 687514

DR   Cosmic; 760223

DR   Cosmic; 809228

DR   Cosmic; 846185

DR   Cosmic; 877466

DR   Cosmic; 928909

DR   Cosmic; 1071909

DR   Cosmic; 1102582

DR   Cosmic; 1131524

DR   Cosmic; 1175837

DR   Cosmic; 1176609

DR   Cosmic; 1193031

DR   Cosmic; 1995503

DR   Cosmic; 2301541

DR   Cosmic; 2546868

DR   Cosmic-CLP; 687514

DR   GDSC; 687514

DR   GEO; GSM113864

DR   GEO; GSM253300

DR   GEO; GSM595618

DR   GEO; GSM675736

DR   GEO; GSM685436

DR   GEO; GSM827202

DR   GEO; GSM1670090

DR   ICLC; HTL96027

DR   IGRhCellID; ME180%20GEO

DR   JCRB; JCRB0810

DR   KCLB; 30033

DR   RCB; RCB2106

DR   TKG; TKG 0437

DR   TOKU-E; 2410

RX   DOI=10.1007/978-1-4757-1647-4_13;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=2990217;

RX   PubMed=3371749;

RX   PubMed=4317734;

RX   PubMed=6500159;

RX   PubMed=6582512;

RX   PubMed=7459858;

RX   PubMed=7751322;

RX   PubMed=8931502;

RX   PubMed=9290701;

RX   PubMed=15531914;

RX   PubMed=17325662;

RX   PubMed=22710073;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=27561551;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-612.html

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Characteristics: Contains a complete HPV68 genome.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 45240; Human papillomavirus type 68 (HPV68).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Discontinued: ATCC; CRL-7932; true.

CC   Derived from metastatic site: Omentum.

ST   Source(s): ATCC; Cosmic-CLP; JCRB; KCLB; PubMed=22710073; PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,13 (ATCC; Cosmic-CLP; JCRB; KCLB; PubMed=25877200; RCB; TKG)

ST   D13S317: 11,12 (PubMed=22710073)

ST   D16S539: 12,13

ST   D18S51: 12

ST   D19S433: 13,15.2

ST   D21S11: 30,31

ST   D2S1338: 18

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 9,10

ST   D8S1179: 14

ST   FGA: 23

ST   Penta D: 9,14

ST   Penta E: 12,14

ST   TH01: 8,9.3 (ATCC; Cosmic-CLP; JCRB; KCLB; PubMed=22710073; PubMed=25877200; TKG)

ST   TH01: 8 (RCB)

ST   TPOX: 8,10

ST   vWA: 15,17 (ATCC; Cosmic-CLP; KCLB; PubMed=22710073; PubMed=25877200; RCB; TKG)

ST   vWA: 15,16,17 (JCRB)

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ME-F1

AC   CVCL_G312

RX   PubMed=8018932;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2110 ! ME-1 [Human leukemia]

SX   Male

CA   Cancer cell line

//

ID   ME-F2

AC   CVCL_G313

RX   PubMed=8018932;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2110 ! ME-1 [Human leukemia]

SX   Male

CA   Cancer cell line

//

ID   ME-F2/ADM100

AC   CVCL_G315

RX   PubMed=9177449;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_G313 ! ME-F2

SX   Male

CA   Cancer cell line

//

ID   ME-F2/ADM200

AC   CVCL_G316

RX   PubMed=9177449;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_G313 ! ME-F2

SX   Male

CA   Cancer cell line

//

ID   ME-F3

AC   CVCL_G314

RX   PubMed=8018932;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2110 ! ME-1 [Human leukemia]

SX   Male

CA   Cancer cell line

//

ID   ME1

AC   CVCL_L911

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME10

AC   CVCL_L917

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me1007

AC   CVCL_C668

SY   ME1007; ME-1007; Mel-007; Mel007; INT-MEL-20

DR   BTO; BTO:0005711

DR   Cosmic; 889005

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=2469723;

RX   PubMed=7520026;

RX   PubMed=8980186;

RX   PubMed=9725211;

RX   PubMed=15048078;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Me10221

AC   CVCL_HE43

SY   Me 10221; INT-MEL-50

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Me10258

AC   CVCL_HF01

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me10538

AC   CVCL_A648

SY   ME10538; Me 10538; Me1053/8; 10538; INT-MEL-12

DR   Cosmic; 889006

DR   Cosmic; 928710

DR   Cosmic; 1211153

DR   GEO; GSM1403082

DR   GEO; GSM1403083

DR   GEO; GSM1403084

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=2469723;

RX   PubMed=2776368;

RX   PubMed=7520026;

RX   PubMed=8459226;

RX   PubMed=8980186;

RX   PubMed=9354451;

RX   PubMed=9725211;

RX   PubMed=9973437;

RX   PubMed=15048078;

RX   PubMed=25576923;

CC   Misspelling: Occasionally 'ME10358'.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C690 ! LCL10538

SX   Female

CA   Cancer cell line

//

ID   Me11-TG6

AC   CVCL_G351

DR   ECACC; 11120838

CC   Breed/subspecies: PVG/c.

DI   NCIt; C60453; Rat malignant mesothelioma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   Me1274

AC   CVCL_HF02

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me13294

AC   CVCL_HE36

SY   Me1329/4; INT-MEL-11

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Me1340

AC   CVCL_C669

RX   PubMed=8459226;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me13443

AC   CVCL_C670

SY   13443-Mel; MI13443-MEL; Mi13443; INT-MEL-23

DR   Cosmic; 1295338

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=8459226;

WW   http://methdb.igh.cnrs.fr/FMPro?-DB=Tissue&-lay=Eingabe&-Format=tissue.html&-op=bw&tissue===MI13443-MEL%20cells&-Find

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me13923

AC   CVCL_HE94

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me13924

AC   CVCL_C671

RX   PubMed=8459226;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me1402

AC   CVCL_C672

SY   ME1402; Me 1402; Me1402/R; Me1402r; Me1402/P

DR   Cosmic; 720625

DR   Cosmic; 889007

DR   Cosmic; 928698

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=2469723;

RX   PubMed=2776368;

RX   PubMed=7520026;

RX   PubMed=8459226;

RX   PubMed=9354451;

RX   PubMed=9973437;

RX   PubMed=15048078;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me14362

AC   CVCL_HF03

SY   Me#14362

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me14464

AC   CVCL_HF04

SY   14464

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=25576923;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me14932

AC   CVCL_C673

SY   Me1493/2; INT-MEL-19

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=8459226;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ME15.C2

AC   CVCL_5999

RX   PubMed=1905566;

CC   Transformant: MYC.

CC   Breed/subspecies: CBA.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Me1509

AC   CVCL_HE40

SY   INT-MEL-43

RX   DOI=10.1007/0-306-46872-7_16;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Me15094

AC   CVCL_HF05

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Derived from metastatic site: Soft tissue.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me15392

AC   CVCL_C604

SY   Me-15392; Me 15392; 15392; 15392M

DR   Cosmic; 2163824

DR   ESTDAB; ESTDAB-114

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9973437;

RX   PubMed=22553342;

RX   PubMed=25576923;

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 9

ST   D3S1358: 17

ST   D5S818: 14

ST   D7S820: 9,10

ST   FGA: 22

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_HE34 ! LCL15392

CA   Cancer cell line

//

ID   Me15479

AC   CVCL_HF06

RX   PubMed=22553342;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME16

AC   CVCL_L918

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me16938

AC   CVCL_C674

SY   Me1693/8; INT-MEL-39

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=8459226;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ME17 [Human melanoma]

AC   CVCL_L919

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME17 [Mouse fetal erythroid]

AC   CVCL_6000

RX   PubMed=1905566;

CC   Transformant: MYC.

CC   Breed/subspecies: CBA.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Me17-TG6

AC   CVCL_G352

DR   ECACC; 11120837

CC   Breed/subspecies: PVG/c.

DI   NCIt; C60453; Rat malignant mesothelioma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   Me17088/1

AC   CVCL_V024

RX   PubMed=9743519;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me17697

AC   CVCL_V019

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9743519;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME18

AC   CVCL_L920

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me1811

AC   CVCL_C675

SY   ME1811; Me 1811

RX   PubMed=8459226;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C689 ! LCL1811

CA   Cancer cell line

//

ID   Me18588

AC   CVCL_HE45

SY   Me1858/8; INT-MEL-10

RX   DOI=10.1007/0-306-46872-7_16;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Me18656

AC   CVCL_HF07

SY   18656

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

RX   PubMed=25576923;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me18732

AC   CVCL_C676

SY   18732

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=8459226;

RX   PubMed=9743519;

RX   PubMed=25576923;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me18816

AC   CVCL_HF08

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME19

AC   CVCL_L921

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me19-TG2

AC   CVCL_G353

DR   ECACC; 11120836

CC   Breed/subspecies: PVG/c.

DI   NCIt; C60453; Rat malignant mesothelioma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   Me19410

AC   CVCL_HF09

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME2

AC   CVCL_L912

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME20

AC   CVCL_L922

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me20842

AC   CVCL_V020

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9743519;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_HE92 ! Me20842M1

OI   CVCL_HE93 ! Me20842M2

CA   Cancer cell line

//

ID   Me20842M1

AC   CVCL_HE92

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V020 ! Me20842

OI   CVCL_HE93 ! Me20842M2

CA   Cancer cell line

//

ID   Me20842M2

AC   CVCL_HE93

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_V020 ! Me20842

OI   CVCL_HE92 ! Me20842M1

CA   Cancer cell line

//

ID   ME21

AC   CVCL_L923

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me21158

AC   CVCL_HE95

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME22

AC   CVCL_L924

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me2211

AC   CVCL_HF10

SY   Me#2211

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME23

AC   CVCL_L925

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me23526

AC   CVCL_HF11

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Misspelling: 'Me2352' in DOI=10.13130/grazia-giulia_phd2016-02-18.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me23682

AC   CVCL_HF12

DR   GEO; GSE34686

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me2559/1

AC   CVCL_V025

SY   Me2559

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9743519;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me26635

AC   CVCL_HF13

DR   GEO; GSM1403055

DR   GEO; GSM1403056

DR   GEO; GSM1403057

DR   GEO; GSM1403058

DR   GEO; GSM1403059

DR   GEO; GSM1403060

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me28

AC   CVCL_HE39

SY   Me 28; Melanoma 28

RX   PubMed=3121738;

RX   PubMed=3158614;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me29318

AC   CVCL_HF14

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me2934

AC   CVCL_HE96

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me3044

AC   CVCL_HF15

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Soft tissue.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me3046

AC   CVCL_HE42

SY   INT-MEL-8

RX   DOI=10.1007/0-306-46872-7_16;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Me3046/2

AC   CVCL_C677

RX   PubMed=8459226;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_HE42 ! Me3046

SX   Male

CA   Cancer cell line

//

ID   Me3068

AC   CVCL_C678

SY   ME3068

RX   PubMed=2469723;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me32562

AC   CVCL_HF16

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me32669

AC   CVCL_HF17

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME361

AC   CVCL_J760

SY   ME 361

DR   ATCC; HB-9325

RX   Patent=US4849509;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   ME361-S2a

AC   CVCL_J761

SY   ME 361-S2a; ME361S2a

DR   CLO; CLO_0007659

DR   ATCC; HB-9326

RX   Patent=US4849509;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   Me3700

AC   CVCL_HE97

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me4023

AC   CVCL_V021

SY   4023

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9743519;

RX   PubMed=25576923;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me4024

AC   CVCL_C679

SY   INT-MEL-52

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=8459226;

RX   PubMed=9973437;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Me4024/1

AC   CVCL_V022

SY   Me 4024/1

DR   Cosmic; 720623

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C679 ! Me4024

SX   Female

CA   Cancer cell line

//

ID   Me4024/2

AC   CVCL_V023

SY   Me 4024/2

DR   Cosmic; 720624

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_C679 ! Me4024

SX   Female

CA   Cancer cell line

//

ID   Me43

AC   CVCL_C665

SY   ME43 ME-43; Me-43

RX   PubMed=6746112;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me4405

AC   CVCL_C680

SY   ME4405; ME-4405; INT-MEL-17

DR   BTO; BTO:0005716

DR   Cosmic; 889008

DR   Cosmic; 929202

DR   GEO; GSM1403049

DR   GEO; GSM1403050

DR   GEO; GSM1403051

DR   GEO; GSM1403052

DR   GEO; GSM1403053

DR   GEO; GSM1403054

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=7520026;

RX   PubMed=8459226;

RX   PubMed=8980186;

RX   PubMed=9725211;

RX   PubMed=10338330;

RX   PubMed=15048078;

RX   PubMed=22553342;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C688 ! LCL4405

SX   Female

CA   Cancer cell line

//

ID   Me4473

AC   CVCL_HE98

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me45

AC   CVCL_K048

SY   Me-45

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=87

CC   From: Department of Radiobiology; M. Sklodowska-Curie Cancer Centre and Institute of Oncology; Gliwice; Poland.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Me4686

AC   CVCL_HE99

SY   4686

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=9973437;

RX   PubMed=25576923;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me4840

AC   CVCL_HE35

SY   INT-MEL-9

RX   DOI=10.1007/0-306-46872-7_16;

CC   Derived from metastatic site: Omentum.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Me4855

AC   CVCL_C681

RX   PubMed=8459226;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME5

AC   CVCL_L913

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me5810

AC   CVCL_C682

SY   Me5810/P; INT-MEL-1

DR   Cosmic; 720626

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=8459226;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C687 ! LCL5810

SX   Female

CA   Cancer cell line

//

ID   Me665/1

AC   CVCL_C667

SY   Me 665/1; 665/1; INT-MEL-60/1

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=2469723;

RX   PubMed=2776368;

RX   PubMed=8459226;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_7077 ! Me665/2

OI   CVCL_HE41 ! Me665/3

SX   Female

CA   Cancer cell line

//

ID   Me665/2

AC   CVCL_7077

AS   CVCL_4725

SY   ME665/2; Me 665/2; 665/2; INT-MEL-60/2

DR   BTO; BTO:0003270

DR   CLO; CLO_0001453

DR   CLDB; cl114

DR   CLDB; cl115

DR   GEO; GSM1403064

DR   GEO; GSM1403065

DR   GEO; GSM1403066

DR   Cosmic; 720621

DR   Cosmic; 1026920

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=2469723;

RX   PubMed=2776368;

RX   PubMed=25576923;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C667 ! Me665/1

OI   CVCL_HE41 ! Me665/3

SX   Female

CA   Cancer cell line

//

ID   Me665/2/21

AC   CVCL_7078

SY   665/2/21

DR   BTO; BTO:0005069

DR   ChEMBL-Cells; CHEMBL3307371

DR   ChEMBL-Targets; CHEMBL614339

DR   TOKU-E; 4285

RX   PubMed=10893182;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7077 ! Me665/2

SX   Female

CA   Cancer cell line

//

ID   Me665/2/60

AC   CVCL_7079

DR   BTO; BTO:0005070

RX   PubMed=10893182;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7077 ! Me665/2

SX   Female

CA   Cancer cell line

//

ID   Me665/3

AC   CVCL_HE41

SY   INT-MEL-60/3

RX   DOI=10.1007/0-306-46872-7_16;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C667 ! Me665/1

OI   CVCL_7077 ! Me665/2

SX   Female

CA   Cancer cell line

//

ID   Me665/R

AC   CVCL_W187

SY   Me 665/R

RX   PubMed=2469723;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_7077 ! Me665/2

SX   Female

CA   Cancer cell line

//

ID   Me6824

AC   CVCL_HF18

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

CC   Derived from metastatic site: Subcutaneous nodules.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME7

AC   CVCL_L914

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ME8

AC   CVCL_L915

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me8530

AC   CVCL_HE44

SY   Me 8530

RX   PubMed=9973437;

RX   PubMed=22553342;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me879

AC   CVCL_HF19

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   PubMed=22553342;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me8959

AC   CVCL_C683

SY   INT-MEL-13

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=8459226;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   ME9

AC   CVCL_L916

RX   PubMed=19001446;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me9-TG3

AC   CVCL_G354

SY   Me9/TG3

DR   ECACC; 11120841

RX   PubMed=7150478;

CC   Breed/subspecies: PVG/c.

DI   NCIt; C60453; Rat malignant mesothelioma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   Me9229

AC   CVCL_F249

SY   Me 9229; 9229; Melanoma 9229; INT-MEL-58

DR   CLO; CLO_0001014

DR   CLDB; cl139

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=2469723;

RX   PubMed=3121738;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Me9229/18

AC   CVCL_HE38

RX   PubMed=3121738;

RX   PubMed=7607705;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F249 ! Me9229

SX   Male

CA   Cancer cell line

//

ID   Me9460

AC   CVCL_C684

RX   PubMed=8459226;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Me9742

AC   CVCL_C685

SY   ME9742

RX   PubMed=8459226;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C686 ! LCL9742

CA   Cancer cell line

//

ID   Me9874

AC   CVCL_HE33

SY   ME9874; INT-MEL-4

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   DOI=10.1007/0-306-46872-7_16;

RX   PubMed=9973437;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Me9923/M

AC   CVCL_HE37

SY   INT-MEL-16/2

RX   DOI=10.1007/0-306-46872-7_16;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_F250 ! Me9923/P

SX   Female

CA   Cancer cell line

//

ID   Me9923/P

AC   CVCL_F250

SY   Me9923p; Me9923; Me 9923; 9923; INT-MEL-16/1

DR   CLO; CLO_0001015

DR   CLDB; cl141

DR   Cosmic; 720622

RX   DOI=10.13130/grazia-giulia_phd2016-02-18;

RX   DOI=10.1007/0-306-46872-7_16;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_HE37 ! Me9923/M

SX   Female

CA   Cancer cell line

//

ID   MEB-4

AC   CVCL_4772

SY   MEB4

DR   BTO; BTO:0001219

DR   CLO; CLO_0050761

DR   RCB; RCB1027

RX   PubMed=3053466;

RX   PubMed=8146177;

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C21790; Mouse melanoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F936 ! B16

SX   Male

CA   Cancer cell line

//

ID   MEB5

AC   CVCL_5221

SY   MEB 5; MEB-5

DR   IFO; IFO50472

DR   JCRB; JCRB0145

RX   PubMed=9719419;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MEB5

CC   Characteristics: EGF dependent. When deprived of EGF, about 50% of the cells die due to apoptosis within 24h. The remaining cells differentiated into neurons, astrncytes, or oligndendrocytes within 2 weeks.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E7].

CC   Breed/subspecies: C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MEC

AC   CVCL_B270

DR   BioSample; SAMN03472009

DR   Cosmic; 1122351

DR   RCB; RCB2129

DR   TKG; TKG 0629

RX   CelloPub=CLPUB00275;

RX   PubMed=1965684;

CC   Discontinued: RCB; RCB2129; true.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 10,14

ST   D13S317: 8,11 (RCB)

ST   D13S317: 9,11 (TKG)

ST   D16S539: 9,12

ST   D5S818: 11,13

ST   D7S820: 11 (RCB)

ST   D7S820: 9.3,11 (TKG)

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 17,18

DI   NCIt; C4436; Cholangiocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MEC-1

AC   CVCL_1870

SY   MEC1

DR   BTO; BTO:0005913

DR   EFO; EFO_0002231

DR   BioSample; SAMN03471015

DR   CCLE; MEC1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1762462

DR   DSMZ; ACC-497

DR   GDSC; 1330943

DR   GEO; GSM887305

DR   GEO; GSM888381

DR   GEO; GSM1374667

DR   GEO; GSM1670091

DR   IGRhCellID; MEC1

RX   PubMed=10071128;

RX   PubMed=22460905;

RX   PubMed=23297799;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~40 hours (DSMZ; PubMed=10071128).

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D18S51: 14

ST   D21S11: 27,29

ST   D3S1358: 15,19

ST   D5S818: 10,12

ST   D7S820: 7,11

ST   D8S1179: 13,15

ST   FGA: 21,25

ST   Penta D: 11,17

ST   Penta E: 10,12

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3163; Chronic lymphocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1871 ! MEC-2

SX   Male

CA   Cancer cell line

//

ID   MEC-2

AC   CVCL_1871

SY   MEC2

DR   BTO; BTO:0005914

DR   EFO; EFO_0006285

DR   CCLE; MEC2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   DSMZ; ACC-500

DR   GEO; GSM887306

DR   GEO; GSM888382

DR   GEO; GSM1374668

DR   GEO; GSM1670092

RX   PubMed=10071128;

RX   PubMed=19358282;

RX   PubMed=22460905;

RX   PubMed=23297799;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: 31 hours (PubMed=10071128); ~40-50 hours (DSMZ).

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D5S818: 10,12

ST   D7S820: 7,11

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C3163; Chronic lymphocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1870 ! MEC-1

SX   Male

CA   Cancer cell line

//

ID   MEC-HH

AC   CVCL_X509

RX   DOI=10.3923/javaa.2012.1166.1172;

CC   Breed/subspecies: Chinese Holstein.

OX   NCBI_TaxID=9913; ! Bos taurus

SX   Female

CA   Finite cell line

//

ID   MEC-LL

AC   CVCL_X510

RX   DOI=10.3923/javaa.2012.1166.1172;

CC   Breed/subspecies: Chinese Holstein.

OX   NCBI_TaxID=9913; ! Bos taurus

SX   Female

CA   Finite cell line

//

ID   MECA-367

AC   CVCL_9221

DR   CLO; CLO_0007662

DR   ATCC; HB-9478

RX   Patent=US5403919;

CC   Monoclonal antibody target: UniProtKB; Q61826; Mouse Madcam1.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MECA-79

AC   CVCL_9222

DR   CLO; CLO_0007663

DR   ATCC; HB-9479

RX   Patent=US5403919;

RX   PubMed=2460470;

CC   Monoclonal antibody target: Sulfated N-acetylglucosamine.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MECA-89

AC   CVCL_9223

DR   CLO; CLO_0007664

DR   ATCC; HB-292

RX   Patent=US5403919;

CC   Monoclonal antibody target: UniProtKB; Q61826; Mouse Madcam1.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MeCo 05

AC   CVCL_3403

SY   MECO

DR   CLDB; cl7181

DR   ICLC; HTL07001

RX   PubMed=23634660;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MED-MEB-8A

AC   CVCL_M137

SY   MEB-Med8A; MEBMED8A; MED8A; Med8A

DR   Cosmic; 2362657

DR   GEO; GSM919363

RX   PubMed=15793295;

RX   PubMed=16946619;

RX   PubMed=22976800;

CC   Misspelling: 'MHH-MED-8A' in Cosmic 2362657 and PubMed=16946619.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M138 ! MED-MEB-8S

SX   Male

CA   Cancer cell line

//

ID   MED-MEB-8S

AC   CVCL_M138

SY   MEBMED8S

DR   Cosmic; 2362658

RX   PubMed=15793295;

RX   PubMed=22976800;

CC   Misspelling: 'MHH-MED-8S' in Cosmic 2362658.

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_M137 ! MED-MEB-8A

SX   Male

CA   Cancer cell line

//

ID   MED17.11

AC   CVCL_4Y33

RX   PubMed=26053673;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MedB-1

AC   CVCL_A649

SY   MedB1; MEDB1

DR   Cosmic; 988832

DR   Cosmic; 1013889

DR   Cosmic; 2297036

DR   Cosmic; 2437270

DR   Cosmic; 2479247

DR   GEO; GSM119538

DR   Lonza; 197

DR   PRIDE; PXD000589

RX   PubMed=11291070;

RX   PubMed=16960149;

RX   PubMed=25894527;

CC   Omics: Cell surface proteome.

DI   NCIt; C9280; Mediastinal (thymic) large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MEDEP-BRC4-1

AC   CVCL_E139

DR   RCB; RCB2692

RX   PubMed=18253492;

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B981 ! BRC4

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   MEDEP-BRC4-2

AC   CVCL_E136

DR   RCB; RCB2932

DR   RCB; RCB2699

RX   PubMed=18253492;

CC   Discontinued: RCB; RCB2699; true.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B981 ! BRC4

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   MEDEP-BRC5

AC   CVCL_E137

SY   MEDEP-BRC-5

DR   RCB; RCB2609

DR   RCB; RCB2911

RX   DOI=10.4051/ibc.2010.2.4.0014;

RX   PubMed=18253492;

CC   Discontinued: RCB; RCB2609; true.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B982 ! BRC5

SX   Male

CA   Embryonic stem cell

//

ID   MEDEP-E14

AC   CVCL_E138

DR   RCB; RCB2660

RX   PubMed=18253492;

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9108 ! ES-E14TG2a

SX   Male

CA   Embryonic stem cell

//

ID   MEDEP-E14 clone 4

AC   CVCL_E143

DR   RCB; RCB2691

CC   Breed/subspecies: 129/Ola.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_E138 ! MEDEP-E14

SX   Male

CA   Embryonic stem cell

//

ID   MEDMC-BRC6

AC   CVCL_E140

DR   RCB; RCB2694

RX   PubMed=18253492;

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_B983 ! BRC6

SX   Female

CA   Embryonic stem cell

//

ID   MEDMC-NT2

AC   CVCL_E141

DR   RCB; RCB2693

RX   PubMed=18253492;

CC   Breed/subspecies: 129.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_E142 ! NTES-2

CA   Embryonic stem cell

//

ID   MEF (C57BL/6)

AC   CVCL_9115

SY   MEF-BL/6-1

DR   CLO; CLO_0007665

DR   ATCC; SCRC-1008

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Mixed sex

CA   Finite cell line

//

ID   MEF (C57BL/6) IRR

AC   CVCL_9117

DR   ATCC; SCRC-1008.1

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9115 ! MEF (C57BL/6)

SX   Mixed sex

CA   Finite cell line

//

ID   MEF (C57BL/6) MITC

AC   CVCL_9118

DR   ATCC; SCRC-1008.2

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9115 ! MEF (C57BL/6)

SX   Mixed sex

CA   Finite cell line

//

ID   MEF PKCe KO

AC   CVCL_AS81

SY   PKCepsilonKO

DR   Ximbio; 151665

RX   PubMed=12110574;

CC   Knockout cell: Method=KO mouse; MGI; MGI:97599; Prkce.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MEF PKCe KO KI

AC   CVCL_AS82

SY   PKCepsilonRE

DR   Ximbio; 151663

RX   PubMed=12110574;

CC   Knockout cell: Method=KO mouse; MGI; MGI:97599; Prkce.

CC   Transfected with: MGI; MGI:97599; Prkce.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_AS81 ! MEF PKCe KO

CA   Spontaneously immortalized cell line

//

ID   MEF-1 [Human myeloma]

AC   CVCL_M515

RX   PubMed=10223569;

RX   PubMed=10936422;

CC   Doubling time: ~36 hours (PubMed=10223569).

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MEF-1 [Mouse fibroblast]

AC   CVCL_4240

SY   MEF1; Mouse Embryo Fibroblast-1

DR   CLO; CLO_0007667

DR   ATCC; CRL-2214

DR   ECACC; 98061101

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: 129 x C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MEF3.8

AC   CVCL_R997

SY   Mef3.8

RX   PubMed=10485464;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MEF3.8/M32

AC   CVCL_R999

SY   MEF3.8 M32; M32

RX   PubMed=10485464;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_R997 ! MEF3.8

CA   Spontaneously immortalized cell line

//

ID   MEF3.8/T6400

AC   CVCL_R998

SY   Mef3.8/T6400; T6400

DR   ChEMBL-Cells; CHEMBL3307255

DR   ChEMBL-Targets; CHEMBL613094

RX   PubMed=10485464;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_R997 ! MEF3.8

CA   Spontaneously immortalized cell line

//

ID   MEG-01

AC   CVCL_0425

SY   Meg-01; MEG01; Meg01

DR   BTO; BTO:0002581

DR   CLO; CLO_0007668

DR   EFO; EFO_0002232

DR   MCCL; MCC:0000322

DR   CLDB; cl3432

DR   CLDB; cl3433

DR   ATCC; CRL-2021

DR   BCRC; 60238

DR   BCRJ; 0262

DR   BioSample; SAMN01821577

DR   BioSample; SAMN01821648

DR   BioSample; SAMN01821734

DR   BioSample; SAMN03471278

DR   CCLE; MEG01_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   CCRID; 3131C0001000700083

DR   ChEMBL-Cells; CHEMBL3308539

DR   ChEMBL-Targets; CHEMBL2366084

DR   Cosmic; 787503

DR   Cosmic; 908126

DR   Cosmic; 924042

DR   Cosmic; 1026578

DR   Cosmic; 1070702

DR   Cosmic; 1078723

DR   Cosmic; 1516634

DR   Cosmic; 1523830

DR   Cosmic-CLP; 908126

DR   DSMZ; ACC-364

DR   ECACC; 94012401

DR   GDSC; 908126

DR   GEO; GSM482498

DR   GEO; GSM887307

DR   GEO; GSM888383

DR   GEO; GSM1374669

DR   GEO; GSM1670093

DR   ICLC; HTL96017

DR   IFO; IFO50151

DR   IGRhCellID; MEG01

DR   Lonza; 959

RX   PubMed=2998511;

RX   PubMed=3332852;

RX   PubMed=9738977;

RX   PubMed=15843827;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~35 hours (DSMZ); 36-48 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10

ST   D13S317: 8

ST   D16S539: 9

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MEG-01s

AC   CVCL_3022

SY   MEG-01S; MEG01s

DR   BTO; BTO:0005297

DR   BioSample; SAMN03472795

DR   Cosmic; 2009519

DR   IFO; IFO50473

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 9

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0425 ! MEG-01

SX   Male

CA   Cancer cell line

//

ID   MEG-01SSF

AC   CVCL_3023

DR   IFO; IFO50294

RX   PubMed=1367286;

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8

ST   D16S539: 9

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 7,8

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3022 ! MEG-01s

SX   Male

CA   Cancer cell line

//

ID   MEG-A2

AC   CVCL_1832

DR   BioSample; SAMN03473398

DR   Cosmic; 1012086

DR   DSMZ; ACC-718

DR   IFO; IFO50478

RX   PubMed=7869773;

RX   PubMed=16408098;

CC   Doubling time: ~40 hours (DSMZ).

ST   Source(s): DSMZ; JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 8,14

ST   D16S539: 11,12

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 6,7

ST   TPOX: 8

ST   vWA: 14,16

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Meg-J

AC   CVCL_G311

SY   MEG-J; MegJ

DR   Cosmic; 919132

DR   Cosmic; 1012087

RX   PubMed=9722312;

RX   PubMed=16408098;

DI   NCIt; C3170; Acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEGAL

AC   CVCL_1833

DR   Cosmic; 787451

DR   Cosmic; 975269

DR   Cosmic; 1012088

DR   Cosmic; 1281327

DR   Cosmic; 2306218

DR   DSMZ; ACC-719

RX   PubMed=19166587;

RX   PubMed=16408098;

CC   Doubling time: ~70 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 11

ST   D5S818: 9,12

ST   D7S820: 11,12

ST   TH01: 9.3

ST   TPOX: 9

ST   vWA: 16

DI   NCIt; C3170; Acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MEGR 07

AC   CVCL_F329

DR   CLDB; cl7213

DR   ICLC; HTL07005

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   mEHE/CH5

AC   CVCL_Y275

RX   PubMed=7670562;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Mehr-80

AC   CVCL_U105

DR   NCBI_Iran; C543

RX   PubMed=15619644;

DI   NCIt; C5672; Large cell lung neuroendocrine carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel 12

AC   CVCL_0D07

SY   Melanoma-12

RX   PubMed=19147538;

RX   PubMed=19231960;

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Mel 1241

AC   CVCL_C616

SY   Mel1241; MEL1241; 1241-mel

DR   Cosmic; 876681

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel 224

AC   CVCL_U915

SY   Mel224; Melanoma cell line 224; 224

DR   Cosmic; 897738

DR   Cosmic; 1054849

DR   Cosmic; 1507622

DR   Cosmic; 2233662

RX   PubMed=12446472;

RX   PubMed=15688405;

RX   PubMed=17308088;

CC   From: Hansson J.; Karolinska Institutet; Stockholm; Sweden.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel 23

AC   CVCL_0D08

SY   Melanoma-23

RX   PubMed=19147538;

RX   PubMed=19231960;

RX   PubMed=25022346;

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Mel 36

AC   CVCL_0D09

SY   Melanoma-36

RX   PubMed=19147538;

RX   PubMed=25022346;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Mel 50

AC   CVCL_0D10

SY   Melanoma-50

RX   PubMed=19147538;

RX   PubMed=19231960;

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Mel 505

AC   CVCL_U916

SY   Mel-505; MEL-505; Mel505

DR   Cosmic; 1054844

DR   Cosmic; 1102387

DR   Cosmic; 1507609

DR   Cosmic; 2233663

RX   PubMed=17308088;

CC   From: Hansson J.; Karolinska Institutet; Stockholm; Sweden.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel 64

AC   CVCL_0D11

SY   Melanoma-64

RX   PubMed=19147538;

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Mel 69

AC   CVCL_0D12

SY   Melanoma-69

RX   PubMed=25022346;

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Mel 83

AC   CVCL_0D13

SY   Melanoma-83

RX   PubMed=25022346;

DI   NCIt; C120298; Canine melanoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   Mel 928

AC   CVCL_C694

SY   Mel928; MEL928; 928-Mel; 928-mel; 928 MEL; 928 mel; 928mel; 928MEL

DR   EFO; EFO_0006360

DR   BioSample; SAMN03471614

DR   CGH-DB; 9310-4

DR   Cosmic; 876701

DR   Cosmic; 905223

DR   Cosmic; 1295545

DR   Cosmic; 1559442

DR   GEO; GSM206441

RX   PubMed=15467732;

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 14

ST   D18S51: 12

ST   D21S11: 29,30

ST   D3S1358: 15,16

ST   D5S818: 11

ST   D7S820: 10,11

ST   D8S1179: 12,13

ST   FGA: 19

ST   Penta D: 11,13

ST   Penta E: 8,13

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel Ei

AC   CVCL_3978

SY   Ei

DR   BTO; BTO:0001672

RX   PubMed=6895502;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel Gerlach

AC   CVCL_IS37

RX   PubMed=18698037;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEL III

AC   CVCL_3850

SY   Mel III; Mel-III

DR   CLO; CLO_0007669

DR   CLDB; cl5230

DR   ATCC; CRL-6308

DR   IZSLER; BS TCL 114

DR   NCBI_Iran; C456

CC   Group: Non-human primate cell line.

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6308; true.

OX   NCBI_TaxID=9544; ! Macaca mulatta

SX   Female

CA   Cancer cell line

//

ID   Mel Ho

AC   CVCL_1402

SY   MEL HO; MEL-HO; MEL-Ho; Mel-HO; MelHo; MELHO; Ho

DR   BTO; BTO:0001587

DR   CLO; CLO_0007675

DR   EFO; EFO_0006647

DR   CLDB; cl3439

DR   BioSample; SAMN03152032

DR   BioSample; SAMN03473130

DR   BioSample; SAMN03473505

DR   CCLE; MELHO_SKIN

DR   ChEMBL-Cells; CHEMBL3308798

DR   ChEMBL-Targets; CHEMBL1075500

DR   Cosmic; 908124

DR   Cosmic; 1995504

DR   Cosmic-CLP; 908124

DR   DSMZ; ACC-62

DR   GDSC; 908124

DR   GEO; GSM887308

DR   GEO; GSM888384

DR   GEO; GSM1670094

RX   PubMed=6895502;

RX   PubMed=10508494;

RX   PubMed=20143388;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Possibly misidentified/contaminated. Shown to be identical to MEL-Wei. This cell line was reported to be isogenic with LCL-Ho (CVCL_1868) but it does not have the same STR profile (PubMed=10508494, PubMed=20143388). According to DSMZ ACC-62 it is a human female cell line.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~24 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 11

ST   D18S51: 12,16

ST   D21S11: 29

ST   D3S1358: 16,18

ST   D5S818: 12

ST   D7S820: 10,11,13 (Cosmic-CLP; DSMZ)

ST   D7S820: 10 (PubMed=25877200)

ST   D8S1179: 11,14

ST   FGA: 22,23

ST   Penta D: 8,9

ST   Penta E: 11,16

ST   TH01: 7

ST   TPOX: 8,10

ST   vWA: 14,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_3981 ! Mel Wei

SX   Female

CA   Cancer cell line

//

ID   Mel Im

AC   CVCL_3980

SY   Im

DR   BTO; BTO:0001674

RX   PubMed=6895502;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel Ju

AC   CVCL_3979

SY   Ju

DR   BTO; BTO:0001673

RX   PubMed=6895502;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel JuSo

AC   CVCL_1403

SY   MEL-Juso; MEL-JUSO; Mel-Juso; Mel Juso; MelJuSo; JuSo

DR   BTO; BTO:0001588

DR   CLO; CLO_0007676

DR   CLDB; cl3440

DR   BioSample; SAMN03471884

DR   CCLE; MELJUSO_SKIN

DR   ChEMBL-Cells; CHEMBL3308761

DR   ChEMBL-Targets; CHEMBL1075501

DR   CLS; 300282/NA

DR   Cosmic; 706091

DR   Cosmic; 888060

DR   Cosmic; 888835

DR   Cosmic; 897474

DR   Cosmic; 908125

DR   Cosmic; 1020272

DR   Cosmic; 1022285

DR   Cosmic; 1459306

DR   Cosmic; 1995505

DR   Cosmic-CLP; 908125

DR   DSMZ; ACC-74

DR   GDSC; 908125

DR   GEO; GSM887309

DR   GEO; GSM888385

DR   GEO; GSM1374670

DR   GEO; GSM1670095

RX   PubMed=2174414;

RX   PubMed=6895502;

RX   PubMed=10766161;

RX   PubMed=15009714;

RX   PubMed=18698037;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~28 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: CLS; 300282; true.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,9

ST   D16S539: 12,13

ST   D18S51: 15,18

ST   D21S11: 29

ST   D3S1358: 14,17

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   D8S1179: 9,14

ST   FGA: 22

ST   Penta D: 13

ST   Penta E: 5,13

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 16

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel Neg

AC   CVCL_3748

DR   CLO; CLO_0007670

DR   ATCC; CRL-1193

DI   NCIt; C125701; Ehlers-Danlos syndrome, type VII

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   Mel Wei

AC   CVCL_3981

SY   MEL-WEI; Wei

DR   BTO; BTO:0001675

DR   BioSample; SAMN03152033

RX   PubMed=6895502;

RX   PubMed=10508494;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Possibly contaminated/misidentified. Shown to be identical to MEL-Ho. This cell line was reported to be isogenic with LCL-Wei (CVCL_1869) but it does not have the same STR profile (PubMed=10508494, PubMed=20143388).

CC   Misspelling: Occasionally 'ME-WEI'.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1402 ! Mel Ho

SX   Female

CA   Cancer cell line

//

ID   MEL-1

AC   CVCL_B863

SY   Mel-1; Mel 1; Mel1; SCSe001-A

DR   BioSamples; SAMEA7783168

DR   hPSCreg; SCSe001-A

DR   ISCR; 510

DR   Millipore; SCC020

RX   PubMed=17572666;

WW   http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/mel-1.aspx

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=425

CC   From: Monash University; Australia.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0139.

CC   Registration: Swiss research registry; BAG-hES-IMP-0003.

CC   Registration: UK Stem Cell Bank (UKSCB); R-08-001, Steering comm. appl. SCSC04-30.

CC   Discontinued: Millipore; SCC020; true.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   MEL-14

AC   CVCL_9224

SY   MEL-14.D54

DR   CLO; CLO_0007671

DR   ATCC; HB-132

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   Mel-18

AC   CVCL_H201

SY   Mel18

DR   Cosmic; 2144975

RX   PubMed=19035443;

RX   PubMed=22578220;

CC   From: Institute for Advanced Medical Research; Keio University School of Medicine; Tokyo; Japan.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mel-2

AC   CVCL_H203

SY   Mel2

DR   Cosmic; 2144974

RX   PubMed=19035443;

RX   PubMed=22578220;

CC   From: Institute for Advanced Medical Research; Keio University School of Medicine; Tokyo; Japan.

CC   Omics: Deep exome analysis.

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C4022; Acral lentiginous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MEL-2

AC   CVCL_B864

SY   Mel-2; Mel2; MEL2; SCSe002-A

DR   hPSCreg; SCSe002-A

DR   ISCR; 511

DR   Millipore; SCC021

RX   PubMed=17572666;

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=426

CC   From: Monash University; Australia.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0140.

CC   Registration: Swiss research registry; BAG-hES-IMP-0002.

CC   Registration: UK Stem Cell Bank (UKSCB); R-08-004, Steering comm. appl. SCSC06-22.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Mel-2183

AC   CVCL_L268

SY   Mel 2183; Mel_2183; Mel2183

DR   EFO; EFO_0005706

DR   ENCODE; ENCBS255AAA

DR   GEO; GSM1008599

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/human/Mel2183_Crawford_protocol.pdf

CC   Part of: ENCODE project common cell types; tier 3.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mel-2a

AC   CVCL_A759

SY   Mel-2A; Mel 2a; Mel 2A; Mel2a; Mel2A

DR   Cosmic; 1181747

DR   Cosmic; 1221592

RX   PubMed=3485457;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MEL-3

AC   CVCL_B865

SY   Mel-3; SCSe003-A

DR   hPSCreg; SCSe003-A

DR   ISCR; 2227

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=483

CC   From: Monash University; Australia.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0141.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-21.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Mel-34

AC   CVCL_W284

SY   Mel34

DR   CGH-DB; 9286-4

DR   Cosmic; 905200

RX   PubMed=15467732;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEL-4

AC   CVCL_B866

SY   Mel-4; SCSe004-A

DR   hPSCreg; SCSe004-A

DR   ISCR; 2228

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=484

CC   From: Monash University; Australia.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-11-0142.

CC   Registration: UK Stem Cell Bank (UKSCB); Steering comm. appl. SCSC07-21.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   Mel-57

AC   CVCL_4454

SY   Mel 57; MEL 57; Mel57

DR   BTO; BTO:0002804

RX   PubMed=1918136;

RX   PubMed=2060184;

RX   PubMed=3485457;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MEL-745A cl. DR10c3

AC   CVCL_W805

SY   DR10c3; MELC DR10

DR   CLO; CLO_0007673

DR   CLDB; cl3444

RX   PubMed=177980;

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2111 ! MEL-745A cl. DS19

CA   Cancer cell line

//

ID   MEL-745A cl. DS19

AC   CVCL_2111

SY   MEL-DS19; MEL DS19; MELDS19; 745/DS19; MELC DS19; DS19; MEL

DR   BTO; BTO:0003902

DR   BTO; BTO:0004475

DR   CLO; CLO_0002823

DR   CLO; CLO_0007674

DR   EFO; EFO_0003971

DR   CLDB; cl1100

DR   CLDB; cl3445

DR   DSMZ; ACC-501

DR   ENCODE; ENCBS002NUU

DR   ENCODE; ENCBS046ENC

DR   ENCODE; ENCBS047ENC

DR   ENCODE; ENCBS048ENC

DR   ENCODE; ENCBS049ENC

DR   ENCODE; ENCBS050ENC

DR   ENCODE; ENCBS217OGM

DR   ENCODE; ENCBS243ENC

DR   ENCODE; ENCBS259BOZ

DR   ENCODE; ENCBS425KAG

DR   ENCODE; ENCBS436ELB

DR   ENCODE; ENCBS437PRW

DR   ENCODE; ENCBS588DZE

DR   ENCODE; ENCBS671NUO

DR   ENCODE; ENCBS706GHU

DR   ENCODE; ENCBS802BLF

DR   ENCODE; ENCBS870FKO

DR   ENCODE; ENCBS892CGC

DR   GEO; GSM1014191

DR   KCB; KCB 200855YJ

RX   PubMed=4527790;

CC   Part of: ENCODE project mouse cell lines.

CC   Doubling time: ~20 hours (DSMZ).

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3988 ! FLC clone 745

CA   Cancer cell line

//

ID   Mel-Ab

AC   CVCL_B425

SY   Mel-ab

DR   BTO; BTO:0003944

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MEL-AC

AC   CVCL_D549

DR   ChEMBL-Cells; CHEMBL3308636

DR   ChEMBL-Targets; CHEMBL614732

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-AT

AC   CVCL_S995

SY   Mel AT

DR   BTO; BTO:0005712

RX   PubMed=10364001;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-BH

AC   CVCL_GR36

RX   PubMed=7520026;

RX   PubMed=8980186;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-BP

AC   CVCL_GR37

RX   PubMed=7520026;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEL-c88

AC   CVCL_C188

SY   MEL c88; MEL-C88; MEL C88; C88 MEL; MEL cell line C88

RX   PubMed=279411;

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3988 ! FLC clone 745

CA   Cancer cell line

//

ID   MEL-CLS-1

AC   CVCL_5619

SY   FO-1; FO #1; FO 1

DR   BTO; BTO:0002943

DR   CLS; 300175/p647_MEL-CLS-1

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=994214;

RX   PubMed=2624919;

RX   PubMed=8537970;

RX   PubMed=15661905;

CC   Doubling time: 38 hours, at 49th passage (PubMed=994214).

CC   Derived from metastatic site: Iliac lymph node.

ST   Source(s): CLS

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 9,12

ST   D18S51: 17

ST   D21S11: 27

ST   D3S1358: 15,18

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   D8S1179: 12,14

ST   FGA: 19,23

ST   Penta D: 9

ST   Penta E: 14,17

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3802; Amelanotic melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MEL-CLS-2

AC   CVCL_6001

DR   CLS; 300283/p586_MEL-CLS-2

ST   Source(s): CLS

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,10

ST   D16S539: 11

ST   D18S51: 12,17

ST   D21S11: 29,30

ST   D3S1358: 15

ST   D5S818: 9,11

ST   D7S820: 7,10

ST   D8S1179: 15

ST   FGA: 23

ST   Penta D: 9,13

ST   Penta E: 7,11

ST   TH01: 9,9.3

ST   TPOX: 8,9

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MEL-CLS-3

AC   CVCL_6002

SY   MRI-H-221

DR   CLS; 300293/p646_MEL-CLS-3

ST   Source(s): CLS

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 10,13

ST   D18S51: 16,17

ST   D21S11: 28,31.2

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 7,10

ST   D8S1179: 12,13

ST   FGA: 21,25

ST   Penta D: 12,13

ST   Penta E: 14

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MEL-CLS-4

AC   CVCL_6003

DR   CLS; 300128/p649_MEL-CLS-4

ST   Source(s): CLS

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 11,14

ST   D21S11: 30

ST   D3S1358: 15,18

ST   D5S818: 13

ST   D7S820: 10,11

ST   D8S1179: 13,16

ST   FGA: 19,23

ST   Penta D: 13

ST   Penta E: 7,19

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mel-CV

AC   CVCL_S996

SY   Mel CV

DR   BTO; BTO:0005713

RX   PubMed=8980186;

RX   PubMed=9725211;

RX   PubMed=10364001;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-DA

AC   CVCL_GR35

RX   PubMed=7520026;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-DH

AC   CVCL_GR38

RX   PubMed=7520026;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-DO

AC   CVCL_C500

DR   ESTDAB; ESTDAB-096

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-DP

AC   CVCL_GR33

RX   PubMed=7520026;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-FC

AC   CVCL_GR39

RX   PubMed=7520026;

RX   PubMed=9725211;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-FH

AC   CVCL_D547

SY   Mel FH

DR   BTO; BTO:0005714

DR   Cosmic; 889009

RX   PubMed=7520026;

RX   PubMed=9725211;

RX   PubMed=10364001;

RX   PubMed=15048078;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-FHH

AC   CVCL_GR44

RX   PubMed=8980186;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEL-GATA-1-ER

AC   CVCL_Y480

SY   mG/ER

DR   EFO; EFO_0005480

DR   ENCODE; ENCBS212ENC

DR   ENCODE; ENCBS533WAU

RX   PubMed=14559825;

WW   http://genome.ucsc.edu/ENCODE/protocols/cell/mouse/mG-ER_Stam_protocol.pdf

CC   Part of: ENCODE project mouse cell lines.

CC   Transfected with: HGNC; 4170; GATA1.

CC   Transformant: NCBI_TaxID; 11795; Friend murine leukemia virus (FrMLV).

CC   Breed/subspecies: DBA/2.

DI   NCIt; C21895; Mouse erythroid leukemia

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2111 ! MEL-745A cl. DS19

CA   Cancer cell line

//

ID   Mel-GL

AC   CVCL_S997

SY   Mel GL

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JB

AC   CVCL_S998

SY   Mel JB

RX   PubMed=8980186;

RX   PubMed=10364001;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JC

AC   CVCL_S999

SY   Mel JC

RX   PubMed=10364001;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JD

AC   CVCL_BS80

SY   MelJD

DR   BTO; BTO:0005718

RX   PubMed=8980186;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JF

AC   CVCL_T000

SY   Mel JF

RX   PubMed=7520026;

RX   PubMed=8980186;

RX   PubMed=10364001;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JG

AC   CVCL_T001

SY   Mel JG

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JN

AC   CVCL_GR41

RX   PubMed=8980186;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JS

AC   CVCL_T002

SY   Mel JS

RX   PubMed=7520026;

RX   PubMed=8980186;

RX   PubMed=9725211;

RX   PubMed=10364001;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-JW

AC   CVCL_GR40

RX   PubMed=7520026;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-KN

AC   CVCL_T003

SY   Mel KN

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-LE

AC   CVCL_C501

SY   EST94

DR   Cosmic; 1047658

DR   Cosmic; 2163813

DR   ESTDAB; ESTDAB-094

DR   GEO; GSM156009

RX   PubMed=17260012;

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12,14

ST   D3S1358: 16

ST   D5S818: 11,13

ST   D7S820: 9,10

ST   FGA: 22,25

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 14,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mel-LG

AC   CVCL_C502

DR   Cosmic; 2163868

DR   ESTDAB; ESTDAB-098

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 10,14

ST   D3S1358: 14,16

ST   D5S818: 12,15

ST   D7S820: 10,11

ST   FGA: 19,20

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel-LT

AC   CVCL_T004

SY   Mel LT

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-MC

AC   CVCL_T005

SY   Mel MC

RX   PubMed=7520026;

RX   PubMed=8980186;

RX   PubMed=10364001;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-MI

AC   CVCL_T006

SY   Mel MI

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-MM

AC   CVCL_T007

SY   Mel MM

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-MS

AC   CVCL_T008

SY   Mel MS; MelMS

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-NG

AC   CVCL_GR42

RX   PubMed=8980186;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-NT1-00

AC   CVCL_C530

DR   Cosmic; 2163825

DR   ESTDAB; ESTDAB-115

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 9,13

ST   D13S317: 9,12

ST   D3S1358: 15

ST   D5S818: 10,11

ST   D7S820: 12

ST   FGA: 24

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mel-NT2-00

AC   CVCL_C531

DR   Cosmic; 2163815

DR   ESTDAB; ESTDAB-100

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 10,12

ST   D3S1358: 14,18

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   FGA: 20,23

ST   TH01: 6,7

ST   TPOX: 11

ST   vWA: 18,19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mel-NT3-00

AC   CVCL_C532

DR   Cosmic; 2163826

DR   ESTDAB; ESTDAB-117

ST   Source(s): ESTDAB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D3S1358: 15

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   FGA: 21,26

ST   TH01: 6

ST   TPOX: 11,12

ST   vWA: 15,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mel-NT4-00

AC   CVCL_C533

DR   ESTDAB; ESTDAB-118

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-NT5-00

AC   CVCL_C534

DR   ESTDAB; ESTDAB-119

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,13

ST   D3S1358: 15,16

ST   D5S818: 9,12

ST   D7S820: 8,12

ST   FGA: 21

ST   TH01: 9

ST   TPOX: 11

ST   vWA: 15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel-NT6-00

AC   CVCL_C535

DR   ESTDAB; ESTDAB-123

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-NT8-00

AC   CVCL_C536

DR   ESTDAB; ESTDAB-126

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-NT9-00

AC   CVCL_C537

DR   Cosmic; 2163828

DR   ESTDAB; ESTDAB-125

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,11

ST   D3S1358: 17

ST   D5S818: 12

ST   D7S820: 8,11

ST   FGA: 22

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 19

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MEL-RC08

AC   CVCL_A012

DR   Cosmic; 1667648

RX   PubMed=22529031;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel-RM

AC   CVCL_D548

SY   Mel RM

DR   BTO; BTO:0005715

DR   Cosmic; 889010

RX   PubMed=7520026;

RX   PubMed=8980186;

RX   PubMed=9725211;

RX   PubMed=10364001;

RX   PubMed=15048078;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-RMu

AC   CVCL_S994

SY   Mel-RMU; Mel RMu; MelRMu

DR   BTO; BTO:0005719

DR   Cosmic; 889011

DR   Cosmic; 1941942

RX   PubMed=10364001;

RX   PubMed=15048078;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-RMu/DR2

AC   CVCL_T017

SY   MelRMu DR2; Mel-RMU-DR2

DR   Cosmic; 1941943

RX   PubMed=22437314;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S994 ! Mel-RMu

CA   Cancer cell line

//

ID   Mel-RMu/DR4

AC   CVCL_T018

SY   MelRMu DR4; Mel-RMU-DR4

DR   Cosmic; 1941944

RX   PubMed=22437314;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S994 ! Mel-RMu

CA   Cancer cell line

//

ID   Mel-RMu/DR6

AC   CVCL_T019

SY   MelRMu DR6; Mel-RMU-DR6

DR   Cosmic; 1941945

RX   PubMed=22437314;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S994 ! Mel-RMu

CA   Cancer cell line

//

ID   Mel-RMu/DR8

AC   CVCL_T020

SY   MelRMu DR8; Mel-RMU-DR8

DR   Cosmic; 1941946

RX   PubMed=22437314;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S994 ! Mel-RMu

CA   Cancer cell line

//

ID   Mel-RMu/DR9

AC   CVCL_T021

SY   MelRMu DR9; Mel-RMU-DR9

DR   Cosmic; 1941947

RX   PubMed=22437314;

CC   Selected for resistance to: ChEBI; CHEBI:75045; Dabrafenib (Tafinlar; GSK2118436).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_S994 ! Mel-RMu

CA   Cancer cell line

//

ID   Mel-SOE

AC   CVCL_C503

SY   EST97

DR   Cosmic; 1047659

DR   Cosmic; 2163867

DR   ESTDAB; ESTDAB-097

DR   GEO; GSM156006

RX   PubMed=17260012;

CC   Omics: Array-based CGH.

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,12

ST   D3S1358: 14,16

ST   D5S818: 11,12

ST   D7S820: 7,12

ST   FGA: 19,25

ST   TH01: 6,9.3

ST   TPOX: 8,12

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel-SP

AC   CVCL_T009

SY   Mel SP

RX   PubMed=10364001;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEL-STM

AC   CVCL_9U70

RX   PubMed=16142232;

CC   Transfected with: HGNC; 7029; MET (activated TPR-MET).

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C854 ! MEL-STR

OI   CVCL_9U71 ! MEL-STV

SX   Male

CA   Transformed cell line

//

ID   MEL-STR

AC   CVCL_C854

DR   Cosmic; 1458969

RX   PubMed=16142232;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9U70 ! MEL-STM

OI   CVCL_9U71 ! MEL-STV

SX   Male

CA   Transformed cell line

//

ID   MEL-STV

AC   CVCL_9U71

DR   Cosmic; 1458968

RX   PubMed=16142232;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_9U70 ! MEL-STM

OI   CVCL_C854 ! MEL-STR

SX   Male

CA   Transformed cell line

//

ID   Mel-Swift

AC   CVCL_A650

SY   Mel-SWIFT; Mel Swift; MEL-SWIFT

DR   Cosmic; 692343

DR   Cosmic; 702099

DR   Cosmic; 706087

DR   Cosmic; 888831

RX   PubMed=10766161;

RX   PubMed=15009714;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEL-TF19

AC   CVCL_B268

RX   PubMed=15250154;

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   Mel-WB

AC   CVCL_T010

SY   Mel WB

RX   PubMed=7520026;

RX   PubMed=9725211;

RX   PubMed=10364001;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-WD

AC   CVCL_GR45

RX   PubMed=8980186;

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-WL

AC   CVCL_C504

DR   Cosmic; 2163814

DR   ESTDAB; ESTDAB-095

ST   Source(s): ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 12,13

ST   D3S1358: 14,15

ST   D5S818: 10,13

ST   D7S820: 9

ST   FGA: 21,24

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 15,17

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel-WN

AC   CVCL_GR34

RX   PubMed=7520026;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEL1

AC   CVCL_DG36

DR   GEO; GSM202114

DR   IGRhCellID; MEL1%20GEO

DI   NCIt; C114828; Mucosal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel120

AC   CVCL_D648

SY   Mel 120

DR   BTO; BTO:0005174

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel1617

AC   CVCL_DG51

SY   MEL1617

DR   GEO; GSM1199180

RX   PubMed=24055054;

CC   Omics: Array-based CGH.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel1617-BR

AC   CVCL_DG52

SY   Mel1617BR; Mel1617-R

RX   PubMed=21156289;

CC   Selected for resistance to: ChEBI; CHEBI:131882; SB-590885.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DG51 ! Mel1617

CA   Cancer cell line

//

ID   Mel1617-MR

AC   CVCL_DG53

DR   GEO; GSM1199181

RX   PubMed=24055054;

CC   Selected for resistance to: ChEBI; CHEBI:75998; Trametinib (Mekinist; GSK1120212).

CC   Omics: Array-based CGH.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DG51 ! Mel1617

CA   Cancer cell line

//

ID   MEL2-mCherry

AC   CVCL_IR29

RX   PubMed=22993664;

CC   Transfected with: UniProtKB; X5DSL3; mCherry fluorescent protein.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B864 ! MEL-2

SX   Female

CA   Embryonic stem cell

//

ID   Mel20-06-039

AC   CVCL_8473

SY   MEL20-06-039

DR   Cosmic; 1665023

RX   PubMed=21386926;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel20-06-045

AC   CVCL_8474

SY   MEL20-06-045

DR   Cosmic; 1665024

RX   PubMed=21386926;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel20-07-070

AC   CVCL_8475

SY   MEL20-07-070

DR   Cosmic; 1665025

RX   PubMed=21386926;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel20-08-128

AC   CVCL_D714

DR   Cosmic; 1665026

RX   PubMed=22515704;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel20-09-196

AC   CVCL_D715

DR   Cosmic; 1665027

RX   PubMed=22515704;

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel202

AC   CVCL_C301

SY   MEL202; Mel-202; Mel 202; mel-202; EST128

DR   Cosmic; 848329

DR   Cosmic; 899894

DR   Cosmic; 916143

DR   Cosmic; 1047643

DR   Cosmic; 1320372

DR   Cosmic; 1628395

DR   Cosmic; 2036706

DR   Cosmic; 2163830

DR   ECACC; 13012457

DR   ESTDAB; ESTDAB-128

DR   GEO; GSM156005

RX   PubMed=1748551;

RX   PubMed=17260012;

RX   PubMed=22236444;

RX   PubMed=24994677;

WW   https://www.kerafast.com/product/2230/uveal-melanoma-cell-line-mel202

CC   Doubling time: 43 hours (PubMed=24994677).

CC   Omics: Array-based CGH.

ST   Source(s): ECACC; ESTDAB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 11,12

ST   FGA: 23,24

ST   TH01: 6 (ECACC)

ST   TH01: 6,7 (ESTDAB)

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel249

AC   CVCL_3974

SY   MEL249

DR   BTO; BTO:0002952

RX   PubMed=16740750;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel270

AC   CVCL_C302

SY   MEL270; Mel-270; Mel 270

DR   Cosmic; 848330

DR   Cosmic; 899898

DR   Cosmic; 916144

DR   Cosmic; 986621

DR   Cosmic; 1628396

DR   Cosmic; 1669124

DR   Cosmic; 2036707

RX   PubMed=9247253;

RX   PubMed=16772116;

RX   PubMed=22236444;

CC   From: Ksander B.; Schepens Eye Research Institute; Boston; USA.

CC   Misspelling: 'Mel207' in Cosmic 848330.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_C305 ! OMM2.2

OI   CVCL_C306 ! OMM2.3

OI   CVCL_C307 ! OMM2.5

OI   CVCL_C308 ! OMM2.6

SX   Male

CA   Cancer cell line

//

ID   Mel285

AC   CVCL_C303

SY   MEL285; Mel-285; Mel 285

DR   Cosmic; 916140

DR   Cosmic; 1628405

DR   Cosmic; 2036708

RX   PubMed=16772116;

RX   PubMed=22236444;

CC   From: Ksander B.; Schepens Eye Research Institute; Boston; USA.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel290

AC   CVCL_C304

SY   MEL290; Mel-290; Mel 290; MEL 290

DR   CLDB; cl7222

DR   Cosmic; 916141

DR   Cosmic; 1628406

DR   Cosmic; 1669125

DR   ICLC; HTL12001

RX   PubMed=16772116;

RX   PubMed=22236444;

CC   From: Ksander B.; Schepens Eye Research Institute; Boston; USA.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel499

AC   CVCL_3975

DR   BTO; BTO:0002953

RX   PubMed=16740750;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mel501A

AC   CVCL_0V14

SY   MEL501A; 501A; 501 A

DR   EFO; EFO_0006356

DR   BioSample; SAMN03473285

RX   PubMed=25485619;

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Not specified.

ST   Source(s): PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 10,13

ST   D16S539: 14

ST   D18S51: 16

ST   D21S11: 29

ST   D3S1358: 14,16

ST   D5S818: 12

ST   D7S820: 10,12

ST   D8S1179: 12

ST   FGA: 24

ST   Penta D: 9

ST   Penta E: 7,13

ST   TH01: 9.3

ST   TPOX: 8,10

ST   vWA: 16,18

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_8054 ! 624-mel

SX   Male

CA   Cancer cell line

//

ID   Mel505

AC   CVCL_3976

DR   BTO; BTO:0002954

RX   PubMed=16740750;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mel592

AC   CVCL_3977

DR   BTO; BTO:0002955

RX   PubMed=16740750;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Melan-a

AC   CVCL_4624

SY   melan-a

DR   BTO; BTO:0003216

DR   Lonza; 161

RX   PubMed=3102392;

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   Melan-a Hm

AC   CVCL_W079

SY   melan-a Hm

DR   BTO; BTO:0005424

RX   PubMed=11734563;

CC   Characteristics: Transfected with a chimeric tyrosine-protein kinase receptor composed of extracellular part of human EGFR and the intracellular part of Xmrk. Stimulation of the chimera with EGF induces activation of the xmrk kinase domain.

CC   Transfected with: HGNC; 3236; EGFR (extracellular domain).

CC   Transfected with: UniProtKB; P13388; Xiphophorus maculatus xmrk (intracellular domain).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4624 ! Melan-a

CA   Spontaneously immortalized cell line

//

ID   Melan-a2

AC   CVCL_C692

SY   melan-a2; melan a2

RX   PubMed=7540532;

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_C693 ! Melb-a

CA   Spontaneously immortalized cell line

//

ID   Melb-a

AC   CVCL_C693

SY   melb-a

RX   PubMed=7540532;

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MELBA

AC   CVCL_6G44

RX   PubMed=3761468;

CC   Derived from metastatic site: Urinary bladder.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Melligen

AC   CVCL_HA63

RX   Patent=US9365829;

RX   PubMed=26029722;

WW   http://www.diabetes.co.uk/forum/threads/potential-type-1-diabetes-treatment-receives-us-patent-approval.102547/

CC   Characteristics: Produces insulin in response to extracellular glucose levels that are equivalent to physiological glucose levels.

CC   Characteristics: When transplanted into diabetic immunoincompetent mice, Melligen cells restore normoglycemia.

CC   Transfected with: HGNC; 4195; GCK.

CC   Transfected with: HGNC; 6081; INS.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_HA62 ! HUH7-ins

SX   Male

CA   Cancer cell line

//

ID   MEMO

AC   CVCL_L300

RX   PubMed=23249835;

DI   NCIt; C5915; Oral cavity mucosal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MeMo 05

AC   CVCL_F330

SY   MEMO

DR   CLDB; cl7211

DR   ICLC; HTL07002

RX   PubMed=23634660;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MEMOR 06

AC   CVCL_F331

DR   CLDB; cl7212

DR   ICLC; HTL07004

CC   Derived from metastatic site: Subcutaneous.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   mEMS88

AC   CVCL_0J51

SY   SXRA-ES

RX   PubMed=12112873;

WW   http://www.flintbox.com/public/project/512/

CC   Breed/subspecies: C57BL/6J-Sxra x 129P3/JEms.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MEN1RGB

AC   CVCL_H212

DR   CLO; CLO_0051606

DR   BioSample; SAMN03472306

DR   RCB; RCB0410

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 8,9

ST   D16S539: 10

ST   D5S818: 10,12

ST   D7S820: 8,10

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 14,15

DI   NCIt; C6432; Multiple endocrine neoplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MEN2RGB

AC   CVCL_H213

DR   CLO; CLO_0051607

DR   BioSample; SAMN03472307

DR   RCB; RCB0421

ST   Source(s): RCB

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 8,9

ST   D16S539: 9,10

ST   D5S818: 9,12

ST   D7S820: 10,11

ST   TH01: 6,9

ST   TPOX: 9

ST   vWA: 19,20

DI   NCIt; C6432; Multiple endocrine neoplasia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MENII-1

AC   CVCL_M431

SY   SF6717

RX   PubMed=18953429;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7].

DI   NCIt; C3230; Meningioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   MEQC1

AC   CVCL_J504

SY   MEQC 1; Myc Embryonic Quail Cardiomyocytes-1

RX   PubMed=1846337;

CC   Group: Bird cell line.

OX   NCBI_TaxID=93934; ! Coturnix coturnix japonica

CA   Cancer cell line

//

ID   MEQC2

AC   CVCL_J505

SY   MEQC 2; Myc Embryonic Quail Cardiomyocytes-2

RX   PubMed=1846337;

CC   Group: Bird cell line.

OX   NCBI_TaxID=93934; ! Coturnix coturnix japonica

CA   Cancer cell line

//

ID   MER,P

AC   CVCL_E774

SY   MER, P

DR   dbMHC; 48969

DR   ECACC; 94082226

DR   IHW; IHW9127

DR   IMGT/HLA; 11670

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl127.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   Mero-14

AC   CVCL_2590

DR   ECACC; 09100101

RX   PubMed=2474517;

RX   PubMed=2790740;

CC   Doubling time: ~24 hours (ECACC).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12

ST   D16S539: 12,13

ST   D5S818: 9

ST   D7S820: 10,11

ST   TH01: 8

ST   TPOX: 9,11

ST   vWA: 15,18

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mero-25

AC   CVCL_2591

DR   ECACC; 09100102

RX   PubMed=2474517;

RX   PubMed=2790740;

CC   Doubling time: ~48 hours (ECACC; PubMed=2474517).

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 9

ST   TH01: 8

ST   TPOX: 9

ST   vWA: 16,17

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mero-41

AC   CVCL_2592

DR   ECACC; 09100103

RX   PubMed=2474517;

RX   PubMed=2790740;

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 13

ST   D16S539: 12

ST   D5S818: 13

ST   D7S820: 9

ST   TH01: 6,8

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mero-48a

AC   CVCL_2593

DR   ECACC; 09100104

RX   PubMed=2474517;

CC   Doubling time: ~24 hours (ECACC).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W102 ! Mero-48b

OI   CVCL_W103 ! Mero-48c

OI   CVCL_W104 ! Mero-48d

SX   Male

CA   Cancer cell line

//

ID   Mero-48b

AC   CVCL_W102

RX   PubMed=2474517;

CC   Derived from metastatic site: Visceral (omental).

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2593 ! Mero-48a

OI   CVCL_W103 ! Mero-48c

OI   CVCL_W104 ! Mero-48d

SX   Male

CA   Cancer cell line

//

ID   Mero-48c

AC   CVCL_W103

RX   PubMed=2474517;

CC   Derived from metastatic site: Liver.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2593 ! Mero-48a

OI   CVCL_W102 ! Mero-48b

OI   CVCL_W104 ! Mero-48d

SX   Male

CA   Cancer cell line

//

ID   Mero-48d

AC   CVCL_W104

RX   PubMed=2474517;

CC   Derived from metastatic site: Pericardium.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2593 ! Mero-48a

OI   CVCL_W102 ! Mero-48b

OI   CVCL_W103 ! Mero-48c

SX   Male

CA   Cancer cell line

//

ID   Mero-72

AC   CVCL_W105

RX   PubMed=2474517;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mero-82

AC   CVCL_2594

DR   ECACC; 09100105

RX   PubMed=2474517;

CC   Doubling time: ~24 hours (ECACC; PubMed=2474517).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 12

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mero-83

AC   CVCL_2595

DR   ECACC; 09100106

RX   PubMed=2474517;

CC   Doubling time: ~40 hours (ECACC).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 9,12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 9

ST   TH01: 7

ST   TPOX: 8,11

ST   vWA: 18,19

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mero-84

AC   CVCL_2596

DR   ECACC; 09100107

RX   PubMed=2474517;

CC   Doubling time: ~48 hours (ECACC).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,12

ST   D16S539: 9

ST   D5S818: 11

ST   D7S820: 9,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 14,17

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mero-91

AC   CVCL_W106

RX   PubMed=2474517;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mero-95

AC   CVCL_2597

DR   ECACC; 09100108

RX   PubMed=2474517;

CC   Doubling time: ~30 hours (ECACC).

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,12

ST   D16S539: 11

ST   D5S818: 11,14

ST   D7S820: 7,9

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 18,19

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   Mero-96

AC   CVCL_W107

RX   PubMed=2474517;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-1

AC   CVCL_H665

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-10

AC   CVCL_H657

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-11

AC   CVCL_H661

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-15

AC   CVCL_H662

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-17

AC   CVCL_H647

SY   Meso 17; Meso-17; Meso17

DR   Lonza; 325

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-19

AC   CVCL_H656

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-2

AC   CVCL_H666

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-20

AC   CVCL_H663

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-29

AC   CVCL_H651

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-30

AC   CVCL_H650

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-35

AC   CVCL_H648

SY   Meso 35; Meso-35

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-36

AC   CVCL_H652

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-37

AC   CVCL_H649

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-45

AC   CVCL_H653

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-49

AC   CVCL_H654

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-5

AC   CVCL_H667

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-50

AC   CVCL_H655

SY   6-53

RX   PubMed=7479897;

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-54

AC   CVCL_H664

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-7

AC   CVCL_H660

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-8

AC   CVCL_H659

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Mes-9

AC   CVCL_H658

SY   1-53

RX   PubMed=7479897;

RX   PubMed=10451704;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MES-OV

AC   CVCL_CZ92

SY   MESOV

DR   ATCC; CRL-3272

DR   GEO; GSM95445

RX   PubMed=12960427;

RX   PubMed=16382445;

CC   Derived from metastatic site: Ascites.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 9,11

ST   D16S539: 11,12

ST   D5S818: 13

ST   D7S820: 11

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MES-OV/T40

AC   CVCL_CZ97

SY   MESOV T40; MESOVT40

DR   GEO; GSM95447

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_CZ92 ! MES-OV

SX   Female

CA   Cancer cell line

//

ID   MES-OV/TxT50

AC   CVCL_CZ96

SY   MESOV TxT50; MESOVTxT50

DR   GEO; GSM95468

RX   PubMed=16382445;

CC   Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).

CC   Derived from metastatic site: Ascites.

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_CZ92 ! MES-OV

SX   Female

CA   Cancer cell line

//

ID   MES-SA

AC   CVCL_1404

SY   MESSA

DR   CLO; CLO_0007677

DR   EFO; EFO_0002233

DR   CLDB; cl3447

DR   CLDB; cl3448

DR   ATCC; CRL-1976

DR   BCRC; 60333

DR   BioSample; SAMN03470984

DR   CCLE; MESSA_SOFT_TISSUE

DR   ChEMBL-Cells; CHEMBL3307599

DR   ChEMBL-Targets; CHEMBL614343

DR   Cosmic; 687553

DR   Cosmic; 848889

DR   Cosmic; 908127

DR   Cosmic; 2008739

DR   Cosmic-CLP; 908127

DR   ECACC; 95051030

DR   GDSC; 908127

DR   GEO; GSM827389

DR   GEO; GSM1670096

DR   GEO; GSM1676304

DR   GEO; GSM1701639

DR   ICLC; HTL96008

DR   IGRhCellID; MESSA

RX   PubMed=6883344;

RX   PubMed=22889595;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-490.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 22-24 hours (ECACC).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Proteome analysis by 2D-DE/MS.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D18S51: 12,15

ST   D19S433: 14.2,15

ST   D21S11: 29,30.2

ST   D2S1338: 17

ST   D3S1358: 14,17

ST   D5S818: 13

ST   D7S820: 7,11

ST   D8S1179: 14,15

ST   FGA: 20,25

ST   Penta D: 13,15

ST   Penta E: 7,10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C6339; Uterine corpus sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MES-SA/Dx1

AC   CVCL_4T93

SY   Mes-SA Dx1; MESSA-DX1; Dx1

RX   PubMed=4028002;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C6339; Uterine corpus sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1404 ! MES-SA

SX   Female

CA   Cancer cell line

//

ID   MES-SA/Dx5

AC   CVCL_2598

SY   MES-SA/Dx-5; MES-SA-Dx5; MES-SA Dx5; MESSA/Dx5; MESSA-DX5; MESSA Dx5; MESSADX5; Dx5

DR   CLO; CLO_0007678

DR   CLDB; cl3449

DR   ATCC; CRL-1977

DR   BCRC; 60331

DR   BioSample; SAMN03470985

DR   BioSample; SAMN03471267

DR   ChEMBL-Cells; CHEMBL3308373

DR   ChEMBL-Targets; CHEMBL613827

DR   ECACC; 95051031

DR   GEO; GSM827348

DR   GEO; GSM1676305

DR   GEO; GSM1701640

DR   IGRhCellID; MESSADX5

RX   PubMed=4028002;

RX   PubMed=22889595;

RX   PubMed=26351324;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 30 hours (ECACC).

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: Proteome analysis by 2D-DE/MS.

CC   Misspelling: 'MES-SA/DxS' in ChEMBL CHEMBL613827 and CHEMBL3308373.

CC   Discontinued: ATCC; CRL-1977; probable.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 11,12

ST   D18S51: 15

ST   D19S433: 14.2,15

ST   D21S11: 29,30.2

ST   D2S1338: 17

ST   D3S1358: 14,17

ST   D5S818: 13

ST   D7S820: 7,11 (ATCC)

ST   D7S820: 11 (PubMed=25877200)

ST   D8S1179: 14,15

ST   FGA: 20,25

ST   Penta D: 13,15

ST   Penta E: 7,10

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 18

DI   NCIt; C6339; Uterine corpus sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1404 ! MES-SA

SX   Female

CA   Cancer cell line

//

ID   MES-SA/DxP5002

AC   CVCL_4T94

SY   DxP

RX   PubMed=9038218;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C6339; Uterine corpus sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2598 ! MES-SA/Dx5

SX   Female

CA   Cancer cell line

//

ID   MES-SA/MX2

AC   CVCL_2599

SY   MES-SA/Mx2; MESSA/MX2

DR   CLO; CLO_0007679

DR   ATCC; CRL-2274

DR   BioSample; SAMN03471858

DR   IGRhCellID; MESSAMX2

CC   Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 11,12

ST   D5S818: 13

ST   D7S820: 7,11

ST   TH01: 6

ST   TPOX: 8,12

ST   vWA: 18

DI   NCIt; C6339; Uterine corpus sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1404 ! MES-SA

SX   Female

CA   Cancer cell line

//

ID   MES1

AC   CVCL_Z508

SY   Mes1; Medaka ES-like line 1

RX   PubMed=9025059;

RX   PubMed=9520425;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8090; ! Oryzias latipes

SX   Sex undetermined

CA   Embryonic stem cell

//

ID   MES23.5

AC   CVCL_J351

SY   MES-23.5; MES 23.5

DR   BTO; BTO:0004476

RX   PubMed=1356145;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_2132 ! N18TG2

CA   Hybrid cell line

//

ID   MESC 16

AC   CVCL_M012

DR   ECACC; 11120811

RX   PubMed=1483967;

CC   Breed/subspecies: 129/Olac.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Embryonic stem cell

//

ID   MESC 17

AC   CVCL_M013

DR   ECACC; 11120817

RX   PubMed=1483967;

CC   Breed/subspecies: C57BL/6J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   MESC 18

AC   CVCL_M014

DR   ECACC; 11120816

RX   PubMed=1483967;

CC   Breed/subspecies: 129/Olac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MESC 19

AC   CVCL_M015

DR   ECACC; 11120813

RX   PubMed=1483967;

CC   Breed/subspecies: 129/Olac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MESC 20

AC   CVCL_M016

DR   ECACC; 11120814

RX   PubMed=1483967;

CC   Breed/subspecies: 129/Olac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MESC 21

AC   CVCL_M017

DR   ECACC; 11120815

RX   PubMed=1483967;

CC   Breed/subspecies: 129/Olac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   MESC 23

AC   CVCL_M018

DR   ECACC; 11120818

CC   Breed/subspecies: 129/Olac.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Embryonic stem cell

//

ID   MESC2.10

AC   CVCL_B061

RX   PubMed=12145295;

RX   PubMed=17222562;

CC   Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.

CC   Transformant: v-Myc.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Conditionally immortalized cell line

//

ID   Meso-10

AC   CVCL_H668

SY   Meso 10; Meso10; MESO10

DR   Cosmic; 1522770

DR   Cosmic; 1541216

DR   GEO; GSM726275

RX   PubMed=16475242;

RX   PubMed=21642991;

RX   PubMed=21774103;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso-9

AC   CVCL_H669

SY   Meso9; Meso09; MESO09

DR   Cosmic; 1522775

DR   Cosmic; 1541214

DR   GEO; GSM726274

RX   PubMed=16475242;

RX   PubMed=21642991;

RX   PubMed=21774103;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso11

AC   CVCL_H670

SY   Meso 11

RX   PubMed=15070823;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso122

AC   CVCL_H671

RX   PubMed=21540305;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso13

AC   CVCL_H672

RX   PubMed=15070823;

RX   PubMed=21540305;

RX   PubMed=22144115;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso144

AC   CVCL_H673

SY   Meso 144

RX   PubMed=21540305;

RX   PubMed=22144115;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso148

AC   CVCL_H674

RX   PubMed=21540305;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso34

AC   CVCL_H675

SY   Meso 34

DR   Cosmic; 1541207

RX   PubMed=21540305;

RX   PubMed=21774103;

RX   PubMed=22144115;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso35

AC   CVCL_H676

SY   Meso 35

RX   PubMed=21540305;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso37

AC   CVCL_H677

SY   MESO37; Meso 37

DR   Cosmic; 1522761

DR   Cosmic; 1541204

DR   GEO; GSM726276

RX   PubMed=21642991;

RX   PubMed=21774103;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso4

AC   CVCL_H678

RX   PubMed=21540305;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso45

AC   CVCL_H679

RX   PubMed=21540305;

RX   PubMed=22144115;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso47

AC   CVCL_H680

SY   Meso 47

RX   PubMed=21540305;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso56

AC   CVCL_H681

SY   MESO56; Meso 56

DR   Cosmic; 1522782

DR   Cosmic; 1541206

DR   GEO; GSM726277

RX   PubMed=21540305;

RX   PubMed=21642991;

RX   PubMed=21774103;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso62

AC   CVCL_H682

RX   PubMed=21540305;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   Meso96

AC   CVCL_H683

RX   PubMed=21540305;

RX   PubMed=22144115;

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MESV

AC   CVCL_D804

SY   Middle Ear cells derived by SV40 infection

RX   PubMed=8382213;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10047; ! Meriones unguiculatus

CA   Transformed cell line

//

ID   Met-1(fvb2)

AC   CVCL_U373

SY   Met-1fvb2

DR   Lonza; 1227

RX   PubMed=16132578;

CC   Breed/subspecies: FVB/N-Tg(MMTV-PyVmT).

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   MeT-4A

AC   CVCL_H531

SY   MeT 4A; Met4A; Mesothelial cells transfected with pRSV-T 4A

RX   PubMed=9175740;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   MeT-5A

AC   CVCL_3749

SY   MeT 5A; MeT5A; Met5A; MET5A; Mesothelial cells transfected with pRSV-T 5A

DR   CLO; CLO_0007680

DR   EFO; EFO_0001218

DR   ATCC; CRL-9444

DR   BCRC; 60352

DR   BioSample; SAMN03471216

DR   IZSLER; BS CL 214

RX   Patent=US4885238;

RX   PubMed=2541616;

RX   PubMed=9533946;

RX   PubMed=15920167;

RX   PubMed=22576795;

RX   PubMed=24926545;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRSV-T].

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11,13

ST   D16S539: 12

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 15,18

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Meta 1

AC   CVCL_4559

SY   Meta-1; META-1

DR   CLO; CLO_0007684

DR   CLDB; cl3451

RX   PubMed=3455746;

CC   Breed/subspecies: BALB/cAnNCrlBR.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_F736 ! TS/A

SX   Female

CA   Cancer cell line

//

ID   Meta 10

AC   CVCL_3851

SY   Meta-10; META-10

DR   CLO; CLO_0007681

DR   CLO; CLO_0007685

DR   CLDB; cl3452

DR   CLDB; cl3453

DR   ECACC; 90062271

RX   PubMed=3455746;

CC   Breed/subspecies: BALB/cAnNCrlBR.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3853 ! Meta 7

SX   Female

CA   Cancer cell line

//

ID   Meta 15

AC   CVCL_3852

SY   Meta-15; META-15

DR   CLO; CLO_0007682

DR   CLDB; cl3450

DR   ECACC; 90062270

RX   PubMed=3455746;

CC   Breed/subspecies: BALB/cAnNCrlBR.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3851 ! Meta 10

SX   Female

CA   Cancer cell line

//

ID   Meta 7

AC   CVCL_3853

SY   Meta-7; META-7

DR   CLO; CLO_0007683

DR   CLO; CLO_0007686

DR   CLDB; cl3454

DR   CLDB; cl3455

DR   ECACC; 90062272

RX   PubMed=3455746;

CC   Breed/subspecies: BALB/cAnNCrlBR.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4559 ! Meta 1

SX   Female

CA   Cancer cell line

//

ID   Meth A Sarcoma

AC   CVCL_5798

SY   Meth A; Meth-A; Meth-A-sarkom

DR   CLS; 400284/p12831_Meth_A_sarcoma

DR   TKG; TKG 0158

RX   PubMed=2529426;

RX   PubMed=11529879;

RX   PubMed=12680876;

CC   Transformant: ChEBI; CHEBI:34342; 3-methylcholanthrene (MCA).

CC   Breed/subspecies: BALB/c.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   METON

AC   CVCL_T055

RX   PubMed=23761224;

DI   NCIt; C5978; Benign salivary gland myoepithelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MeWo

AC   CVCL_0445

SY   MEWO; Mewo; Me Wo; Me-Wo; Mevo; SK-MEL-MeWo; BI-Mel; EST50

DR   BTO; BTO:0003301

DR   CLO; CLO_0007687

DR   CLO; CLO_0007688

DR   EFO; EFO_0006648

DR   MCCL; MCC:0000341

DR   CLDB; cl3456

DR   CLDB; cl3458

DR   ATCC; HTB-65

DR   BCRC; 60540

DR   BCRJ; 0358

DR   BioSample; SAMN01821578

DR   BioSample; SAMN01821699

DR   BioSample; SAMN03470821

DR   CCLE; MEWO_SKIN

DR   ChEMBL-Cells; CHEMBL3308024

DR   ChEMBL-Targets; CHEMBL613300

DR   CLS; 300285/p1765_MEWO

DR   Cosmic; 721835

DR   Cosmic; 886829

DR   Cosmic; 908128

DR   Cosmic; 928689

DR   Cosmic; 932713

DR   Cosmic; 933141

DR   Cosmic; 972284

DR   Cosmic; 1047647

DR   Cosmic; 1060422

DR   Cosmic; 1132584

DR   Cosmic; 1238113

DR   Cosmic; 1303046

DR   Cosmic; 1995506

DR   Cosmic; 2036702

DR   Cosmic; 2159442

DR   Cosmic; 2163794

DR   Cosmic-CLP; 908128

DR   ECACC; 93082609

DR   ESTDAB; ESTDAB-050

DR   GDSC; 908128

DR   GEO; GSM156016

DR   GEO; GSM188224

DR   GEO; GSM188254

DR   GEO; GSM188313

DR   GEO; GSM206525

DR   GEO; GSM827470

DR   GEO; GSM887310

DR   GEO; GSM888386

DR   GEO; GSM1670097

DR   ICLC; HTL97019

DR   JCRB; JCRB0066

DR   Lonza; 437

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1383272;

RX   PubMed=2068080;

RX   PubMed=6582512;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=7908310;

RX   PubMed=9290701;

RX   PubMed=17260012;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-532.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: ERK genetic alteration cell panel (ATCC TCP-1033).

CC   From: Memorial Sloan-Kettering Cancer Center; New York; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ESTDAB; JCRB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12 (ATCC; CLS; Cosmic-CLP; JCRB; PubMed=25877200)

ST   CSF1PO: 10,12 (ESTDAB)

ST   D13S317: 8 (Cosmic-CLP; ESTDAB)

ST   D13S317: 8,9 (ATCC; CLS; JCRB; PubMed=25877200)

ST   D16S539: 10,12

ST   D18S51: 14,17

ST   D21S11: 30,32.2

ST   D3S1358: 17

ST   D5S818: 12,13

ST   D7S820: 10,12

ST   D8S1179: 13,15

ST   FGA: 22

ST   Penta D: 10

ST   Penta E: 5 (CLS)

ST   Penta E: 5,15 (PubMed=25877200)

ST   TH01: 7,9

ST   TPOX: 8,10 (ATCC; CLS; Cosmic-CLP; JCRB; PubMed=25877200)

ST   TPOX: 9,11 (ESTDAB)

ST   vWA: 15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MeWo CIS 0.01

AC   CVCL_AZ60

SY   MeWo-cisplatin 0.01

RX   PubMed=11001322;

RX   PubMed=11058868;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo CIS 1

AC   CVCL_AZ74

SY   MeWo CIS 1.0; MeWo CIS; MeWo-cisplatin 1

RX   PubMed=11001322;

RX   PubMed=11058868;

RX   PubMed=21475863;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo ETO 0.1

AC   CVCL_AZ61

SY   MeWo-etoposide 0.1

RX   PubMed=11001322;

RX   PubMed=11058868;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo ETO 1

AC   CVCL_AZ62

SY   MeWo ETO 1.0; MeWo ETO; MeWo-etoposide 1

RX   PubMed=11001322;

RX   PubMed=11058868;

RX   PubMed=21475863;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo FOTE 4

AC   CVCL_AZ75

SY   MeWo FOTE 4.0; MeWo-fotemustine 4

RX   PubMed=11058868;

RX   PubMed=21475863;

CC   Selected for resistance to: ChEBI; CHEBI:131848; Fotemustine.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo FOTE 40

AC   CVCL_AZ76

SY   MeWo FOTE; MeWo-fotemustine 40

RX   PubMed=11001322;

RX   PubMed=11058868;

RX   PubMed=21475863;

CC   Selected for resistance to: ChEBI; CHEBI:131848; Fotemustine.

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo LNI 6I

AC   CVCL_Y663

RX   PubMed=1383272;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo VIN 0.5

AC   CVCL_AZ63

SY   MeWo-vindesine 0.5

RX   PubMed=11001322;

RX   PubMed=11058868;

CC   Selected for resistance to: ChEBI; CHEBI:36373; Vindesine.

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo VIN 5

AC   CVCL_AZ77

SY   MeWo VIN 5.0; MeWo VIN; MeWo-vindesine 5

RX   PubMed=11001322;

RX   PubMed=11058868;

RX   PubMed=21475863;

CC   Selected for resistance to: ChEBI; CHEBI:36373; Vindesine.

CC   Omics: Proteome analysis by 2D-DE.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MeWo-LC1

AC   CVCL_U937

RX   PubMed=3000950;

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   Mewo-Luc

AC   CVCL_J260

DR   JCRB; JCRB1396

DR   JCRB; NIHS0643

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0643; true.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 8,9

ST   D16S539: 10,12

ST   D5S818: 12,13

ST   D7S820: 10,12

ST   TH01: 7,9

ST   TPOX: 8,10

ST   vWA: 15

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0445 ! MeWo

SX   Male

CA   Cancer cell line

//

ID   MEXF 276L

AC   CVCL_D132

SY   MEXF276L; MEXF 276

DR   ChEMBL-Cells; CHEMBL3307542

DR   ChEMBL-Targets; CHEMBL614130

DR   Cosmic; 907392

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEXF 462NL

AC   CVCL_D128

SY   MEXF462NL; MEXF 462; MEXF462

DR   Cosmic; 907393

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MEXF 514L

AC   CVCL_D129

SY   MEXF514L; MEXF 514; MEXF514

DR   ChEMBL-Cells; CHEMBL3307728

DR   ChEMBL-Targets; CHEMBL614873

DR   Cosmic; 907394

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MF

AC   CVCL_Y126

DR   ATCC; CRL-1375

CC   Discontinued: ATCC; CRL-1375; true.

DI   NCIt; C85036; Pseudoxanthoma elasticum

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Finite cell line

//

ID   MF 116

AC   CVCL_J762

SY   MF116

DR   CLO; CLO_0007689

DR   ATCC; HB-8411

RX   Patent=US4666845;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MF 61

AC   CVCL_J843

SY   MF61

DR   ATCC; HB-8410

RX   Patent=US4666845;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MF-1

AC   CVCL_0C47

RX   PubMed=18594539;

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0C42 ! BLC-1

OI   CVCL_0C52 ! HCC-1.1

OI   CVCL_0C53 ! HCC-1.2

SX   Male

CA   Cancer cell line

//

ID   MF-2

AC   CVCL_0C48

RX   PubMed=18594539;

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0C43 ! BLC-2

OI   CVCL_0C54 ! HCC-2

SX   Male

CA   Cancer cell line

//

ID   MF-3

AC   CVCL_0C49

RX   PubMed=18594539;

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0C55 ! HCC-3

SX   Male

CA   Cancer cell line

//

ID   MF-5

AC   CVCL_0C50

RX   PubMed=18594539;

CC   Derived from metastatic site: Subcutis.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MF-6

AC   CVCL_0C51

RX   PubMed=18594539;

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0C45 ! BLC-6

SX   Female

CA   Cancer cell line

//

ID   MF1-PI 30

AC   CVCL_9W14

DR   NCBI_Iran; C440

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   MF14

AC   CVCL_DI53

SY   UCLA-SO-MF14

RX   PubMed=954005;

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1395 ! M14

OI   CVCL_DI50 ! ML14

SX   Male

CA   Finite cell line

//

ID   MF20

AC   CVCL_DI54

SY   UCLA-SO-MF20

RX   PubMed=954005;

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DI51 ! M20 [Human melanoma]

CA   Finite cell line

//

ID   Mf4/4

AC   CVCL_U655

SY   MF4/4

RX   PubMed=9605128;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-535.html

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   MFA00335IN

AC   CVCL_E166

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Transformed cell line

//

ID   MFA00336IN

AC   CVCL_E167

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Transformed cell line

//

ID   MFA00337IN

AC   CVCL_E168

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Transformed cell line

//

ID   MFA00338IN

AC   CVCL_E169

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Transformed cell line

//

ID   MFA00340IN

AC   CVCL_E170

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Male

CA   Transformed cell line

//

ID   MFA00341IN

AC   CVCL_E171

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Female

CA   Transformed cell line

//

ID   MFA00342IN

AC   CVCL_E172

WW   http://www.biologia.uniba.it/primates/cell_lines.html

CC   Group: Non-human primate cell line.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9541; ! Macaca fascicularis

SX   Female

CA   Transformed cell line

//

ID   MFB-F11

AC   CVCL_5333

RX   PubMed=16549026;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MFB-F11

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MFBY2

AC   CVCL_M082

DR   BTO; BTO:0003526

RX   PubMed=14623275;

RX   PubMed=17760834;

CC   Breed/subspecies: Wistar.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Spontaneously immortalized cell line

//

ID   MFC

AC   CVCL_5J48

SY   Mouse Forestomach Carcinoma

DR   CCRID; 3111C0001CCC000143

DR   CCRID; 3131C0001000800023

DR   KCB; KCB 92020YJ

RX   PubMed=3678016;

DI   NCIt; C24225; Mouse gastric carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MFC-GFP

AC   CVCL_BT06

DR   CCRID; 3111C0001CCC000226

CC   Transfected with: UniProtKB; P42212; GFP.

DI   NCIt; C24225; Mouse gastric carcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_5J48 ! MFC

CA   Cancer cell line

//

ID   MFE-280

AC   CVCL_1405

SY   MFE 280; MFE280

DR   CLO; CLO_0007692

DR   CLDB; cl5080

DR   BioSample; SAMN03473586

DR   CCLE; MFE280_ENDOMETRIUM

DR   ChEMBL-Cells; CHEMBL3308455

DR   ChEMBL-Targets; CHEMBL1075502

DR   Cosmic; 908129

DR   Cosmic; 1434185

DR   Cosmic; 1576462

DR   Cosmic; 2030478

DR   Cosmic-CLP; 908129

DR   DSMZ; ACC-410

DR   ECACC; 98050131

DR   GDSC; 908129

DR   GEO; GSM374974

DR   GEO; GSM375433

DR   GEO; GSM844603

DR   GEO; GSM887311

DR   GEO; GSM888387

DR   GEO; GSM1670098

RX   PubMed=9615781;

RX   PubMed=9620227;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~60-90 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 10,12

ST   D16S539: 12

ST   D5S818: 11,12

ST   D7S820: 10

ST   TH01: 7

ST   TPOX: 9,10

ST   vWA: 17

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MFE-294

AC   CVCL_DI49

RX   PubMed=9620227;

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MFE-296

AC   CVCL_1406

SY   MFE 296; MFE296

DR   CLO; CLO_0007693

DR   CLDB; cl5081

DR   BioSample; SAMN03473590

DR   CCLE; MFE296_ENDOMETRIUM

DR   ChEMBL-Cells; CHEMBL3308374

DR   ChEMBL-Targets; CHEMBL1075503

DR   Cosmic; 908130

DR   Cosmic; 1105621

DR   Cosmic; 1177684

DR   Cosmic; 1434195

DR   Cosmic; 1576463

DR   Cosmic; 2030479

DR   Cosmic-CLP; 908130

DR   DSMZ; ACC-419

DR   ECACC; 98031101

DR   GDSC; 908130

DR   GEO; GSM374975

DR   GEO; GSM375434

DR   GEO; GSM844604

DR   GEO; GSM844605

DR   GEO; GSM887312

DR   GEO; GSM888388

DR   GEO; GSM1670099

RX   PubMed=8150529;

RX   PubMed=9620227;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,13

ST   D16S539: 11,14

ST   D5S818: 11,12 (Cosmic-CLP; DSMZ)

ST   D5S818: 11,13 (ECACC)

ST   D7S820: 8,10

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 14,18

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MFE-319

AC   CVCL_2112

SY   MFE319

DR   CLO; CLO_0007694

DR   BioSample; SAMN03473593

DR   CCLE; MFE319_ENDOMETRIUM

DR   Cosmic; 1434187

DR   Cosmic-CLP; 1240174

DR   DSMZ; ACC-423

DR   GDSC; 1240174

DR   GEO; GSM374976

DR   GEO; GSM375435

DR   GEO; GSM887313

DR   GEO; GSM888389

DR   GEO; GSM1670100

RX   PubMed=9620227;

RX   PubMed=22460905;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~100 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,13 (Cosmic-CLP)

ST   CSF1PO: 10,14 (DSMZ)

ST   D13S317: 13

ST   D16S539: 9,11

ST   D5S818: 11,12

ST   D7S820: 8,12 (Cosmic-CLP)

ST   D7S820: 8,8.1,12 (DSMZ)

ST   TH01: 8,9.3

ST   TPOX: 8,11

ST   vWA: 18,20 (Cosmic-CLP)

ST   vWA: 18,19,20 (DSMZ)

DI   NCIt; C114656; Endometrial adenosquamous carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MFF-1

AC   CVCL_R912

SY   Mandarin Fish Fry-1

RX   PubMed=18485510;

CC   Group: Fish cell line.

OX   NCBI_TaxID=119488; ! Siniperca chuatsi

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MFF-8C1

AC   CVCL_1K31

RX   PubMed=24101440;

RX   PubMed=25903999;

CC   Group: Fish cell line.

CC   Group: Vaccine production cell line.

OX   NCBI_TaxID=119488; ! Siniperca chuatsi

HI   CVCL_R912 ! MFF-1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MFH-3

AC   CVCL_W489

RX   PubMed=12237927;

CC   Derived from metastatic site: Lung.

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MFH-H

AC   CVCL_M824

RX   PubMed=10470134;

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MFH-I

AC   CVCL_M790

RX   PubMed=3025391;

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MFH-II

AC   CVCL_M791

RX   PubMed=3025391;

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MFH-ino

AC   CVCL_1407

DR   CLO; CLO_0050084

DR   BioSample; SAMN03472224

DR   ChEMBL-Cells; CHEMBL3308269

DR   ChEMBL-Targets; CHEMBL2366262

DR   Cosmic; 925343

DR   Cosmic-CLP; 925343

DR   GDSC; 925343

DR   GEO; GSM1670101

DR   RCB; RCB0749

RX   PubMed=1653597;

RX   PubMed=27397505;

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): Cosmic-CLP; RCB

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 11

ST   D5S818: 12

ST   D7S820: 9,11

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MFH-ToE

AC   CVCL_M825

RX   PubMed=10536176;

CC   Doubling time: 37 hours, at 20th passage (PubMed=10536176).

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MFH1NR

AC   CVCL_M800

RX   PubMed=6290021;

CC   Transformant: ChEBI; CHEBI:28469; 4-(hydroxyamino)quinoline N-oxide (4-HAQO).

CC   Breed/subspecies: Fischer 344.

DI   NCIt; C60442; Rat malignant fibrous histiocytoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

SX   Male

CA   Cancer cell line

//

ID   MFHm-2

AC   CVCL_W490

RX   PubMed=12237927;

CC   Derived from metastatic site: Retroperitoneal space.

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MFM-223

AC   CVCL_1408

SY   MFM223

DR   BTO; BTO:0001961

DR   CLO; CLO_0007695

DR   EFO; EFO_0006649

DR   BioSample; SAMN03473045

DR   BioSample; SAMN03473592

DR   ChEMBL-Cells; CHEMBL3308115

DR   ChEMBL-Targets; CHEMBL1075504

DR   Cosmic; 910948

DR   Cosmic; 2165000

DR   Cosmic-CLP; 910948

DR   DSMZ; ACC-422

DR   ECACC; 98050130

DR   GDSC; 910948

DR   GEO; GSM344380

DR   GEO; GSM344430

DR   GEO; GSM595616

DR   GEO; GSM783967

DR   GEO; GSM1670102

DR   Lonza; 162

DR   PRIDE; PXD000309

RX   PubMed=1913690;

RX   PubMed=22414580;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~5-7 days (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Derived from metastatic site: Pleural effusion.

ST   Source(s): Cosmic-CLP; DSMZ; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 8,12

ST   D16S539: 11

ST   D18S51: 21

ST   D21S11: 29,30

ST   D3S1358: 18

ST   D5S818: 11,12

ST   D7S820: 8,10 (Cosmic-CLP; ECACC; PubMed=25877200)

ST   D7S820: 8 (DSMZ)

ST   D8S1179: 14

ST   FGA: 19,23

ST   Penta D: 8,9,12

ST   Penta E: 15,17

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mfn1-null MEFs

AC   CVCL_L691

DR   ATCC; CRL-2992

RX   PubMed=12527753;

CC   Knockout cell: Method=KO mouse; MGI:1914664; Mfn1.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Mfn1/Mfn2-null MEFs

AC   CVCL_L692

DR   ATCC; CRL-2994

RX   PubMed=12527753;

CC   Knockout cell: Method=KO mouse; MGI:1914664; Mfn1.

CC   Knockout cell: Method=KO mouse; MGI:2442230; Mfn2.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Mfn2-null MEFs

AC   CVCL_L693

DR   ATCC; CRL-2993

RX   PubMed=12527753;

CC   Knockout cell: Method=KO mouse; MGI:2442230; Mfn2.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MFP-2

AC   CVCL_9V34

DR   ATCC; HB-12482

DR   NCBI_Iran; C605

RX   Patent=US6197582;

CC   Group: Hybridoma fusion partner cell line.

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_9V32 ! B6B11

CA   Hybrid cell line

//

ID   MFS5

AC   CVCL_B868

SY   MFS 5

DR   ISCR; 1379

WW   http://grants.nih.gov/stem_cells/registry/current.htm?id=394

CC   From: Stanford University; Stanford; USA.

CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0052.

DI   NCIt; C34807; Marfan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Embryonic stem cell

//

ID   mFS6

AC   CVCL_L882

SY   FS6

DR   CLO; CLO_0007696

DR   CLDB; cl3460

RX   PubMed=7426348;

CC   Transformant: ChEBI; CHEBI:29865; Benzo[a]pyrene.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MFS8

AC   CVCL_0J40

SY   MFS-8; MFS 8; Mouse FibroSarcoma No. 8

RX   PubMed=5954138;

RX   PubMed=9753870;

RX   PubMed=13990732;

CC   Breed/subspecies: Swiss.

DI   NCIt; C24017; Mouse fibrosarcoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MG-22A

AC   CVCL_U248

SY   MG22A; MG22a

DR   ChEMBL-Cells; CHEMBL3307374

DR   ChEMBL-Targets; CHEMBL614346

CC   Caution: Erroneously indicated as originating from human in ChEMBL CHEMBL614346 and CHEMBL3307374.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MG-3

AC   CVCL_J029

SY   Mrigal Gill-3

RX   CelloPub=CLPUB00080;

CC   Group: Fish cell line.

OX   NCBI_TaxID=683832; ! Cirrhinus mrigala

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   MG-63

AC   CVCL_0426

SY   M-G63; MG63

DR   BTO; BTO:0001596

DR   CLO; CLO_0007699

DR   CLO; CLO_0007701

DR   CLO; CLO_0050808

DR   EFO; EFO_0002234

DR   MCCL; MCC:0000323

DR   CLDB; cl3462

DR   CLDB; cl3463

DR   CLDB; cl3464

DR   CLDB; cl3465

DR   CLDB; cl4934

DR   ATCC; CRL-1427

DR   BCRC; 60279

DR   BCRJ; 0173

DR   BioSample; SAMN03471910

DR   BioSample; SAMN03472771

DR   CCLE; MG63_BONE

DR   CCRID; 3111C0001CCC000080

DR   CCRID; 3131C0001000700124

DR   CCRID; 3142C0001000000073

DR   ChEMBL-Cells; CHEMBL3308498

DR   ChEMBL-Targets; CHEMBL614347

DR   CLS; 300441/p2938_MG-63

DR   Cosmic; 755310

DR   Cosmic; 908131

DR   Cosmic; 931036

DR   Cosmic; 931913

DR   Cosmic; 1044085

DR   Cosmic; 1070844

DR   Cosmic; 1074394

DR   Cosmic; 1082504

DR   Cosmic; 1188475

DR   Cosmic; 1529903

DR   Cosmic-CLP; 908131

DR   ECACC; 86051601

DR   ENCODE; ENCBS091SUW

DR   ENCODE; ENCBS462PMF

DR   GDSC; 908131

DR   GEO; GSM170251

DR   GEO; GSM320828

DR   GEO; GSM827317

DR   GEO; GSM879217

DR   GEO; GSM887314

DR   GEO; GSM888390

DR   GEO; GSM1670103

DR   ICLC; HTL99003

DR   IFO; IFO50108

DR   IGRhCellID; MG63

DR   IZSLER; BS TCL 40

DR   KCB; KCB 200528YJ

DR   KCLB; 21427

DR   Lonza; 872

DR   NCBI_Iran; C555

DR   RCB; RCB1890

DR   TKG; TKG 0294

DR   TOKU-E; 2429

RX   PubMed=2823272;

RX   PubMed=7873286;

RX   PubMed=8617485;

RX   PubMed=12645653;

RX   PubMed=15736406;

RX   PubMed=19363654;

RX   PubMed=19787792;

RX   PubMed=21519327;

RX   PubMed=22460905;

RX   PubMed=25382592;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-91.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 28.3 hours (PubMed=19363654).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Metabolome analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB; PubMed=25877200; RCB; TKG

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 11 (ATCC; CLS; Cosmic-CLP; ECACC; PubMed=25877200; RCB; TKG)

ST   D16S539: 11,12 (JCRB)

ST   D18S51: 13 (CLS)

ST   D18S51: 16 (PubMed=25877200)

ST   D21S11: 28,29 (CLS)

ST   D21S11: 30 (PubMed=25877200)

ST   D3S1358: 15,17 (CLS)

ST   D3S1358: 15 (KCLB; PubMed=25877200)

ST   D5S818: 11,12

ST   D7S820: 10

ST   D8S1179: 11,15 (CLS)

ST   D8S1179: 13 (PubMed=25877200)

ST   FGA: 20,21 (CLS)

ST   FGA: 21,25 (KCLB; PubMed=25877200)

ST   Penta D: 11,13 (CLS)

ST   Penta D: 9,13 (PubMed=25877200)

ST   Penta E: 12 (CLS)

ST   Penta E: 11,12 (PubMed=25877200)

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 16,19

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MG-63.3A

AC   CVCL_IR36

SY   MG63.3A

RX   PubMed=2533054;

RX   PubMed=3068006;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0426 ! MG-63

SX   Male

CA   Cancer cell line

//

ID   MG0001

AC   CVCL_8Y19

DR   ECACC; 00080908

CC   Part of: ECACC chromosomal abnormality collection.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   MG1.19

AC   CVCL_C314

DR   BTO; BTO:0003561

CC   Breed/subspecies: 129S/SvEv-Gpi1<c>.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_C313 ! CCE

SX   Male

CA   Embryonic stem cell

//

ID   MG1361

AC   CVCL_3404

SY   MG-1361

DR   CLO; CLO_0007697

DR   CLDB; cl3461

DR   ICLC; ATL97003

RX   PubMed=9497105;

CC   Transfected with: RGD; 2561; Erbb2 (with E-661).

CC   Transformant: Activated Erbb2/neu.

CC   Breed/subspecies: (C57BL/6 x DBA)F1 x CD-1 MMTV-neu transgenic.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   MG20

AC   CVCL_5T82

RX   PubMed=17121794;

CC   Breed/subspecies: Tga20.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MG38

AC   CVCL_J763

DR   CLO; CLO_0007698

DR   ATCC; CRL-2640

RX   PubMed=10980384;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MG5

AC   CVCL_5556

DR   IFO; IFO50520

RX   PubMed=9383038;

CC   Knockout cell: Method=KO mouse; MGI; MGI:98834; Trp53.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MG6

AC   CVCL_8732

SY   MG6-1

DR   CLO; CLO_0050905

DR   RCB; RCB2403

RX   PubMed=16122875;

CC   Transfected with: HGNC; 7553; MYC.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Sex undetermined

CA   Transformed cell line

//

ID   MG63/DXR1000

AC   CVCL_9U34

RX   PubMed=10854558;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0426 ! MG-63

SX   Male

CA   Cancer cell line

//

ID   MG63.2

AC   CVCL_R705

RX   PubMed=19363654;

CC   Doubling time: 36.1 hours (PubMed=19363654).

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0426 ! MG-63

SX   Male

CA   Cancer cell line

//

ID   MG87

AC   CVCL_U510

SY   MG-87

RX   PubMed=7657612;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-122.html

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Transformed cell line

//

ID   MGAR

AC   CVCL_E775

SY   MGar

DR   dbMHC; 48970

DR   ECACC; 88022014

DR   IHW; IHW9014

DR   IMGT/HLA; 11069

RX   PubMed=23619976;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl14.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   MGC-803

AC   CVCL_5334

SY   MGC803

DR   BTO; BTO:0004953

DR   EFO; EFO_0006286

DR   CCRID; 3111C0001CCC000227

DR   CCRID; 3131C0001000700084

DR   Cosmic; 2267321

DR   GEO; GSM844588

DR   GEO; GSM1374671

RX   DOI=10.1007/BF02948354;

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'MCG803' in GEO GSM844588.

DI   NCIt; C4911; Gastric carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   mGC11CEA

AC   CVCL_X065

RX   PubMed=16536871;

DI   NCIt; C24227; Mouse gastric adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   mGC2CEA

AC   CVCL_X066

RX   PubMed=16536871;

DI   NCIt; C24227; Mouse gastric adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   mGC3

AC   CVCL_X067

RX   PubMed=16536871;

DI   NCIt; C24227; Mouse gastric adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   mGC4CEA

AC   CVCL_X068

RX   PubMed=16536871;

DI   NCIt; C24227; Mouse gastric adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   mGC5

AC   CVCL_X069

RX   PubMed=16536871;

DI   NCIt; C24227; Mouse gastric adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Cancer cell line

//

ID   mGC8

AC   CVCL_X070

RX   PubMed=16536871;

DI   NCIt; C24227; Mouse gastric adenocarcinoma

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Cancer cell line

//

ID   MGE02

AC   CVCL_6B98

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGE12-1

AC   CVCL_6B99

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGE3-2

AC   CVCL_6C00

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGE503

AC   CVCL_6C01

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGE507

AC   CVCL_6C02

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGE509

AC   CVCL_6C03

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGE511

AC   CVCL_6C04

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGE727

AC   CVCL_6C05

RX   PubMed=12743444;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MGH-13

AC   CVCL_W788

SY   MGH13

RX   PubMed=8382008;

RX   PubMed=9649128;

RX   PubMed=11369051;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-14

AC   CVCL_W789

SY   MGH14

RX   PubMed=8382008;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-24

AC   CVCL_W790

SY   MGH24

RX   PubMed=8382008;

RX   PubMed=9649128;

RX   PubMed=11369051;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-26

AC   CVCL_W791

SY   MGH26

RX   PubMed=8382008;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-30

AC   CVCL_W792

SY   MGH30

RX   PubMed=8382008;

RX   PubMed=9649128;

RX   PubMed=11369051;

DI   NCIt; C9133; Adenosquamous lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-4

AC   CVCL_W785

SY   MGH4

RX   PubMed=8382008;

RX   PubMed=9649128;

RX   PubMed=11369051;

DI   NCIt; C4450; Large cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-7

AC   CVCL_W786

SY   MGH7

RX   PubMed=8382008;

RX   PubMed=9649128;

RX   PubMed=11369051;

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MGH-8

AC   CVCL_W787

SY   MGH8

RX   PubMed=8382008;

RX   PubMed=9649128;

RX   PubMed=11369051;

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-BA-1

AC   CVCL_A651

SY   BA-1

DR   Cosmic; 706099

DR   Cosmic; 897492

RX   PubMed=9692547;

RX   PubMed=10766161;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-BO-1

AC   CVCL_A652

SY   BO-1

DR   Cosmic; 706100

DR   Cosmic; 888841

DR   Cosmic; 897488

RX   PubMed=9692547;

RX   PubMed=10766161;

RX   PubMed=15009714;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-GO-1

AC   CVCL_W794

DR   Cosmic; 706094

RX   PubMed=10766161;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-LA-1

AC   CVCL_W795

DR   Cosmic; 706109

RX   PubMed=10766161;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-MC-1

AC   CVCL_9878

DR   Cosmic; 888854

DR   Cosmic; 897485

RX   PubMed=15009714;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-MC-2

AC   CVCL_9879

DR   Cosmic; 706085

DR   Cosmic; 888830

DR   Cosmic; 897470

RX   PubMed=10766161;

RX   PubMed=15009714;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-mcc1

AC   CVCL_D781

DR   Cosmic; 1693012

RX   PubMed=22261808;

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MGH-PO-1

AC   CVCL_A653

DR   Cosmic; 706088

DR   Cosmic; 888832

DR   Cosmic; 897472

RX   PubMed=10766161;

RX   PubMed=15009714;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH-U2

AC   CVCL_9826

SY   MGHU2; MGH-U2 (HM); HM

DR   BioSample; SAMN03151950

DR   Cosmic; 925831

RX   PubMed=3708594;

RX   PubMed=4027986;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594, PubMed=20143388).

ST   Source(s): PubMed=11416159

ST   Amelogenin: X

ST   D18S51: 16,18

ST   D21S11: 29

ST   D8S1179: 14

ST   FGA: 17,22

ST   TH01: 6

ST   vWA: 17

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0554 ! T24

SX   Female

CA   Cancer cell line

//

ID   MGH-U3

AC   CVCL_9827

SY   MGHU3; MG-HU-3; MGH-U3 (RN); RN

DR   Cosmic; 928825

DR   Cosmic; 1016886

DR   Cosmic; 1068090

DR   Cosmic; 1285123

DR   Cosmic; 1286013

DR   Cosmic; 1302361

DR   Cosmic; 1927290

DR   Cosmic; 1938479

DR   Cosmic; 2037951

DR   Cosmic; 2050458

DR   GEO; GSM1374672

DR   GEO; GSM1374673

DR   GEO; GSM1574573

RX   PubMed=4027986;

RX   PubMed=8873383;

RX   PubMed=16885334;

RX   PubMed=23401075;

RX   PubMed=24018021;

RX   PubMed=24367658;

RX   PubMed=25997541;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MGH-U4

AC   CVCL_9828

SY   MGHU4; MG-HU-4; MGH-U4 (RB); RB

DR   Cosmic; 928826

DR   Cosmic; 1016879

DR   Cosmic; 1927291

DR   Cosmic; 2037952

DR   GEO; GSM1574549

RX   PubMed=4027986;

RX   PubMed=8873383;

RX   PubMed=16885334;

RX   PubMed=23401075;

RX   PubMed=24018021;

RX   PubMed=25997541;

RX   PubMed=26621286;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MGH021-4

AC   CVCL_AY54

DR   Cosmic; 2275266

RX   PubMed=24675041;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH045

AC   CVCL_AY55

DR   Cosmic; 2275265

RX   PubMed=24675041;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH051

AC   CVCL_AY56

DR   Cosmic; 2275267

RX   PubMed=24675041;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH056-1

AC   CVCL_EI95

DR   Cosmic; 2245570

RX   PubMed=25228534;

CC   Derived from metastatic site: Liver.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH119

AC   CVCL_DH47

DR   GEO; GSM1568545

RX   PubMed=25758528;

CC   Omics: Transcriptome analysis.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH119-R

AC   CVCL_DH48

SY   MGH119-GR

DR   GEO; GSM1568546

RX   PubMed=25758528;

CC   Selected for resistance to: ChEBI; CHEBI:49668; Gefitinib (ZD1839; Iressa).

CC   Omics: Transcriptome analysis.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH47 ! MGH119

CA   Cancer cell line

//

ID   MGH121

AC   CVCL_DH49

DR   GEO; GSM1568547

RX   PubMed=25758528;

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH125

AC   CVCL_DH50

DR   GEO; GSM1568548

DR   GEO; GSM1579487

RX   PubMed=25758528;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MGH126

AC   CVCL_DH51

DR   GEO; GSM1568549

RX   PubMed=25758528;

CC   Omics: Transcriptome analysis.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH131-1

AC   CVCL_DH52

DR   GEO; GSM1568553

DR   GEO; GSM1579486

RX   PubMed=25758528;

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DH53 ! MGH131-2

SX   Male

CA   Cancer cell line

//

ID   MGH131-2

AC   CVCL_DH53

DR   GEO; GSM1568554

RX   PubMed=25758528;

CC   Omics: Transcriptome analysis.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_DH52 ! MGH131-1

SX   Male

CA   Cancer cell line

//

ID   MGH134

AC   CVCL_DH54

DR   GEO; GSM1568550

RX   PubMed=25758528;

CC   Omics: Transcriptome analysis.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH141

AC   CVCL_DH55

DR   GEO; GSM1568551

RX   PubMed=25758528;

CC   Omics: Transcriptome analysis.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH156

AC   CVCL_DH56

RX   PubMed=25758528;

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGH157

AC   CVCL_DH57

DR   GEO; GSM1568552

RX   PubMed=25758528;

CC   Omics: Transcriptome analysis.

DI   NCIt; C2926; Non-small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGL8

AC   CVCL_D892

SY   MGL-8

DR   BTO; BTO:0005260

RX   PubMed=605378;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   MGM-1

AC   CVCL_W447

RX   PubMed=7556648;

RX   PubMed=9234071;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MGM-2

AC   CVCL_W448

RX   PubMed=7556648;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MGM-3

AC   CVCL_W449

RX   PubMed=7556648;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MGM-A

AC   CVCL_X197

RX   PubMed=8513002;

RX   PubMed=8519890;

OX   NCBI_TaxID=10047; ! Meriones unguiculatus

OI   CVCL_X198 ! MGM-S

SX   Male

CA   Cancer cell line

//

ID   MGM-S

AC   CVCL_X198

RX   PubMed=8519890;

OX   NCBI_TaxID=10047; ! Meriones unguiculatus

OI   CVCL_X197 ! MGM-A

SX   Male

CA   Cancer cell line

//

ID   MGR1

AC   CVCL_8563

SY   MGR 1; MGR-1; UWR1; UWR-1

RX   PubMed=2208164;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGR2

AC   CVCL_8564

SY   MGR 2; UWR2; UWR-2

RX   PubMed=2208164;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGR3

AC   CVCL_8565

SY   MGR 3; UWR3; UWR-3

DR   Lonza; 710

RX   PubMed=2208164;

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MGS

AC   CVCL_6A84

SY   Mongolian gerbil Gastric epithelial cells with SV-40

RX   DOI=10.1016/S0016-5085(08)83714-6;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10047; ! Meriones unguiculatus

CA   Transformed cell line

//

ID   mGS-DBA1

AC   CVCL_1T53

DR   RCB; AES0004

DR   RCB; RCB2003

RX   PubMed=15620358;

CC   Characteristics: Germ stem cell line.

CC   Discontinued: RCB; RCB2003; true.

CC   Breed/subspecies: DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MGSO-3

AC   CVCL_6847

DR   BTO; BTO:0005047

RX   PubMed=19725227;

RX   PubMed=23404580;

DI   NCIt; C4872; Breast carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   mh

AC   CVCL_6780

AS   CVCL_4242

SY   mocha; Mocha; MOCHA

DR   CLO; CLO_0007706

DR   ATCC; CRL-2709

DR   ECACC; 02111901

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Finite cell line

//

ID   MH [Human mesothelioma]

AC   CVCL_W085

DR   Cosmic; 1522783

DR   GEO; GSM726278

RX   PubMed=21642991;

CC   Omics: SNP array analysis.

DI   NCIt; C3234; Mesothelioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MH [Human ovarian carcinoma]

AC   CVCL_F845

DR   CGH-DB; 339-2

DR   Cosmic; 931365

RX   PubMed=7844449;

RX   PubMed=8217948;

RX   PubMed=17671176;

DI   NCIt; C7978; Ovarian serous cystadenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MH 55

AC   CVCL_J224

SY   MH55

DR   CLO; CLO_0007712

DR   ATCC; HB-8412

RX   Patent=US4666845;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH 94

AC   CVCL_J844

DR   ATCC; HB-8413

RX   Patent=US4666845;

CC   Discontinued: ATCC; HB-8413; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH-1

AC   CVCL_H639

DR   Cosmic; 1086351

RX   CelloPub=CLPUB00081;

RX   PubMed=2456698;

RX   PubMed=15356658;

DI   NCIt; C3720; Anaplastic large cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MH-12

AC   CVCL_AT87

DR   Cosmic; 888858

RX   PubMed=15009714;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MH-17

AC   CVCL_AT88

DR   Cosmic; 888863

RX   PubMed=15009714;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MH-2

AC   CVCL_AT89

DR   Cosmic; 888859

RX   PubMed=15009714;

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MH-22a

AC   CVCL_3854

SY   MH-22A

DR   CLO; CLO_0007710

DR   CLO; CLO_0007711

DR   CLDB; cl3472

DR   CLDB; cl5082

DR   ECACC; 96121721

CC   Breed/subspecies: C3HA.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MH-3924A

AC   CVCL_5799

SY   MH 3924A; MH3924A; MH-3924 A; MH 3924 A; 3924A; Morris hepatoma 3924A; MH-3924; MH3924; MH 3924

DR   BTO; BTO:0000577

DR   ChEMBL-Cells; CHEMBL3307989

DR   ChEMBL-Targets; CHEMBL612581

DR   CLS; 500286/p2646_MH-3924A

CC   Breed/subspecies: ACI.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   MH-7777A

AC   CVCL_2113

SY   MH 7777A; MH7777A

DR   BTO; BTO:0000217

DR   CLO; CLO_0007713

DR   DSMZ; ACC-345

RX   PubMed=7498532;

CC   Doubling time: ~48 hours (DSMZ).

CC   Breed/subspecies: Buffalo.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

OI   CVCL_0444 ! McA-RH7777

OI   CVCL_0F78 ! 7777-14b-aza

SX   Female

CA   Cancer cell line

//

ID   MH-S

AC   CVCL_3855

DR   CLO; CLO_0007721

DR   CLDB; cl3473

DR   CLDB; cl5231

DR   ATCC; CRL-2019

DR   BCRC; 60419

DR   CCRID; 3131C0001001200005

DR   ECACC; 95090612

DR   IZSLER; BS CL 141

RX   PubMed=2787372;

WW   http://www.infarktforschung.de/macrophages_cell_lines.html

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/cJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   MH-SVM16

AC   CVCL_J764

SY   SVM-16

DR   ATCC; HB-8880

RX   Patent=US4843011;

CC   Discontinued: ATCC; HB-8880; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH-SVM23

AC   CVCL_J765

SY   SVM-23

DR   CLO; CLO_0007722

DR   ATCC; HB-8870

RX   Patent=US4843011;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH-SVM25

AC   CVCL_J766

SY   SVM-25

DR   CLO; CLO_0007723

DR   ATCC; HB-8871

RX   Patent=US4843011;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH-SVM26

AC   CVCL_J767

SY   SVM-26

DR   CLO; CLO_0007724

DR   ATCC; HB-8872

RX   Patent=US4843011;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH-SVM33C9

AC   CVCL_J768

SY   MH-SVM33; SVM-33

DR   CLO; CLO_0007725

DR   ATCC; HB-8975

RX   Patent=US4843011;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH-TC-5123

AC   CVCL_5800

DR   CLS; 500287/p592_MH-TC-5123

CC   Breed/subspecies: Buffalo.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   MH/Nike

AC   CVCL_DN29

SY   Nike

DR   GEO; GSM1974795

RX   PubMed=26842912;

RX   PubMed=27197945;

RX   PubMed=27257868;

CC   Part of: FACC canine tumor cell line panel.

CC   Omics: Transcriptome analysis.

DI   NCIt; C128125; Canine histiocytic sarcoma

OX   NCBI_TaxID=9615; ! Canis lupus familiaris

CA   Cancer cell line

//

ID   MH01

AC   CVCL_J222

DR   ECACC; 93062401

OX   NCBI_TaxID=9606; ! Homo sapiens

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_3940 ! NS0

CA   Hybridoma

//

ID   MH1

AC   CVCL_J223

DR   CLO; CLO_0007708

DR   ATCC; HB-9739

RX   Patent=US5091512;

RX   Patent=US5120834;

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   MH1-BS

AC   CVCL_M227

RX   PubMed=3030788;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV7].

DI   NCIt; C2903; Bloom syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J657 ! GM02548

SX   Male

CA   Transformed cell line

//

ID   MH11

AC   CVCL_8893

RX   PubMed=1283157;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MH11

CC   Characteristics: Requires feeder cells. Maintenance of MH11 depends on the presence of cell line ST-2 (CVCL_2205).

CC   Characteristics: IL7 dependent.

CC   Breed/subspecies: C57BL/6 x BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Factor-dependent cell line

//

ID   MH129

AC   CVCL_8110

SY   MH-129; MH 129

CC   Breed/subspecies: C3H/He.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MH129F-TC

AC   CVCL_8Z12

SY   MH129F

DR   TKG; TKG 0159

DR   TKG; TKG 0569

CC   Breed/subspecies: C3H/He.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8110 ! MH129

CA   Cancer cell line

//

ID   MH129P-TC

AC   CVCL_8Z13

SY   MH129P

DR   TKG; TKG 0160

DR   TKG; TKG 0570

CC   Breed/subspecies: C3H/He.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_8110 ! MH129

CA   Cancer cell line

//

ID   MH134-TC

AC   CVCL_8111

SY   MH-134; MH 134; MH134

DR   BTO; BTO:0001083

DR   TKG; TKG 0161

DR   TKG; TKG 0568

CC   Breed/subspecies: C3H/He.

DI   NCIt; C38756; Hepatocellular carcinoma of the mouse

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Cancer cell line

//

ID   MH1C1

AC   CVCL_2114

SY   MH 1 C 1

DR   BTO; BTO:0000220

DR   CLO; CLO_0007707

DR   CLO; CLO_0007709

DR   CLDB; cl3474

DR   CLDB; cl3475

DR   CLDB; cl3476

DR   CLDB; cl3477

DR   CLDB; cl4918

DR   ATCC; CCL-144

DR   BCRC; 60143

DR   ChEMBL-Cells; CHEMBL3307375

DR   ChEMBL-Targets; CHEMBL614349

DR   DSMZ; ACC-106

DR   ECACC; 85112702

DR   GEO; GSM1240490

DR   GEO; GSM1240491

DR   GEO; GSM1240492

DR   GEO; GSM1240493

DR   GEO; GSM1240494

DR   GEO; GSM1240495

DR   GEO; GSM1240496

DR   GEO; GSM1240497

DR   GEO; GSM1240498

DR   GEO; GSM1240499

DR   GEO; GSM1240500

DR   GEO; GSM1240501

DR   ICLC; ATL98014

DR   IZSLER; BS TCL 41

RX   PubMed=4177659;

RX   PubMed=24386269;

CC   Doubling time: ~33-60 hours (DSMZ).

CC   Omics: Transcriptome analysis.

CC   Discontinued: ECACC; 85112702; probable.

CC   Breed/subspecies: Buffalo.

DI   NCIt; C60416; Rat hepatocellular carcinoma

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Cancer cell line

//

ID   MH2-FA

AC   CVCL_M228

RX   PubMed=3030788;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV7].

DI   NCIt; C62505; Fanconi anemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_F593 ! GM02053

SX   Female

CA   Transformed cell line

//

ID   MH3-XPD

AC   CVCL_M229

RX   PubMed=3030788;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV7].

DI   NCIt; C3967; Xeroderma pigmentosum, complementation group D

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_L754 ! GM00434

SX   Male

CA   Transformed cell line

//

ID   MH60.BSF2

AC   CVCL_7201

SY   MH60.BSF-2; MH60-BSF-2

DR   TKG; TKG 0226

RX   PubMed=3260187;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MH60-BSF-2

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Hybridoma

//

ID   MH7A

AC   CVCL_0427

DR   BTO; BTO:0003437

DR   CLO; CLO_0050142

DR   BioSample; SAMN03472146

DR   MCCL; MCC:0000324

DR   RCB; RCB1512

RX   PubMed=9832620;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): RCB

ST   Amelogenin: X

ST   CSF1PO: 12,14

ST   D13S317: 8

ST   D16S539: 10,11

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 6,9

ST   TPOX: 8

ST   vWA: 15,17

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   MHCC97

AC   CVCL_4971

SY   MHCC-97; MHCC 97

DR   BTO; BTO:0004168

DR   GEO; GSM1374674

RX   PubMed=10555751;

CC   Characteristics: Has lost chromosome Y.

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHCC97-H

AC   CVCL_4972

SY   MHCC 97-H; MHCC97H

DR   BTO; BTO:0004169

DR   GEO; GSM936771

DR   GEO; GSM1374675

DR   PRIDE; PXD000529

DR   PRIDE; PXD000533

DR   PRIDE; PXD000535

RX   PubMed=11819844;

RX   PubMed=15048980;

RX   PubMed=15146329;

RX   PubMed=23505090;

CC   Characteristics: Has lost chromosome Y.

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4971 ! MHCC97

SX   Male

CA   Cancer cell line

//

ID   MHCC97-L

AC   CVCL_4973

SY   MHCC 97-L; MHCC97L

DR   BTO; BTO:0004170

DR   GEO; GSM936772

DR   GEO; GSM1374676

RX   PubMed=11819844;

RX   PubMed=15048980;

RX   PubMed=15146329;

RX   PubMed=23505090;

CC   Characteristics: Has lost chromosome Y.

CC   Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C3099; Hepatocellular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_4971 ! MHCC97

SX   Male

CA   Cancer cell line

//

ID   MHEC5-T

AC   CVCL_2115

SY   Mouse Heart Endothelial Cell clone 5-Transformed

DR   CLO; CLO_0007714

DR   DSMZ; ACC-336

RX   PubMed=7655744;

CC   Doubling time: ~30 hours (DSMZ).

CC   Breed/subspecies: NMRI.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   MHH-CALL-2

AC   CVCL_1409

SY   Mhh-Call 2; MHH-CALL2; MHHCALL2

DR   CLO; CLO_0007715

DR   BioSample; SAMN03473355

DR   CCLE; MHHCALL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   ChEMBL-Cells; CHEMBL3308333

DR   ChEMBL-Targets; CHEMBL2366286

DR   Cosmic; 908132

DR   Cosmic; 1012089

DR   Cosmic; 1130251

DR   Cosmic; 1524803

DR   Cosmic; 1943387

DR   Cosmic; 2491071

DR   Cosmic-CLP; 908132

DR   DSMZ; ACC-341

DR   GDSC; 908132

DR   GEO; GSM236789

DR   GEO; GSM236825

DR   GEO; GSM887315

DR   GEO; GSM888391

DR   GEO; GSM931335

DR   GEO; GSM1670104

RX   PubMed=9067587;

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~100 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 14

ST   D13S317: 8

ST   D16S539: 14

ST   D5S818: 12

ST   D7S820: 9

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 18

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MHH-CALL-3

AC   CVCL_0089

SY   Mhh-Call 3; MHH cALL 3; MHH-CALL3; MHH-cALL3; MHHCALL3

DR   CLO; CLO_0007716

DR   BioSample; SAMN03473353

DR   CCLE; MHHCALL3_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 1281374

DR   Cosmic; 1524844

DR   Cosmic; 2491072

DR   DSMZ; ACC-339

DR   GEO; GSM236790

DR   GEO; GSM236826

DR   GEO; GSM887316

DR   GEO; GSM888392

RX   PubMed=9067587;

RX   PubMed=15843827;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~120 hours (DSMZ).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 12,13

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 6,8

ST   TPOX: 8,10

ST   vWA: 16

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MHH-CALL-4

AC   CVCL_1410

SY   MHH-CALL4; MHHCALL4

DR   CLO; CLO_0007717

DR   BioSample; SAMN03473351

DR   CCLE; MHHCALL4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 908133

DR   Cosmic; 1012090

DR   Cosmic; 1278370

DR   Cosmic; 1524804

DR   Cosmic-CLP; 908133

DR   DSMZ; ACC-337

DR   GEO; GSM887317

DR   GEO; GSM888393

DR   GEO; GSM1670105

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~80-100 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 9,10

ST   D16S539: 11

ST   D5S818: 13

ST   D7S820: 9,11

ST   TH01: 7,9.3

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C9140; Childhood B acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHH-ES-1

AC   CVCL_1411

SY   MHH-ES1

DR   CLO; CLO_0007718

DR   EFO; EFO_0006650

DR   CLDB; cl3478

DR   BioSample; SAMN03471911

DR   BioSample; SAMN03473362

DR   CCLE; MHHES1_BONE

DR   ChEMBL-Cells; CHEMBL3308762

DR   ChEMBL-Targets; CHEMBL1075505

DR   CLS; 300136/p724_MHH-ES1

DR   Cosmic; 908134

DR   Cosmic; 1718436

DR   Cosmic; 2250463

DR   Cosmic-CLP; 908134

DR   DSMZ; ACC-167

DR   GDSC; 908134

DR   GEO; GSM887318

DR   GEO; GSM888394

DR   GEO; GSM1670106

RX   DOI=10.1016/0165-4608(89)90568-2;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=25223734;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~28 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): CLS; Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8 (CLS; PubMed=25877200)

ST   D13S317: 8,13 (Cosmic-CLP; DSMZ)

ST   D16S539: 11

ST   D18S51: 14,16

ST   D21S11: 28,32.2

ST   D3S1358: 15,16

ST   D5S818: 13

ST   D7S820: 9,11

ST   D8S1179: 11,13

ST   FGA: 22

ST   Penta D: 11,12

ST   Penta E: 11,15

ST   TH01: 8,9

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHH-MED-1

AC   CVCL_7988

SY   MHH-Med-1; MED1

DR   Cosmic; 975026

DR   Cosmic; 2362654

DR   GEO; GSM919362

RX   PubMed=8205550;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHH-MED-2

AC   CVCL_7989

DR   Cosmic; 2362655

RX   PubMed=8205550;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MHH-MED-3

AC   CVCL_7990

DR   Cosmic; 2362656

RX   PubMed=8205550;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MHH-MED-4

AC   CVCL_7991

RX   PubMed=8205550;

DI   NCIt; C3222; Medulloblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHH-NB-11

AC   CVCL_1412

SY   MHH-NB11; MHHNB11

DR   CLO; CLO_0007719

DR   EFO; EFO_0006651

DR   CLDB; cl3479

DR   BioSample; SAMN03473088

DR   CCLE; MHHNB11_AUTONOMIC_GANGLIA

DR   ChEMBL-Cells; CHEMBL3308310

DR   ChEMBL-Targets; CHEMBL2366185

DR   Cosmic; 908135

DR   Cosmic; 2485948

DR   Cosmic-CLP; 908135

DR   DSMZ; ACC-157

DR   GDSC; 908135

DR   GEO; GSM887319

DR   GEO; GSM888395

DR   GEO; GSM1366409

DR   GEO; GSM1670107

RX   DOI=10.1016/B978-0-12-333530-2.50006-X;

RX   PubMed=3218965;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~100 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Adrenal gland.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9,13

ST   D18S51: 16,17

ST   D21S11: 30,31.2

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 13,14

ST   FGA: 20,21

ST   Penta D: 11,12

ST   Penta E: 5,12

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C3270; Neuroblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHH-PNET-5

AC   CVCL_7992

RX   PubMed=8205550;

DI   NCIt; C5406; Spinal cord primitive neuroectodermal tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MHH-PREB-1

AC   CVCL_1413

SY   MHHPREB1

DR   CLO; CLO_0007720

DR   EFO; EFO_0002235

DR   BioSample; SAMN03471645

DR   BioSample; SAMN03473315

DR   ChEMBL-Cells; CHEMBL3308334

DR   ChEMBL-Targets; CHEMBL2366127

DR   Cosmic; 908136

DR   Cosmic; 2276316

DR   Cosmic; 2491097

DR   Cosmic-CLP; 908136

DR   DSMZ; ACC-354

DR   GDSC; 908136

DR   GEO; GSM1670108

DR   IGRhCellID; MHHPREB1

RX   PubMed=9067587;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: ~20-40 hours (DSMZ).

CC   Microsatellite instability: Instable (MSI-high) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 8,12

ST   D16S539: 8,13

ST   D18S51: 11,18

ST   D21S11: 29,30

ST   D3S1358: 17,19

ST   D5S818: 11,13,14 (Cosmic-CLP)

ST   D5S818: 11,13 (DSMZ; PubMed=25877200)

ST   D7S820: 11,12 (Cosmic-CLP; DSMZ)

ST   D7S820: 11,12.3 (PubMed=25877200)

ST   D8S1179: 10,16

ST   FGA: 21,23

ST   Penta D: 9,13

ST   Penta E: 7,16

ST   TH01: 7,9

ST   TPOX: 9,11

ST   vWA: 15,20

DI   NCIt; C3457; B-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHH-TALL-1

AC   CVCL_9824

SY   MHH-TALL1

DR   Cosmic; 1281375

DR   Cosmic; 1498421

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MHH-TALL-2

AC   CVCL_9825

SY   MHH-TALL2

DR   Cosmic; 1281376

DR   DSMZ; ACC-728

CC   Doubling time: ~60-72 hours (DSMZ).

ST   Source(s): DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 11,12

ST   D5S818: 10,12

ST   D7S820: 8,11

ST   TH01: 9

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C9142; Adult T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MHH225

AC   CVCL_8894

SY   MHH-225; MHH 225

DR   BioSample; SAMN03151807

RX   PubMed=7548328;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a Jurkat derivative (PubMed=12592342, PubMed=20143388). Was originally thought to originate from an acute myeloid leukemia.

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0065 ! Jurkat

SX   Male

CA   Cancer cell line

//

ID   MHHZ-00020533

AC   CVCL_V376

DR   IMGT/HLA; 14464

RX   PubMed=16948657;

CC   Part of: International Histocompatibility Workshop cell lines.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   mHippoE-14

AC   CVCL_D375

RX   PubMed=20619320;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU198?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Swiss Webster.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHippoE-18

AC   CVCL_D376

RX   PubMed=20619320;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU199?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Swiss Webster.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHippoE-2

AC   CVCL_D377

RX   PubMed=20619320;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU196?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Swiss Webster.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHippoE-5

AC   CVCL_D378

RX   PubMed=20619320;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU197?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Swiss Webster.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MHM

AC   CVCL_B426

SY   MHMX

DR   Cosmic; 1529904

DR   GEO; GSM879218

RX   PubMed=8198963;

RX   PubMed=19787792;

RX   PubMed=21519327;

DI   NCIt; C9145; Osteosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MHM-25

AC   CVCL_GZ63

DR   GEO; GSM1676342

DR   GEO; GSM1701673

RX   PubMed=26351324;

DI   NCIt; C9118; Sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MHM-8

AC   CVCL_GZ64

DR   GEO; GSM1676307

DR   GEO; GSM1701641

RX   PubMed=26351324;

DI   NCIt; C9118; Sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MHP36

AC   CVCL_U372

DR   Lonza; 705

RX   PubMed=9316014;

RX   PubMed=11447341;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   MHR14

AC   CVCL_DE45

SY   GM11535

DR   CLO; CLO_0021002

DR   Coriell; GM11535

RX   PubMed=1765380;

CC   Group: Human/rodent somatic cell hybrid.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DE39 ! HHW890

CA   Hybrid cell line

//

ID   mHypoA-1/1

AC   CVCL_D379

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU178?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-1/2

AC   CVCL_D380

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU172?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-1/3

AC   CVCL_D381

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU173?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-1/6

AC   CVCL_D382

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU179?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-1/9

AC   CVCL_D383

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU180?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/10

AC   CVCL_D384

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU176?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/12

AC   CVCL_D385

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU177?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/21

AC   CVCL_D386

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU181?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/22

AC   CVCL_D387

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU182?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/23

AC   CVCL_D388

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU183?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/24

AC   CVCL_D389

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU184?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/25

AC   CVCL_D390

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU185?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/26

AC   CVCL_D391

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU186?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/27

AC   CVCL_D392

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU187?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/28

AC   CVCL_D393

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU188?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/29

AC   CVCL_D394

DR   BCRJ; 0296

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU189?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Misspelling: 'CLU-189' in BCRJ (based on the Cellutions Biosystems catalog number).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/30

AC   CVCL_D395

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU190?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/31

AC   CVCL_D396

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU191?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/32

AC   CVCL_D397

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU192?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/33

AC   CVCL_D398

RX   PubMed=19703933;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU193.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/34

AC   CVCL_D399

RX   PubMed=19703933;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: Cedarlane Cellutions Systems; Catalog number CLU194.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/4

AC   CVCL_D400

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU174?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-2/6

AC   CVCL_D401

RX   PubMed=19703933;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU175?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-41

AC   CVCL_D402

WW   https://www.cedarlanelabs.com/Products/Detail/CLU450?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-42

AC   CVCL_D403

WW   https://www.cedarlanelabs.com/Products/Detail/CLU451?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-43

AC   CVCL_D404

WW   https://www.cedarlanelabs.com/Products/Detail/CLU452?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-44

AC   CVCL_D405

WW   https://www.cedarlanelabs.com/Products/Detail/CLU453?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-45

AC   CVCL_D406

WW   https://www.cedarlanelabs.com/Products/Detail/CLU454?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-46

AC   CVCL_D407

WW   https://www.cedarlanelabs.com/Products/Detail/CLU455?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-47

AC   CVCL_D408

WW   https://www.cedarlanelabs.com/Products/Detail/CLU456?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-48

AC   CVCL_D409

WW   https://www.cedarlanelabs.com/Products/Detail/CLU457?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-49

AC   CVCL_D410

WW   https://www.cedarlanelabs.com/Products/Detail/CLU458?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-50

AC   CVCL_D411

WW   https://www.cedarlanelabs.com/Products/Detail/CLU459?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-51

AC   CVCL_D412

WW   https://www.cedarlanelabs.com/Products/Detail/CLU460?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-52

AC   CVCL_D413

WW   https://www.cedarlanelabs.com/Products/Detail/CLU461?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-53

AC   CVCL_D414

WW   https://www.cedarlanelabs.com/Products/Detail/CLU462?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-54

AC   CVCL_D415

WW   https://www.cedarlanelabs.com/Products/Detail/CLU463?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-55

AC   CVCL_D416

WW   https://www.cedarlanelabs.com/Products/Detail/CLU464?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-56

AC   CVCL_D417

WW   https://www.cedarlanelabs.com/Products/Detail/CLU465?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-57

AC   CVCL_D418

WW   https://www.cedarlanelabs.com/Products/Detail/CLU466?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-58

AC   CVCL_D419

WW   https://www.cedarlanelabs.com/Products/Detail/CLU467?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-59

AC   CVCL_D420

RX   PubMed=21914774;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU468?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-60

AC   CVCL_D421

WW   https://www.cedarlanelabs.com/Products/Detail/CLU469?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-61

AC   CVCL_D422

WW   https://www.cedarlanelabs.com/Products/Detail/CLU470?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-62

AC   CVCL_D423

WW   https://www.cedarlanelabs.com/Products/Detail/CLU471?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-63

AC   CVCL_D424

WW   https://www.cedarlanelabs.com/Products/Detail/CLU472?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-GnRH/GFP

AC   CVCL_DP31

WW   https://www.cedarlanelabs.com/Products/Detail/CLU498?lob=Cellutions

CC   Transfected with: UniProtKB; Q963I9; Renilla GFP.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-NPY/GFP

AC   CVCL_Y000

RX   PubMed=21914774;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU499?lob=Cellutions

CC   Transfected with: UniProtKB; Q963I9; Renilla GFP.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: B6.FVB-Tg(Npy-hrGFP)1Lowl/J.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoA-POMC/GFP-1

AC   CVCL_EP66

RX   PubMed=24134870;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU500?lob=Cellutions

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-POMC/GFP-2

AC   CVCL_EP67

RX   PubMed=24134870;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU501?lob=Cellutions

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-POMC/GFP-3

AC   CVCL_EP68

RX   PubMed=24134870;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU502?lob=Cellutions

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-POMC/GFP-4

AC   CVCL_EP69

RX   PubMed=24134870;

WW   https://www.cedarlanelabs.com/Products/Detail/CLU503?lob=Cellutions

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6J-Tg(Pomc-EGFP)1Low/J.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   mHypoA-SCN

AC   CVCL_5I56

WW   https://www.cedarlanelabs.com/Products/Detail/CLU497?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Transformed cell line

//

ID   mHypoE-N1

AC   CVCL_D425

SY   N1

WW   https://www.cedarlanelabs.com/Products/Detail/CLU101?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N11

AC   CVCL_D426

SY   N11

WW   https://www.cedarlanelabs.com/Products/Detail/CLU107?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N20/1

AC   CVCL_D427

SY   N20/1

WW   https://www.cedarlanelabs.com/Products/Detail/CLU108?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N20/2

AC   CVCL_D428

SY   N20/2

WW   https://www.cedarlanelabs.com/Products/Detail/CLU109?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N25/2

AC   CVCL_D429

SY   N25/2

WW   https://www.cedarlanelabs.com/Products/Detail/CLU110?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N25/3

AC   CVCL_D430

SY   N25/3

WW   https://www.cedarlanelabs.com/Products/Detail/CLU111?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N29/1

AC   CVCL_D431

SY   N29/1

WW   https://www.cedarlanelabs.com/Products/Detail/CLU112?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N29/2

AC   CVCL_D432

SY   N29/2

WW   https://www.cedarlanelabs.com/Products/Detail/CLU113?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N29/3

AC   CVCL_D433

SY   N29/3

WW   https://www.cedarlanelabs.com/Products/Detail/CLU114?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N29/4

AC   CVCL_D434

SY   N29/4

WW   https://www.cedarlanelabs.com/Products/Detail/CLU115?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N3

AC   CVCL_D435

SY   N3

WW   https://www.cedarlanelabs.com/Products/Detail/CLU102?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N36/1

AC   CVCL_D436

AS   CVCL_0446

SY   N36/1; N-36/1

DR   MCCL; MCC:0000343

WW   https://www.cedarlanelabs.com/Products/Detail/CLU116?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N37

AC   CVCL_D437

SY   N37

WW   https://www.cedarlanelabs.com/Products/Detail/CLU117?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N38

AC   CVCL_D438

AS   CVCL_0447

SY   N38; N-38

DR   BTO; BTO:0003956

DR   MCCL; MCC:0000344

WW   https://www.cedarlanelabs.com/Products/Detail/CLU118?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N39

AC   CVCL_D439

AS   CVCL_0448

SY   N39; N-39

DR   MCCL; MCC:0000345

WW   https://www.cedarlanelabs.com/Products/Detail/CLU119?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N4

AC   CVCL_D440

SY   N4

WW   https://www.cedarlanelabs.com/Products/Detail/CLU103?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N40

AC   CVCL_D441

SY   N40

WW   https://www.cedarlanelabs.com/Products/Detail/CLU120?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N41

AC   CVCL_D442

SY   N41

WW   https://www.cedarlanelabs.com/Products/Detail/CLU121?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N42

AC   CVCL_D443

AS   CVCL_0449

SY   N42; N-42

DR   MCCL; MCC:0000346

WW   https://www.cedarlanelabs.com/Products/Detail/CLU122?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/1

AC   CVCL_D444

SY   N43/1

WW   https://www.cedarlanelabs.com/Products/Detail/CLU123?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/10

AC   CVCL_D445

SY   N43/10

WW   https://www.cedarlanelabs.com/Products/Detail/CLU132?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/13

AC   CVCL_D446

SY   N43/13

WW   https://www.cedarlanelabs.com/Products/Detail/CLU133?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/14

AC   CVCL_D447

SY   N43/14

WW   https://www.cedarlanelabs.com/Products/Detail/CLU134?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/15

AC   CVCL_D448

SY   N43/15

WW   https://www.cedarlanelabs.com/Products/Detail/CLU135?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/2

AC   CVCL_D449

SY   N43/2

WW   https://www.cedarlanelabs.com/Products/Detail/CLU124?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/3

AC   CVCL_D450

SY   N43/3

WW   https://www.cedarlanelabs.com/Products/Detail/CLU125?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/4

AC   CVCL_D451

SY   N43/4

WW   https://www.cedarlanelabs.com/Products/Detail/CLU126?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/5

AC   CVCL_D452

SY   N43/5

WW   https://www.cedarlanelabs.com/Products/Detail/CLU127?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/6

AC   CVCL_D453

SY   N43/6

WW   https://www.cedarlanelabs.com/Products/Detail/CLU128?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/7

AC   CVCL_D454

SY   N43/7

WW   https://www.cedarlanelabs.com/Products/Detail/CLU129?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/8

AC   CVCL_D455

SY   N43/8

WW   https://www.cedarlanelabs.com/Products/Detail/CLU130?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N43/9

AC   CVCL_D456

SY   N43/9

WW   https://www.cedarlanelabs.com/Products/Detail/CLU131?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N44

AC   CVCL_D457

SY   N44

WW   https://www.cedarlanelabs.com/Products/Detail/CLU136?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N45

AC   CVCL_D458

SY   N45

WW   https://www.cedarlanelabs.com/Products/Detail/CLU137?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N46

AC   CVCL_D459

SY   N46

WW   https://www.cedarlanelabs.com/Products/Detail/CLU138?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N47

AC   CVCL_D460

SY   N47

WW   https://www.cedarlanelabs.com/Products/Detail/CLU139?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N6

AC   CVCL_D461

SY   N6

WW   https://www.cedarlanelabs.com/Products/Detail/CLU104?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N7

AC   CVCL_D462

SY   N7

WW   https://www.cedarlanelabs.com/Products/Detail/CLU105?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mHypoE-N8

AC   CVCL_D463

SY   N8

WW   https://www.cedarlanelabs.com/Products/Detail/CLU106?lob=Cellutions

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MI #1

AC   CVCL_1E43

SY   MI 1

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=994214;

CC   Doubling time: 48 hours, at 46th passage (PubMed=994214).

CC   Derived from metastatic site: Inguinal lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Mi Ten

AC   CVCL_3024

AS   CVCL_V561

SY   Mi-Ten; MiTen

DR   ATCC; CRL-1113

DR   BioSample; SAMN03471061

DR   JCRB; JCRB0072

RX   PubMed=7471105;

CC   Discontinued: ATCC; CRL-1113; true.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 11,13

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 12,14

ST   D7S820: 8,11

ST   TH01: 9.3

ST   TPOX: 11

ST   vWA: 14,17

DI   NCIt; C61255; Lesch-Nyhan syndrome

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   MI-4 [Human glioblastoma]

AC   CVCL_N722

RX   PubMed=8055485;

RX   PubMed=16102584;

DI   NCIt; C3058; Glioblastoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MI-4 [Human lung adenocarcinoma]

AC   CVCL_6294

RX   PubMed=12079515;

RX   PubMed=16820947;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MI-4

DI   NCIt; C3512; Lung adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MIA PaCa-2

AC   CVCL_0428

SY   MIA-PaCa-2; MIA-PACA-2; MIA-Pa-Ca-2; MIA Paca2; MIA PaCa2; MiaPaCa-2; MiaPaca.2; MiaPaCa2; Miapaca2; MIAPaCa2; MIAPACA2; Mia PACA 2; MIAPaCa-2; PaCa2

DR   BTO; BTO:0002137

DR   BTO; BTO:0002138

DR   CLO; CLO_0007726

DR   CLO; CLO_0050101

DR   EFO; EFO_0002236

DR   MCCL; MCC:0000325

DR   CLDB; cl3480

DR   CLDB; cl3481

DR   CLDB; cl3482

DR   ATCC; CRL-1420

DR   ATCC; CRM-CRL-1420

DR   BCRC; 60139

DR   BCRJ; 0174

DR   BioSample; SAMN01821579

DR   BioSample; SAMN01821700

DR   BioSample; SAMN03472131

DR   CCLE; MIAPACA2_PANCREAS

DR   CGH-DB; 321-1

DR   CGH-DB; 9374-4

DR   ChEMBL-Cells; CHEMBL3307341

DR   ChEMBL-Cells; CHEMBL3308500

DR   ChEMBL-Targets; CHEMBL614228

DR   ChEMBL-Targets; CHEMBL614725

DR   Cosmic; 707249

DR   Cosmic; 710861

DR   Cosmic; 719677

DR   Cosmic; 724644

DR   Cosmic; 724870

DR   Cosmic; 730532

DR   Cosmic; 808172

DR   Cosmic; 868243

DR   Cosmic; 872996

DR   Cosmic; 913313

DR   Cosmic; 918056

DR   Cosmic; 922249

DR   Cosmic; 923170

DR   Cosmic; 932520

DR   Cosmic; 947399

DR   Cosmic; 948373

DR   Cosmic; 948731

DR   Cosmic; 949234

DR   Cosmic; 968107

DR   Cosmic; 1006368

DR   Cosmic; 1066202

DR   Cosmic; 1108337

DR   Cosmic; 1198208

DR   Cosmic; 1299302

DR   Cosmic; 1320461

DR   Cosmic; 1366278

DR   Cosmic; 1477431

DR   Cosmic; 1571779

DR   Cosmic; 1534318

DR   Cosmic; 1609545

DR   Cosmic; 1644314

DR   Cosmic; 1995507

DR   Cosmic; 2434084

DR   Cosmic-CLP; 724870

DR   DSMZ; ACC-733

DR   ECACC; 85062806

DR   GDSC; 724870

DR   GEO; GSM206526

DR   GEO; GSM244425

DR   GEO; GSM621895

DR   GEO; GSM784703

DR   GEO; GSM887320

DR   GEO; GSM888396

DR   GEO; GSM1024404

DR   GEO; GSM1374677

DR   GEO; GSM1374678

DR   GEO; GSM1374679

DR   GEO; GSM1588612

DR   GEO; GSM1670109

DR   IGRhCellID; MIAPaCa

DR   IZSLER; BS TCL 42

DR   JCRB; JCRB0070

DR   KCLB; 21420

DR   NCBI_Iran; C459

DR   PRIDE; PXD001260

DR   PRIDE; PXD003198

DR   RCB; RCB2094

DR   SKY/M-FISH/CGH; 1996

DR   TKG; TKG 0227

RX   PubMed=9290701;

RX   PubMed=10027410;

RX   PubMed=11169957;

RX   PubMed=11169959;

RX   PubMed=11787853;

RX   PubMed=12692724;

RX   PubMed=14695172;

RX   PubMed=17254797;

RX   PubMed=18380791;

RX   PubMed=20418756;

RX   PubMed=22460905;

RX   PubMed=23386380;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/MIA%20PaCA-2.html

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=MIA%20PaCa-2

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=64

WW   http://www.addexbio.com/productdetail?pid=59

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 26 hours (PubMed=25984343); 25.7 +- 4.3 hours (PubMed=27067801); 40 hours, 18 hours, in serum-free medium (PubMed=23386380); ~40 hours (ATCC); ~30-40 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; KCLB; PubMed=17254797; PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 12,13

ST   D16S539: 10,13 (AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=25877200; RCB; TKG)

ST   D16S539: 11,13 (PubMed=17254797)

ST   D18S51: 12

ST   D21S11: 29,31 (PubMed=17254797)

ST   D21S11: 29,31.2 (PubMed=25877200)

ST   D3S1358: 16

ST   D5S818: 12,13 (AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=25877200; RCB; TKG)

ST   D5S818: 13 (PubMed=17254797)

ST   D7S820: 12,13 (AddexBio; ATCC; Cosmic-CLP; DSMZ; ECACC; JCRB; PubMed=17254797; PubMed=25877200; RCB; TKG)

ST   D7S820: 12 (KCLB)

ST   D8S1179: 16

ST   FGA: 22

ST   Penta D: 12,16

ST   Penta E: 13,18

ST   TH01: 9,10

ST   TPOX: 9

ST   vWA: 15

DI   NCIt; C9120; Pancreatic ductal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MIA PaCa-3

AC   CVCL_4011

SY   Mia-Paca 3; PaCa3; PaCa-3; Paca-3; PACA3; Pc3

DR   Cosmic; 710862

DR   Cosmic; 1108336

DR   Cosmic; 1320460

RX   PubMed=11169959;

RX   PubMed=12800145;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/PaCa-3.html

DI   NCIt; C3850; Pancreatic carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MI5-4

AC   CVCL_IP24

RX   PubMed=9753618;

RX   PubMed=20331963;

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MI8-5

AC   CVCL_IP25

DR   BTO; BTO:0005972

RX   PubMed=9753618;

RX   PubMed=9884408;

RX   PubMed=20331963;

CC   Characteristics: Lacks glucosyltransferase I (ALG6) activity.

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MIC

AC   CVCL_EI96

DR   Cosmic; 2250464

RX   PubMed=25223734;

CC   From: Delattre O.; Institut Curie; Paris; France.

DI   NCIt; C4817; Ewing sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MiCl1 (S+L-)

AC   CVCL_3405

SY   S+L- MiCl1; MiCl1; S+L-Mink

DR   CLO; CLO_0007727

DR   CLO; CLO_0007728

DR   CLO; CLO_0051611

DR   CLDB; cl3483

DR   CLDB; cl3484

DR   CLDB; cl3485

DR   ATCC; CCL-64.1

DR   ECACC; 86020603

DR   ICLC; ATL97001

DR   IZSLER; BS CL 66

DR   RCB; RCB1834

RX   PubMed=52940;

RX   PubMed=170737;

CC   Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).

OX   NCBI_TaxID=452646; ! Neovison vison

HI   CVCL_0593 ! Mv1Lu

SX   Mixed sex

CA   Transformed cell line

//

ID   Middle91

AC   CVCL_W860

SY   Middle 91

RX   PubMed=8704258;

RX   PubMed=8847894;

RX   PubMed=9454894;

RX   PubMed=12967475;

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: Transcriptome analysis.

DI   NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MIEU

AC   CVCL_H208

SY   Mieu

CC   From: Al Saati T.; Purpan Hospital; Toulouse; France.

DI   NCIt; C8851; Diffuse large B-cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   MiF-6

AC   CVCL_3750

SY   MiF-6 [Mutatect]

DR   CLO; CLO_0007729

DR   ATCC; CRL-2802

RX   PubMed=14732341;

CC   Breed/subspecies: C57BL/10.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4982 ! MC-TGS17-51

SX   Male

CA   Cancer cell line

//

ID   MIH5

AC   CVCL_CW88

RX   PubMed=14515261;

CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   MIH5(GIT)

AC   CVCL_C663

DR   CLO; CLO_0050519

DR   RCB; RCB2305

CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_CW88 ! MIH5

CA   Hybridoma

//

ID   MIH5(RPMI)

AC   CVCL_C664

DR   CLO; CLO_0050520

DR   RCB; RCB2324

CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_CW88 ! MIH5

CA   Hybridoma

//

ID   MIH6

AC   CVCL_CW89

RX   PubMed=12421930;

RX   PubMed=14515261;

CC   Monoclonal antibody target: UniProtKB; Q9EP73; Mouse Cd274.

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3412 ! P3X63Ag8U.1

CA   Hybridoma

//

ID   MIKA

AC   CVCL_E776

SY   5194

DR   dbMHC; 48971

DR   ECACC; 94071407

DR   IHW; IHW9274

DR   IMGT/HLA; 11075

WW   http://bioinformatics.hsanmartino.it/ecbr/cl274.html

CC   Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   Mil Kin

AC   CVCL_0F66

DR   ATCC; CRL-1123

CC   Discontinued: ATCC; CRL-1123; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   Mili-KO GS

AC   CVCL_1T54

DR   RCB; AES0197

RX   PubMed=23611983;

CC   Characteristics: Germ stem cell line.

CC   Breed/subspecies: DBA/2.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Embryonic stem cell

//

ID   MIM/8

AC   CVCL_Y662

RX   PubMed=1383272;

CC   Derived from metastatic site: Inguinal lymph node.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   mIMCD-3

AC   CVCL_0429

SY   mIMCD3; IMCD-3; IMCD3; mouse Inner Medullary Collecting Duct-3

DR   BTO; BTO:0003913

DR   CLO; CLO_0007730

DR   EFO; EFO_0002073

DR   MCCL; MCC:0000500

DR   ATCC; CRL-2123

DR   Wikidata; Q28472922

RX   PubMed=8214101;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mIMCD-K2

AC   CVCL_0430

SY   mouse Inner Medullary Collecting Duct-K2

DR   MCCL; MCC:0000501

RX   PubMed=7864176;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Tg(SV40E)Bri/7 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   MIN

AC   CVCL_E777

DR   dbMHC; 48972

DR   ECACC; 940822102

DR   IHW; IHW9198

DR   IMGT/HLA; 11739

RX   PubMed=8307784;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl198.html

CC   Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Sex undetermined

CA   Transformed cell line

//

ID   MIN01i-32517.A

AC   CVCL_AS51

SY   MIN32517 A; 32517-A

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min01i-32517-a.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS52 ! MIN02i-32517.B

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN02i-32517.B

AC   CVCL_AS52

SY   MIN32517 B; 32517-B

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min02i-32517-b.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS51 ! MIN01i-32517.A

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN03i-32642.B

AC   CVCL_AS53

SY   MIN32642 B; 32642-B

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min03i-32642-b.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   MIN04i-33109.2B

AC   CVCL_AS54

SY   MIN33109 2B; 33109-2B

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min04i-33109-2b.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN05i-33110.2F

AC   CVCL_AS55

SY   MIN33110 2F; 33110-2F

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min05i-33110-2f.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS56 ! MIN06i-33110.2H

SX   Female

CA   Induced pluripotent stem cell

//

ID   MIN06i-33110.2H

AC   CVCL_AS56

SY   MIN33110 2H; 33110-2H

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min06i-33110-2h.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS55 ! MIN05i-33110.2F

SX   Female

CA   Induced pluripotent stem cell

//

ID   MIN07i-33113.2D

AC   CVCL_AS57

SY   MIN33113 2D; 33113-2D

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min07i-33113-2d.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS72 ! MIN22i-33113.2I

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN08i-33114.B

AC   CVCL_AS58

SY   MIN33114 B; 33114-B

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min08i-33114-b.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS59 ! MIN09i-33114.C

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN09i-33114.C

AC   CVCL_AS59

SY   MIN33114 C; 33114-C

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min09i-33114-c.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS58 ! MIN08i-33114.B

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN10i-33360.A

AC   CVCL_AS60

SY   MIN33360 A; 33360-A

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min10i-33360-a.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS61 ! MIN11i-33360.B

SX   Female

CA   Induced pluripotent stem cell

//

ID   MIN11i-33360.B

AC   CVCL_AS61

SY   MIN33360 B; 33360-B

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min11i-33360-b.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS60 ! MIN10i-33360.A

SX   Female

CA   Induced pluripotent stem cell

//

ID   MIN12i-33362.C

AC   CVCL_AS62

SY   MIN33362 C; 33362-C

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min12i-33362-c.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS63 ! MIN13i-33362.D

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN13i-33362.D

AC   CVCL_AS63

SY   MIN33362 D; 33362-D

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min13i-33362-d.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS62 ! MIN12i-33362.C

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN14i-33363.C

AC   CVCL_AS64

SY   MIN33363 C; 33363-C

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min14i-33363-c.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS65 ! MIN15i-33363.D

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN15i-33363.D

AC   CVCL_AS65

SY   MIN33363 D; 33363-D

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min15i-33363-d.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS64 ! MIN14i-33363.C

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN16i-33808.A

AC   CVCL_AS66

SY   MIN33808 A; 33808-A

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min16i-33808-a.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS67 ! MIN17i-33808.B

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN17i-33808.B

AC   CVCL_AS67

SY   MIN33808 B; 33808-B

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min17i-33808-b.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS66 ! MIN16i-33808.A

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN18i-33811.A

AC   CVCL_AS68

SY   MIN33811 A; 33811-A

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min18i-33811-a.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS69 ! MIN19i-33811.D

SX   Female

CA   Induced pluripotent stem cell

//

ID   MIN19i-33811.D

AC   CVCL_AS69

SY   MIN33811 D; 33811-D

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min19i-33811-d.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS68 ! MIN18i-33811.A

SX   Female

CA   Induced pluripotent stem cell

//

ID   MIN20i-34363.A

AC   CVCL_AS70

SY   MIN34363 A; 34363-A

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min20i-34363-a.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS71 ! MIN21i-34363.B

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN21i-34363.B

AC   CVCL_AS71

SY   MIN34363 B; 34363-B

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min21i-34363-b.cmsx

DI   NCIt; C126330; X-linked dystonia parkinsonism

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS70 ! MIN20i-34363.A

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN22i-33113.2I

AC   CVCL_AS72

SY   MIN33113 2I; 33113-2I

RX   PubMed=26769797;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/min22i-33113-2i.cmsx

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_AS57 ! MIN07i-33113.2D

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIN6

AC   CVCL_0431

SY   Min6; MIN-6; Mouse INsulinoma 6

DR   BTO; BTO:0002284

DR   EFO; EFO_0002829

DR   MCCL; MCC:0000326

DR   BCRJ; 0293

DR   PRIDE; PXD000589

DR   PRIDE; PXD001081

DR   Wikidata; Q12513178

RX   PubMed=2163307;

RX   PubMed=18845907;

RX   PubMed=22538498;

RX   PubMed=22808281;

RX   PubMed=25546123;

RX   PubMed=25894527;

WW   http://www.addexbio.com/productdetail?pid=403

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-93.html

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Cell surface proteome.

CC   Omics: Endoplasmic reticulum proteome analysis.

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34053; Mouse insulinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MIN6-m14

AC   CVCL_4372

DR   BTO; BTO:0003538

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34053; Mouse insulinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0431 ! MIN6

CA   Transformed cell line

//

ID   MIN6-m9

AC   CVCL_4371

DR   BTO; BTO:0003537

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34053; Mouse insulinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0431 ! MIN6

CA   Transformed cell line

//

ID   MIN6N8

AC   CVCL_D686

SY   MIN6-N8; Min6 N8

DR   BTO; BTO:0005320

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34053; Mouse insulinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0431 ! MIN6

CA   Transformed cell line

//

ID   MIN6N8a

AC   CVCL_0432

DR   MCCL; MCC:0000327

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34053; Mouse insulinoma

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_D686 ! MIN6N8

CA   Transformed cell line

//

ID   MIN7

AC   CVCL_J994

SY   Mouse INsulinoma 7

RX   PubMed=2163307;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

DI   NCIt; C34053; Mouse insulinoma

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   Minami-1

AC   CVCL_8528

DR   JCRB; JCRB1404

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 8,10

ST   D16S539: 9

ST   D5S818: 12,13

ST   D7S820: 8,10

ST   TH01: 7,9.3

ST   TPOX: 11

ST   vWA: 16,18

DI   NCIt; C3209; Follicular lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Minami-2

AC   CVCL_8529

DR   JCRB; JCRB1405

CC   Characteristics: EBV-negative.

ST   Source(s): JCRB

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 9,10

ST   D5S818: 10,11

ST   D7S820: 9,11

ST   TH01: 7,9

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C2912; Burkitt lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MINE

AC   CVCL_B867

SY   IMHe007-A

DR   hPSCreg; IMHe007-A

DR   ISCR; 1119

RX   DOI=10.5772/25010;

RX   PubMed=20349214;

CC   From: Istanbul Memorial Hospital; Istanbul; Turkey.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Minnesota EE

AC   CVCL_8264

SY   Minnesota-EE; Minn. EE

DR   ATCC; CCL-4

DR   BioSample; SAMN03151744

RX   PubMed=566722;

RX   PubMed=1246601;

RX   PubMed=13472685;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=566722, PubMed=1246601, PubMed=20143388).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Discontinued: ATCC; CCL-4; true.

DI   NCIt; C4029; Cervical adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0030 ! HeLa

SX   Female

CA   Cancer cell line

//

ID   Mino

AC   CVCL_1872

SY   MINO

DR   ATCC; CRL-3000

DR   BioSample; SAMN03471705

DR   CCLE; MINO_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 2078181

DR   Cosmic; 2088019

DR   DSMZ; ACC-687

DR   GEO; GSM887321

DR   GEO; GSM888397

DR   GEO; GSM907522

DR   GEO; GSM1670110

DR   Lonza; 165

RX   PubMed=12127561;

RX   PubMed=12683869;

RX   PubMed=22460905;

RX   PubMed=25315077;

RX   PubMed=25355872;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: Lymphoma Research Foundation Mantle Cell Lymphoma cell bank (LRF MCL cell bank).

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 72 hours (PubMed=25315077); ~50 hours (DSMZ).

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC; DSMZ

ST   Amelogenin: X,Y

ST   CSF1PO: 9,11

ST   D13S317: 12

ST   D16S539: 11,12

ST   D5S818: 11,12

ST   D7S820: 10,11

ST   TH01: 9.3

ST   TPOX: 8,11

ST   vWA: 14,17

DI   NCIt; C4337; Mantle cell lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MIO-M1

AC   CVCL_0433

SY   Moorfields/Institute of Ophthalmology-Muller 1

DR   BTO; BTO:0003062

DR   MCCL; MCC:0000328

RX   PubMed=11867609;

RX   PubMed=22065927;

WW   http://www.e-lucid.com/i/materials/MIO_M1_cells.html

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Spontaneously immortalized cell line

//

ID   MIP-101

AC   CVCL_H689

SY   MIP 101; MIP101

DR   Cosmic; 1374639

DR   GEO; GSM587038

DR   GEO; GSM1448116

RX   PubMed=2228514;

RX   PubMed=3442732;

RX   PubMed=15902309;

RX   PubMed=20835245;

RX   PubMed=23671654;

RX   PubMed=25926053;

CC   Microsatellite instability: Instable (MSI) (PubMed=23671654; PubMed=25926053).

CC   Omics: Deep RNAseq analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MIP/5FU

AC   CVCL_HE61

SY   MIP5FU

DR   GEO; GSM587039

RX   PubMed=15902309;

RX   PubMed=20835245;

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

CC   Omics: Deep RNAseq analysis.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H689 ! MIP-101

SX   Male

CA   Cancer cell line

//

ID   MIP/CIS

AC   CVCL_HE62

RX   PubMed=15902309;

CC   Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H689 ! MIP-101

SX   Male

CA   Cancer cell line

//

ID   MIP/CPT

AC   CVCL_HE63

RX   PubMed=15902309;

CC   Selected for resistance to: ChEBI; CHEBI:80630; Irinotecan (Camptothecin-11; CPT-11).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H689 ! MIP-101

SX   Male

CA   Cancer cell line

//

ID   MIP/ETO

AC   CVCL_HE64

RX   PubMed=15902309;

CC   Selected for resistance to: ChEBI; CHEBI:4911; Etoposide (VP-16).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_H689 ! MIP-101

SX   Male

CA   Cancer cell line

//

ID   MIPS-2

AC   CVCL_M826

RX   PubMed=15277221;

DI   NCIt; C4247; Unclassified pleomorphic sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MIRJT6i-mND1-4

AC   CVCL_U172

SY   mND1-4

DR   ISCR; 2143

RX   PubMed=21478862;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/mirjt6i-mnd1-4.cmsx

WW   http://shared.eagle-i.net/i/00000144-8e8f-244a-5797-c9ee80000000

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   MIRJT7i-mND2-0

AC   CVCL_U173

SY   mND2-0

DR   ISCR; 2144

RX   PubMed=21478862;

WW   http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/mirjt7i-mnd2-0.cmsx

WW   http://shared.eagle-i.net/i/00000144-8e87-5f87-5797-c9ee80000000

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   MISCES-01

AC   CVCL_C655

DR   ISCR; 1380

RX   PubMed=20178002;

CC   From: Monash University; Australia.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MISK81-5

AC   CVCL_W332

RX   PubMed=7531680;

CC   Derived from metastatic site: Neck lymph node.

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MIT

AC   CVCL_D526

RX   PubMed=7949178;

RX   PubMed=10936422;

DI   NCIt; C3242; Plasma cell myeloma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   mitoLUHMES

AC   CVCL_HL95

RX   PubMed=27832395;

CC   Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).

CC   Transfected with: DsRed2; a bright red fluorescent protein derived from drFP583 (DsRed).

CC   Transfected with: UniProtKB; P01110; Avian myelocytomatosis virus MC29 v-Myc.

CC   Transformant: v-Myc.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_B056 ! LUHMES

SX   Female

CA   Conditionally immortalized cell line

//

ID   Miz-1

AC   CVCL_3025

DR   IFO; IFO50300

CC   Discontinued: IFO; IFO50300; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   Miz-hES1

AC   CVCL_9262

SY   MizhES1; MIZ1; MI01; MIZMe001-A

DR   hPSCreg; MIZMe001-A

DR   ISCR; 1120

RX   PubMed=12930726;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Miz-hES10

AC   CVCL_9263

SY   MIZMe012-A

DR   hPSCreg; MIZMe012-A

DR   ISCR; 1121

RX   PubMed=15750339;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Miz-hES11

AC   CVCL_9264

SY   MIZMe013-A

DR   hPSCreg; MIZMe013-A

DR   ISCR; 1122

RX   PubMed=15750339;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES12

AC   CVCL_9265

SY   MIZMe014-A

DR   hPSCreg; MIZMe014-A

DR   ISCR; 1123

RX   PubMed=15750339;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES13

AC   CVCL_9266

SY   MIZ13; MIZMe015-A

DR   hPSCreg; MIZMe015-A

DR   ISCR; 1124

RX   PubMed=15750339;

CC   From: MizMedi Hospital; Seoul; South Korea.

DI   NCIt; C36425; Trisomy 3

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES14

AC   CVCL_9267

SY   MIZMe005-A

DR   hPSCreg; MIZMe005-A

DR   ISCR; 1125

RX   PubMed=15317691;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES15

AC   CVCL_9268

SY   MIZMe006-A

DR   hPSCreg; MIZMe006-A

DR   ISCR; 1126

RX   PubMed=15317691;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES2

AC   CVCL_9269

SY   MIZMe002-A

DR   hPSCreg; MIZMe002-A

DR   ISCR; 1127

RX   PubMed=12930726;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Miz-hES3

AC   CVCL_9270

SY   MIZMe003-A

DR   hPSCreg; MIZMe003-A

DR   ISCR; 1128

RX   PubMed=12930726;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES4

AC   CVCL_9271

SY   Miz-hES 4; Kor-hES12; MIZ4; MIZMe007-A

DR   hPSCreg; MIZMe007-A

DR   ISCR; 1129

RX   PubMed=15750339;

RX   PubMed=17464211;

RX   PubMed=24159464;

CC   From: MizMedi Hospital; Seoul; South Korea.

CC   Registration: Korea Center for Disease Control and Prevention Stem Cell Registry; hES12010016.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Miz-hES5

AC   CVCL_9272

SY   MIZMe008-A

DR   hPSCreg; MIZMe008-A

DR   ISCR; 1130

RX   PubMed=15750339;

RX   PubMed=17464211;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Embryonic stem cell

//

ID   Miz-hES6

AC   CVCL_9273

SY   MIZ6; MIZMe009-A

DR   hPSCreg; MIZMe009-A

DR   ISCR; 1131

RX   PubMed=15750339;

RX   PubMed=17464211;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES7

AC   CVCL_9274

SY   MIZMe010-A

DR   hPSCreg; MIZMe010-A

DR   ISCR; 1132

RX   PubMed=15750339;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES8

AC   CVCL_9275

SY   MIZMe011-A

DR   hPSCreg; MIZMe011-A

DR   ISCR; 1133

RX   PubMed=15750339;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   Miz-hES9

AC   CVCL_9276

SY   MIZMe004-A

DR   hPSCreg; MIZMe004-A

DR   ISCR; 1134

RX   PubMed=15317691;

CC   From: MizMedi Hospital; Seoul; South Korea.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Embryonic stem cell

//

ID   MJ

AC   CVCL_1414

SY   G11

DR   CLO; CLO_0007731

DR   EFO; EFO_0002237

DR   ATCC; CRL-8294

DR   BCRC; 60543

DR   BioSample; SAMN03471200

DR   CCLE; MJ_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE

DR   Cosmic; 908137

DR   GEO; GSM887322

DR   GEO; GSM888398

DR   IGRhCellID; MJ

RX   Patent=US4743678;

RX   PubMed=6604130;

RX   PubMed=22460905;

RX   PubMed=25355872;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Transformant: NCBI_TaxID; 11908; Human T-lymphotropic virus 1 (HTLV-1).

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Omics: Virome analysis using RNAseq.

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 12,14

ST   D16S539: 11,12

ST   D5S818: 11,13

ST   D7S820: 8,11

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 15,17

DI   NCIt; C3467; Cutaneous T-cell non-Hodgkin lymphoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MJ-170

AC   CVCL_AQ03

SY   3A3-2A6

DR   ATCC; PTA-5286

RX   Patent=US7202346;

CC   Monoclonal antibody target: UniProtKB; P15941; Human MUC1.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MJ-171

AC   CVCL_AQ04

SY   4E2-2D1-1B10

DR   ATCC; PTA-5287

RX   Patent=US7202346;

CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MJ-172

AC   CVCL_AQ05

SY   2F9-1F8-1C10

DR   ATCC; PTA-5288

RX   Patent=US7202346;

CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MJ-173

AC   CVCL_AQ06

SY   2F9-1E8-1D7

DR   ATCC; PTA-5302

RX   Patent=US7202346;

CC   Monoclonal antibody target: UniProtKB; Q8WXI7; Human MUC16.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   MJD1-11

AC   CVCL_W570

DR   SKIP; SKIP000310

RX   PubMed=22113611;

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

DI   NCIt; C84830; Machado-Joseph disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W571 ! MJD1-9

SX   Male

CA   Induced pluripotent stem cell

//

ID   MJD1-9

AC   CVCL_W571

SY   LB-32-R9; iLB-MJD1-32m-r9; UKBi003-A

DR   BioSamples; SAMEA2614075

DR   EBiSC; UKBi003-A

DR   ECACC; 66540007

DR   hPSCreg; UKBi003-A

DR   SKIP; SKIP000309

RX   PubMed=22113611;

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

DI   NCIt; C84830; Machado-Joseph disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W570 ! MJD1-11

SX   Male

CA   Induced pluripotent stem cell

//

ID   MJD2-2

AC   CVCL_W572

SY   iLB-MJD2-29m-R2; UKBi001-A

DR   hPSCreg; UKBi001-A

DR   SKIP; SKIP000311

RX   PubMed=22113611;

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

DI   NCIt; C84830; Machado-Joseph disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W573 ! MJD2-9

SX   Male

CA   Induced pluripotent stem cell

//

ID   MJD2-9

AC   CVCL_W573

SY   UKBi001-B

DR   BioSamples; SAMEA3855072

DR   EBiSC; UKBi001-B

DR   ECACC; 66540043

DR   hPSCreg; UKBi001-B

DR   SKIP; SKIP000312

RX   PubMed=22113611;

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

DI   NCIt; C84830; Machado-Joseph disease

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_W572 ! MJD2-2

SX   Male

CA   Induced pluripotent stem cell

//

ID   MJD3-5

AC   CVCL_W574

SY   UKBi007-A; LB-33-5; iLB-MJD3-33f-r5

DR   BioSamples; SAMEA2825788

DR   EBiSC; UKBi007-A

DR   ECACC; 66540011

DR   hPSCreg; UKBi007-A

DR   SKIP; SKIP000313

RX   PubMed=22113611;

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

DI   NCIt; C84830; Machado-Joseph disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Induced pluripotent stem cell

//

ID   MJD4-1

AC   CVCL_W575

SY   LB-34-1; iLB-MJD4-34m-r1; UKBi008-A

DR   BioSamples; SAMEA2590882

DR   EBiSC; UKBi008-A

DR   ECACC; 66540003

DR   hPSCreg; UKBi008-A

DR   SKIP; SKIP000314

RX   PubMed=22113611;

CC   From: Institut fur Rekonstruktive Neurobiologie - University Clinic of Bonn; Bonn; Germany.

DI   NCIt; C84830; Machado-Joseph disease

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Induced pluripotent stem cell

//

ID   MJM

AC   CVCL_J312

DR   Cosmic; 1132583

RX   PubMed=752115;

RX   PubMed=6819484;

CC   Doubling time: ~63 hours (PubMed=752115).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MK-1

AC   CVCL_W863

RX   PubMed=6802943;

DI   NCIt; C4833; Oral cavity squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MK-D6

AC   CVCL_4543

DR   CLO; CLO_0007732

DR   CLDB; cl5232

DR   ATCC; HB-3

DR   IZSLER; BS Hy 30

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2199 ! Sp2/0-Ag14

CA   Hybridoma

//

ID   MK-S4

AC   CVCL_G336

DR   CLO; CLO_0007734

DR   ATCC; HB-4

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4090 ! 45.6.TG1.7

CA   Hybridoma

//

ID   MK/T-1

AC   CVCL_9Y67

RX   PubMed=11344338;

CC   Transfected with: HGNC; 11730; TERT.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Telomerase immortalized cell line

//

ID   mK1

AC   CVCL_9T76

SY   mouse Kidney 1

RX   CelloPub=CLPUB00308;

RX   PubMed=11850199;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mK10

AC   CVCL_9T77

SY   mouse Kidney 10

RX   CelloPub=CLPUB00308;

RX   PubMed=12060755;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mK2

AC   CVCL_9T78

SY   mouse Kidney 2

RX   CelloPub=CLPUB00308;

RX   PubMed=11850199;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6 x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MK2-23

AC   CVCL_4W11

DR   ATCC; HB-10288

RX   Patent=US5493009;

CC   Discontinued: ATCC; HB-10288; probable.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4032 ! P3X63Ag8.653

CA   Hybridoma

//

ID   mK3

AC   CVCL_9T79

SY   MK3; mouse Kidney 3

RX   CelloPub=CLPUB00308;

RX   PubMed=11850199;

RX   PubMed=23867747;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: CHIP-Seq histone signature analysis.

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: C57BL/6 x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   mK4

AC   CVCL_9T80

SY   MK4; mouse Kidney 4

RX   CelloPub=CLPUB00308;

RX   PubMed=11850199;

RX   PubMed=23867747;

WW   http://discovery.lifemapsc.com/stem-cell-differentiation/in-vitro-cells/kidney-mus-musculus-mk4-childrens-hospital-medical-center-cincinnati

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: CHIP-Seq histone signature analysis.

CC   Omics: Transcriptome analysis.

CC   Breed/subspecies: C57BL/6 x C3H/He.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MKB-1

AC   CVCL_8265

DR   BioSample; SAMN03151620

DR   Cosmic; 999729

DR   Cosmic; 1524807

RX   PubMed=2486667;

RX   PubMed=9933131;

RX   PubMed=10508494;

RX   PubMed=12592342;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a CCRF-CEM derivative (PubMed=10508494, PubMed=12592342, PubMed=20143388).

DI   NCIt; C7953; Childhood T acute lymphoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0207 ! CCRF-CEM

SX   Female

CA   Cancer cell line

//

ID   MKL-1

AC   CVCL_2600

SY   MKL1

DR   Cosmic; 1693072

DR   Cosmic; 1699817

DR   Cosmic; 2273916

DR   ECACC; 09111801

RX   PubMed=3546933;

RX   PubMed=20444890;

CC   Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.

CC   Doubling time: ~120 hours (ECACC).

CC   Derived from metastatic site: Left axillary lymph node.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 11,12

ST   D13S317: 8,11

ST   D16S539: 10,12

ST   D5S818: 11,12

ST   D7S820: 8,11

ST   TH01: 9,9.3

ST   TPOX: 8

ST   vWA: 16,18

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_ER19 ! MKL-1-FB

SX   Male

CA   Cancer cell line

//

ID   MKL-1 subclone 1

AC   CVCL_EQ70

SY   MKL-1 (subclone 1)

RX   PubMed=12209990;

CC   Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.

CC   Derived from metastatic site: Left axillary lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2600 ! MKL-1

SX   Male

CA   Cancer cell line

//

ID   MKL-1 subclone 2

AC   CVCL_EQ71

SY   MKL-1-subclone-2; MKL-1 (subclone 2)

DR   GDSC; 1333014

RX   PubMed=12209990;

CC   Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.

CC   Derived from metastatic site: Left axillary lymph node.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2600 ! MKL-1

SX   Male

CA   Cancer cell line

//

ID   MKL-1-FB

AC   CVCL_ER19

RX   PubMed=3546933;

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_2600 ! MKL-1

SX   Male

CA   Finite cell line

//

ID   MKL-2

AC   CVCL_D027

SY   MKL2

DR   Cosmic; 1693073

DR   Cosmic; 2273917

DR   GDSC; 1333015

RX   PubMed=1717086;

RX   PubMed=12209990;

RX   PubMed=20444890;

CC   Characteristics: Contains a Merkel cell polyomavirus (MCPyV) genome.

DI   NCIt; C9231; Merkel cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MKN-1/CMV-Luc

AC   CVCL_J261

DR   JCRB; JCRB1433

DR   JCRB; NIHS0720

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D5S818: 11

ST   D7S820: 10

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C5474; Gastric adenosquamous carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1415 ! MKN1

SX   Male

CA   Cancer cell line

//

ID   MKN-45P

AC   CVCL_Y476

RX   PubMed=17380436;

RX   PubMed=22531121;

CC   Transfected with: HGNC; 11820; TIMP1.

CC   Derived from metastatic site: Liver.

ST   Source(s): DSMZ

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 10

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 18,19

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0434 ! MKN45

SX   Female

CA   Cancer cell line

//

ID   MKN1

AC   CVCL_1415

SY   MKN-1

DR   BTO; BTO:0002384

DR   CLO; CLO_0050804

DR   EFO; EFO_0002830

DR   BioSample; SAMN03473129

DR   CCLE; MKN1_STOMACH

DR   CGH-DB; 117-1

DR   CGH-DB; 9019-4

DR   ChEMBL-Cells; CHEMBL3307492

DR   ChEMBL-Targets; CHEMBL614352

DR   Cosmic; 733174

DR   Cosmic; 801337

DR   Cosmic; 848145

DR   Cosmic; 848379

DR   Cosmic; 887252

DR   Cosmic; 888824

DR   Cosmic; 897532

DR   Cosmic; 908138

DR   Cosmic; 922692

DR   Cosmic; 926111

DR   Cosmic; 1007600

DR   Cosmic; 1090459

DR   Cosmic; 1187282

DR   Cosmic; 1223586

DR   Cosmic; 1436023

DR   Cosmic; 1482076

DR   Cosmic; 1627263

DR   Cosmic; 1995508

DR   Cosmic; 2443801

DR   Cosmic; 2484957

DR   Cosmic-CLP; 908138

DR   GDSC; 908138

DR   GEO; GSM562394

DR   GEO; GSM827531

DR   GEO; GSM844606

DR   GEO; GSM887323

DR   GEO; GSM888399

DR   GEO; GSM1374680

DR   GEO; GSM1670111

DR   JCRB; JCRB0252

DR   KCLB; 80101

DR   RCB; RCB1003

RX   PubMed=1778766;

RX   PubMed=9290701;

RX   PubMed=11107048;

RX   PubMed=15723654;

RX   PubMed=15767549;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MKN-1

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; JCRB; KCLB; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 9,12

ST   D13S317: 10,12

ST   D16S539: 11,12

ST   D18S51: 13,16

ST   D21S11: 29

ST   D3S1358: 15,17

ST   D5S818: 11

ST   D7S820: 10

ST   D8S1179: 14

ST   FGA: 20,23

ST   Penta D: 10

ST   Penta E: 21

ST   TH01: 9

ST   TPOX: 8

ST   vWA: 16

DI   NCIt; C5474; Gastric adenosquamous carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MKN28

AC   CVCL_1416

SY   MKN-28; MKN 28

DR   BTO; BTO:0002381

DR   EFO; EFO_0002831

DR   BioSample; SAMN03151847

DR   CGH-DB; 119-1

DR   CGH-DB; 9021-4

DR   ChEMBL-Cells; CHEMBL3307602

DR   ChEMBL-Targets; CHEMBL614353

DR   Cosmic; 801338

DR   Cosmic; 848146

DR   Cosmic; 848371

DR   Cosmic; 873710

DR   Cosmic; 875905

DR   Cosmic; 877041

DR   Cosmic; 887249

DR   Cosmic; 888826

DR   Cosmic; 897534

DR   Cosmic; 908139

DR   Cosmic; 918496

DR   Cosmic; 922694

DR   Cosmic; 926113

DR   Cosmic; 968348

DR   Cosmic; 983726

DR   Cosmic; 1066230

DR   Cosmic; 1067208

DR   Cosmic; 1090460

DR   Cosmic; 1223588

DR   Cosmic; 1436025

DR   Cosmic; 1460710

DR   Cosmic; 1482081

DR   Cosmic; 1627264

DR   Cosmic; 1995509

DR   Cosmic; 2036660

DR   Cosmic; 2069778

DR   Cosmic-CLP; 908139

DR   GDSC; 908139

DR   GEO; GSM562396

DR   GEO; GSM1670112

DR   JCRB; JCRB0253

DR   JCRB; NIHS0324

DR   JCRB; NIHS0325

DR   KCLB; 80102

DR   RCB; RCB1000

RX   PubMed=3962675;

RX   PubMed=9290701;

RX   PubMed=11107048;

RX   PubMed=15723654;

RX   PubMed=15767549;

RX   PubMed=20143388;

RX   PubMed=22336246;

RX   PubMed=23671654;

RX   PubMed=27397505;

WW   http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a MKN74 derivative (PubMed=20143388).

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Doubling time: 28-32 hours (PubMed=3962675).

CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Discontinued: JCRB; NIHS0324; true.

CC   Discontinued: JCRB; NIHS0325; true.

CC   Discontinued: RCB; RCB1000; true.

CC   Derived from metastatic site: Liver.

ST   Source(s): Cosmic-CLP; JCRB; KCLB; RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 9

ST   FGA: 23

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,20

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2791 ! MKN74

SX   Female

CA   Cancer cell line

//

ID   MKN45

AC   CVCL_0434

SY   MKN-45; MKN 45

DR   BTO; BTO:0001225

DR   CLO; CLO_0007733

DR   CLO; CLO_0050797

DR   EFO; EFO_0002832

DR   MCCL; MCC:0000329

DR   BioSample; SAMN03473237

DR   BioSample; SAMN03473585

DR   CCLE; MKN45_STOMACH

DR   CCRID; 3111C0001CCC000229

DR   CGH-DB; 120-1

DR   CGH-DB; 9022-4

DR   ChEMBL-Cells; CHEMBL3307603

DR   ChEMBL-Targets; CHEMBL614354

DR   Cosmic; 685596

DR   Cosmic; 801339

DR   Cosmic; 848147

DR   Cosmic; 848373

DR   Cosmic; 873711

DR   Cosmic; 877042

DR   Cosmic; 887256

DR   Cosmic; 888827

DR   Cosmic; 897535

DR   Cosmic; 918497

DR   Cosmic; 922696

DR   Cosmic; 925340

DR   Cosmic; 926114

DR   Cosmic; 983727

DR   Cosmic; 1001651

DR   Cosmic; 1001655

DR   Cosmic; 1007602

DR   Cosmic; 1090461

DR   Cosmic; 1187283

DR   Cosmic; 1223589

DR   Cosmic; 1329185

DR   Cosmic; 1436026

DR   Cosmic; 1460707

DR   Cosmic; 1518241

DR   Cosmic; 1518255

DR   Cosmic; 1582430

DR   Cosmic; 1627265

DR   Cosmic; 1995510

DR   Cosmic; 2036663

DR   Cosmic-CLP; 925340

DR   DSMZ; ACC-409

DR   GDSC; 925340

DR   GEO; GSM562395

DR   GEO; GSM618013

DR   GEO; GSM618014

DR   GEO; GSM618015

DR   GEO; GSM618016

DR   GEO; GSM827532

DR   GEO; GSM828836

DR   GEO; GSM844607

DR   GEO; GSM887324

DR   GEO; GSM888400

DR   GEO; GSM1374681

DR   GEO; GSM1670113

DR   JCRB; JCRB0254

DR   KCLB; 80103

DR   NCBI_Iran; C615

DR   RCB; RCB1001

DR   Wikidata; Q28473066

RX   PubMed=1486568;

RX   PubMed=1778766;

RX   PubMed=3962675;

RX   PubMed=9290701;

RX   PubMed=9665481;

RX   PubMed=11107048;

RX   PubMed=15723654;

RX   PubMed=15767549;

RX   PubMed=18804159;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=22531121;

RX   PubMed=23671654;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/m/cell-lines-detail-496.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 30-33 hours (PubMed=3962675); ~60 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=23671654; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: Occasionally 'MNK-45'.

CC   Misspelling: Occasionally 'MNK45'.

CC   Misspelling: Occasionally 'NKM-45'.

CC   Misspelling: Occasionally 'NKM45'.

CC   Derived from metastatic site: Liver.

ST   Source(s): Cosmic-CLP; DSMZ; JCRB; KCLB; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 10

ST   D18S51: 16

ST   D21S11: 31

ST   D3S1358: 15,16

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   D8S1179: 13,17

ST   FGA: 19 (KCLB)

ST   FGA: 19,24 (PubMed=25877200)

ST   Penta D: 10

ST   Penta E: 10

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 19

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MKN45-Luc

AC   CVCL_J262

SY   MKN-45-Luc

DR   JCRB; JCRB1379

DR   JCRB; NIHS0634

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0634; true.

CC   Derived from metastatic site: Liver.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 8,11

ST   D16S539: 10

ST   D5S818: 10,11

ST   D7S820: 10,11

ST   TH01: 7

ST   TPOX: 8

ST   vWA: 19

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0434 ! MKN45

SX   Female

CA   Cancer cell line

//

ID   MKN45/TP

AC   CVCL_9645

SY   MKN-45/TP

RX   PubMed=18922971;

CC   Transfected with: HGNC; 3148; TYMP.

CC   Derived from metastatic site: Liver.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0434 ! MKN45

SX   Female

CA   Cancer cell line

//

ID   MKN45R0.05

AC   CVCL_Z941

RX   CelloPub=CLPUB00210;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Liver.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0434 ! MKN45

SX   Female

CA   Cancer cell line

//

ID   MKN45R0.08

AC   CVCL_Z942

RX   CelloPub=CLPUB00210;

CC   Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).

CC   Derived from metastatic site: Liver.

DI   NCIt; C4004; Gastric adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0434 ! MKN45

SX   Female

CA   Cancer cell line

//

ID   MKN7

AC   CVCL_1417

SY   MKN-7; MKN 7

DR   BTO; BTO:0002382

DR   CLO; CLO_0050805

DR   EFO; EFO_0002895

DR   BioSample; SAMN03472197

DR   BioSample; SAMN03473201

DR   CCLE; MKN7_STOMACH

DR   CGH-DB; 118-1

DR   CGH-DB; 9020-4

DR   ChEMBL-Cells; CHEMBL3307377

DR   ChEMBL-Targets; CHEMBL614355

DR   Cosmic; 733175

DR   Cosmic; 848370

DR   Cosmic; 877040

DR   Cosmic; 888825

DR   Cosmic; 889106

DR   Cosmic; 897533

DR   Cosmic; 922693

DR   Cosmic; 924250

DR   Cosmic; 926112

DR   Cosmic; 968347

DR   Cosmic; 983725

DR   Cosmic; 1007601

DR   Cosmic; 1066229

DR   Cosmic; 1187284

DR   Cosmic; 1223587

DR   Cosmic; 1436024

DR   Cosmic; 1460708

DR   Cosmic; 1482077

DR   Cosmic; 1518242

DR   Cosmic; 1995511

DR   Cosmic-CLP; 924250

DR   GDSC; 924250

DR   GEO; GSM562401

DR   GEO; GSM827584

DR   GEO; GSM844608

DR   GEO; GSM887326

DR   GEO; GSM888402

DR   GEO; GSM1237677

DR   GEO; GSM1237702

DR   GEO; GSM1670114

DR   JCRB; JCRB1025

DR   RCB; RCB0999

DR   TKG; TKG 0228

RX   PubMed=3962675;

RX   PubMed=11107048;

RX   PubMed=15723654;

RX   PubMed=15767549;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27397505;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MKN-7

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Doubling time: 64-66 hours (PubMed=3962675); 86 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB; TKG

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 8,12

ST   D16S539: 9,10

ST   D18S51: 13,18

ST   D21S11: 29,32.2

ST   D3S1358: 17

ST   D5S818: 9,13

ST   D7S820: 9 (JCRB; PubMed=25877200; TKG)

ST   D7S820: 9,11 (Cosmic-CLP; RCB)

ST   D8S1179: 15

ST   FGA: 23

ST   Penta D: 10,11

ST   Penta E: 18

ST   TH01: 7,9

ST   TPOX: 9

ST   vWA: 17

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   MKN7/CMV-Luc

AC   CVCL_4Y05

SY   MKN-7/CMV-Luc

DR   JCRB; NIHS0721

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1417 ! MKN7

SX   Male

CA   Cancer cell line

//

ID   MKN74

AC   CVCL_2791

SY   MKN-74; MKN 74

DR   BTO; BTO:0002383

DR   CLO; CLO_0050798

DR   EFO; EFO_0002834

DR   BioSample; SAMN01821701

DR   BioSample; SAMN03473122

DR   CCLE; MKN74_STOMACH

DR   CGH-DB; 121-1

DR   CGH-DB; 9023-4

DR   ChEMBL-Cells; CHEMBL3307287

DR   ChEMBL-Targets; CHEMBL614048

DR   Cosmic; 685597

DR   Cosmic; 801340

DR   Cosmic; 848148

DR   Cosmic; 848372

DR   Cosmic; 873712

DR   Cosmic; 877043

DR   Cosmic; 887253

DR   Cosmic; 888828

DR   Cosmic; 897536

DR   Cosmic; 918498

DR   Cosmic; 922695

DR   Cosmic; 926115

DR   Cosmic; 983728

DR   Cosmic; 1007603

DR   Cosmic; 1067209

DR   Cosmic; 1090462

DR   Cosmic; 1122338

DR   Cosmic; 1187285

DR   Cosmic; 1223590

DR   Cosmic; 1436027

DR   Cosmic; 1460709

DR   Cosmic; 1477424

DR   Cosmic; 1518244

DR   Cosmic; 2484974

DR   GEO; GSM562418

DR   GEO; GSM827533

DR   GEO; GSM844609

DR   GEO; GSM887325

DR   GEO; GSM888401

DR   GEO; GSM1374682

DR   JCRB; JCRB0255

DR   KCLB; 80104

DR   RCB; RCB1002

RX   PubMed=3962675;

RX   PubMed=9290701;

RX   PubMed=11107048;

RX   PubMed=15723654;

RX   PubMed=15767549;

RX   PubMed=22336246;

RX   PubMed=22460905;

RX   PubMed=24807215;

RX   PubMed=25485619;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: JFCR39 cancer cell line panel.

CC   Part of: JFCR45 cancer cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Doubling time: 42-46 hours (PubMed=3962675).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Liver.

ST   Source(s): JCRB; KCLB; PubMed=25877200; RCB

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11

ST   D16S539: 9,11

ST   D18S51: 12

ST   D21S11: 32.2

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 9

ST   D8S1179: 11,16

ST   FGA: 23

ST   Penta D: 9

ST   Penta E: 11,14,15

ST   TH01: 6

ST   TPOX: 8,11

ST   vWA: 16,20

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   MKN74/CMV-Luc

AC   CVCL_4Y06

SY   MKN-74/CMV-Luc

DR   JCRB; NIHS0722

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Derived from metastatic site: Liver.

DI   NCIt; C5473; Gastric tubular adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2791 ! MKN74

SX   Female

CA   Cancer cell line

//

ID   MKPL-1

AC   CVCL_2116

DR   BioSample; SAMN03473446

DR   Cosmic; 787452

DR   Cosmic; 975270

DR   Cosmic; 1012091

DR   Cosmic; 1281328

DR   Cosmic; 2306219

DR   DSMZ; ACC-697

DR   JCRB; JCRB1325

DR   JCRB; NIHS0536

RX   PubMed=16408098;

CC   Doubling time: ~50-60 hours (DSMZ).

CC   Discontinued: JCRB; NIHS0536; true.

ST   Source(s): DSMZ; JCRB

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,11

ST   D16S539: 9

ST   D5S818: 11,12

ST   D7S820: 11

ST   TH01: 8,9.3

ST   TPOX: 10,11

ST   vWA: 17,18

DI   NCIt; C7965; Adult acute megakaryoblastic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   mKS-A TU-5

AC   CVCL_5T88

SY   TU-5; TU5

RX   PubMed=4310402;

RX   PubMed=4348218;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   MKT-BR

AC   CVCL_7080

SY   MKTBR; MkTBr

DR   BTO; BTO:0002735

DR   Cosmic; 986618

DR   GEO; GSM276741

RX   PubMed=9154388;

RX   PubMed=15714118;

RX   PubMed=17487557;

CC   Omics: Transcriptome analysis.

DI   NCIt; C7712; Uveal melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ML

AC   CVCL_W799

DR   Cosmic; 706110

DR   Cosmic; 888853

RX   PubMed=9692547;

RX   PubMed=10766161;

RX   PubMed=15009714;

DI   NCIt; C3510; Cutaneous melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ML-1 [Human bone marrow]

AC   CVCL_IQ95

DR   ATCC; CRL-11451

RX   Patent=US5981708;

CC   Discontinued: ATCC; CRL-11451; probable.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Spontaneously immortalized cell line

//

ID   ML-1 [Human leukemia]

AC   CVCL_0436

SY   ML1

DR   BTO; BTO:0001884

DR   CLO; CLO_0007735

DR   MCCL; MCC:0000331

DR   CLDB; cl3489

DR   Cosmic; 787453

DR   Cosmic; 798669

DR   Cosmic; 919125

DR   Cosmic; 924048

DR   Cosmic; 947369

DR   Cosmic; 994171

DR   Cosmic; 998746

DR   Cosmic; 999727

DR   Cosmic; 1037658

DR   Cosmic; 1078735

DR   Cosmic; 1078738

DR   Cosmic; 1127255

DR   Cosmic; 2089662

DR   Cosmic; 2301563

DR   ECACC; 88113007

RX   PubMed=3458526;

RX   PubMed=6091813;

RX   PubMed=8814454;

RX   PubMed=23955599;

ST   Source(s): COG; ECACC

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 9,12

ST   D18S51: 14,18

ST   D19S433: 14

ST   D21S11: 29

ST   D2S1338: 16,17

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 8,13

ST   FGA: 23,25

ST   TH01: 7,9.3

ST   TPOX: 8,10

ST   vWA: 16

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_1418 ! ML-2

OI   CVCL_H526 ! ML-3

SX   Male

CA   Cancer cell line

//

ID   ML-1 [Human thyroid carcinoma]

AC   CVCL_H525

SY   ML1

DR   BioSample; SAMN03473557

DR   CCLE; ML1_THYROID

DR   Cosmic; 1239975

DR   Cosmic; 2054099

DR   Cosmic-CLP; 1240178

DR   DSMZ; ACC-464

DR   GDSC; 1240178

DR   GEO; GSM887327

DR   GEO; GSM888403

DR   GEO; GSM1670115

RX   PubMed=10794546;

RX   PubMed=18713817;

RX   PubMed=22460905;

RX   PubMed=23833040;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Doubling time: ~4-7 days (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=18713817

ST   Amelogenin: X

ST   CSF1PO: 10,14

ST   D13S317: 10

ST   D16S539: 10,12

ST   D18S51: 18

ST   D21S11: 31.2,33.2

ST   D3S1358: 15

ST   D5S818: 12,13

ST   D7S820: 10

ST   D8S1179: 10,13

ST   FGA: 22,25

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 17,18

DI   NCIt; C8054; Thyroid gland follicular carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   ML-1a

AC   CVCL_0435

SY   ML1a

DR   MCCL; MCC:0000330

CC   From: Takeda K.; Showa University; Tokyo; Japan.

DI   NCIt; C7463; Acute myelomonocytic leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   ML-2

AC   CVCL_1418

SY   ML2

DR   BTO; BTO:0001885

DR   CLO; CLO_0007736

DR   EFO; EFO_0002238

DR   CLDB; cl3490

DR   BioSample; SAMN03472168

DR   ChEMBL-Cells; CHEMBL3307604

DR   ChEMBL-Targets; CHEMBL614356

DR   Cosmic; 787454

DR   Cosmic; 908141

DR   Cosmic; 975271

DR   Cosmic; 999728

DR   Cosmic; 1012092

DR   Cosmic; 1078727

DR   Cosmic; 1078739

DR   Cosmic; 1151785

DR   Cosmic; 1181602

DR   Cosmic; 1281329

DR   Cosmic; 1524834

DR   Cosmic; 2131545

DR   Cosmic; 2391904

DR   Cosmic-CLP; 908141

DR   DSMZ; ACC-15

DR   GDSC; 908141

DR   GEO; GSM236791

DR   GEO; GSM236827

DR   GEO; GSM482497

DR   GEO; GSM1374683

DR   GEO; GSM1670116

DR   IGRhCellID; ML2

RX   PubMed=3458526;

RX   PubMed=6091813;

RX   PubMed=15843827;

RX   PubMed=16408098;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Doubling time: ~60 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,12

ST   D16S539: 9,12

ST   D18S51: 15,18

ST   D21S11: 29

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 8,13

ST   FGA: 23,25

ST   Penta D: 12

ST   Penta E: 5,7

ST   TH01: 7,9.3

ST   TPOX: 8,10

ST   vWA: 16

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0436 ! ML-1 [Human leukemia]

OI   CVCL_H526 ! ML-3

SX   Male

CA   Cancer cell line

//

ID   ML-3

AC   CVCL_H526

SY   ML3

DR   Cosmic; 1070691

DR   Cosmic; 1176586

RX   PubMed=3458526;

RX   PubMed=6091813;

DI   NCIt; C9154; Adult acute myeloid leukemia

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0436 ! ML-1 [Human leukemia]

OI   CVCL_1418 ! ML-2

SX   Male

CA   Cancer cell line

//

ID   ML-DmBG1

AC   CVCL_Z709

DR   DGRC; 49

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG1-c1

AC   CVCL_Z857

SY   BG1c1

DR   EFO; EFO_0005821

DR   DGRC; 50

DR   ENCODE; ENCBS002ZRD

DR   GEO; GSM409485

DR   GEO; GSM409486

DR   GEO; GSM409487

DR   GEO; GSM609222

DR   GEO; GSM980233

RX   CelloPub=CLPUB00203;

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=24985917;

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z709 ! ML-DmBG1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2

AC   CVCL_Z710

DR   DGRC; 51

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c1

AC   CVCL_Z717

DR   DGRC; 52

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c10

AC   CVCL_Z718

DR   DGRC; 62

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c11

AC   CVCL_Z797

DR   DGRC; 63

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c12

AC   CVCL_Z798

DR   DGRC; 64

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c2

AC   CVCL_Z719

SY   BG2-c2; BG2c2

DR   EFO; EFO_0005822

DR   DGRC; 53

DR   ENCODE; ENCBS193GRU

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

RX   PubMed=21177962;

RX   PubMed=24434506;

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c3

AC   CVCL_Z720

DR   DGRC; 54

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c4

AC   CVCL_Z721

DR   DGRC; 55

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c5

AC   CVCL_Z722

DR   DGRC; 56

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c6

AC   CVCL_Z723

SY   BG2-C6

DR   DGRC; 3

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

WW   http://www.entu.cas.cz/zurovec/eng/research/cultures.html

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c7

AC   CVCL_Z724

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c8

AC   CVCL_Z725

DR   DGRC; 60

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG2-c9

AC   CVCL_Z726

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z710 ! ML-DmBG2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG3

AC   CVCL_Z711

DR   DGRC; 66

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG3-c1

AC   CVCL_Z727

SY   BG3-c1

DR   DGRC; 67

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z711 ! ML-DmBG3

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG3-c2

AC   CVCL_Z728

SY   BG3-c2; BG3c2

DR   EFO; EFO_0005823

DR   DGRC; 68

DR   ENCODE; ENCBS005WGE

DR   ENCODE; ENCBS073JKW

DR   ENCODE; ENCBS101CUQ

DR   ENCODE; ENCBS108FTY

DR   ENCODE; ENCBS174JPC

DR   ENCODE; ENCBS216EMV

DR   ENCODE; ENCBS275KHY

DR   ENCODE; ENCBS303TQC

DR   ENCODE; ENCBS315UOB

DR   ENCODE; ENCBS329HUS

DR   ENCODE; ENCBS417TZL

DR   ENCODE; ENCBS424ESD

DR   ENCODE; ENCBS489VDG

DR   ENCODE; ENCBS494EED

DR   ENCODE; ENCBS557LTF

DR   ENCODE; ENCBS565CSY

DR   ENCODE; ENCBS637AYT

DR   ENCODE; ENCBS745OPA

DR   ENCODE; ENCBS804ZFU

DR   ENCODE; ENCBS832ABW

DR   ENCODE; ENCBS834HSY

DR   ENCODE; ENCBS843UOH

DR   ENCODE; ENCBS848TVS

DR   ENCODE; ENCBS927DOE

DR   ENCODE; ENCBS936VAG

DR   ENCODE; ENCBS946SBT

DR   ENCODE; ENCBS980BNS

DR   ENCODE; ENCBS985ADJ

DR   ENCODE; ENCBS987RFJ

RX   CelloPub=CLPUB00203;

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=24985917;

RX   PubMed=25262759;

CC   Group: Insect cell line.

CC   Part of: modENCODE project cell lines.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z711 ! ML-DmBG3

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG3-c2-Mt-GFP-Act5C

AC   CVCL_Z853

DR   DGRC; 174

RX   PubMed=24434506;

CC   Group: Insect cell line.

CC   Transfected with: FlyBase; FBgn0000042; Act5C.

CC   Transfected with: UniProtKB; P42212; GFP.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z728 ! ML-DmBG3-c2

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG3-c3

AC   CVCL_Z729

DR   DGRC; 69

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z711 ! ML-DmBG3

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG3-c4

AC   CVCL_Z730

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z711 ! ML-DmBG3

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG3-c5

AC   CVCL_Z731

RX   CelloPub=CLPUB00203;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z711 ! ML-DmBG3

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG4

AC   CVCL_Z712

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG5

AC   CVCL_Z713

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG6

AC   CVCL_Z714

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG7

AC   CVCL_Z715

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmBG8

AC   CVCL_Z716

DR   DGRC; 77

RX   CelloPub=CLPUB00203;

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD1

AC   CVCL_Z736

SY   ML-DmD 1

RX   PubMed=3117765;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD1-c3

AC   CVCL_Z756

DR   DGRC; 81

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z736 ! ML-DmD1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD1-c4

AC   CVCL_Z757

DR   DGRC; 82

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z736 ! ML-DmD1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD1-c5

AC   CVCL_Z758

DR   DGRC; 122

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z736 ! ML-DmD1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD1-c6

AC   CVCL_Z759

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z736 ! ML-DmD1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD1-c7

AC   CVCL_Z760

DR   DGRC; 83

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z736 ! ML-DmD1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD1-c8

AC   CVCL_Z761

DR   DGRC; 84

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z736 ! ML-DmD1

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD10

AC   CVCL_Z737

SY   ML-DmD 10

RX   PubMed=3117765;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD11

AC   CVCL_Z738

SY   D11

DR   EFO; EFO_0005824

DR   DGRC; 94

DR   ENCODE; ENCBS640WXH

RX   PubMed=21177962;

RX   PubMed=24434506;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD11-c1

AC   CVCL_Z762

DR   DGRC; 208

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z738 ! ML-DmD11

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD11-c2

AC   CVCL_Z763

DR   DGRC; 209

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z738 ! ML-DmD11

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD11-c3

AC   CVCL_Z764

DR   DGRC; 210

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z738 ! ML-DmD11

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD15

AC   CVCL_Z739

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16

AC   CVCL_Z740

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16-c1

AC   CVCL_Z765

DR   DGRC; 96

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z740 ! ML-DmD16

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16-c3

AC   CVCL_Z766

SY   D16c3

DR   EFO; EFO_0005825

DR   DGRC; 97

DR   ENCODE; ENCBS810BML

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=24985917;

RX   PubMed=25262759;

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z740 ! ML-DmD16

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16-c4

AC   CVCL_Z767

DR   DGRC; 98

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z740 ! ML-DmD16

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16-c6

AC   CVCL_Z768

DR   DGRC; 100

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z740 ! ML-DmD16

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16-c7

AC   CVCL_Z769

DR   DGRC; 101

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z740 ! ML-DmD16

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16-c8

AC   CVCL_Z770

DR   DGRC; 102

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z740 ! ML-DmD16

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD16-c9

AC   CVCL_Z771

DR   DGRC; 103

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z740 ! ML-DmD16

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD17

AC   CVCL_Z741

RX   PubMed=8069443;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD17-c3

AC   CVCL_Z772

SY   D17c3

DR   EFO; EFO_0005826

DR   DGRC; 107

DR   ENCODE; ENCBS006QKV

DR   ENCODE; ENCBS122LBB

DR   ENCODE; ENCBS141CJX

DR   ENCODE; ENCBS146SLV

DR   ENCODE; ENCBS166WDM

DR   ENCODE; ENCBS203HRH

DR   ENCODE; ENCBS248SBY

DR   ENCODE; ENCBS332YXG

DR   ENCODE; ENCBS342RHG

DR   ENCODE; ENCBS361KVW

DR   ENCODE; ENCBS397DQG

DR   ENCODE; ENCBS434TLI

DR   ENCODE; ENCBS468KEJ

DR   ENCODE; ENCBS476QMP

DR   ENCODE; ENCBS635RCT

DR   ENCODE; ENCBS787HWT

DR   ENCODE; ENCBS817KQD

DR   ENCODE; ENCBS866KNJ

DR   ENCODE; ENCBS896CUM

DR   ENCODE; ENCBS919OTC

DR   ENCODE; ENCBS999UOC

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=25262759;

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z741 ! ML-DmD17

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD2

AC   CVCL_Z742

SY   ML-DmD 2

RX   PubMed=3117765;

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD20

AC   CVCL_Z743

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD20-c1

AC   CVCL_Z773

DR   DGRC; 108

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z743 ! ML-DmD20

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD20-c2

AC   CVCL_Z774

SY   D20-c2; D20c2

DR   EFO; EFO_0005827

DR   DGRC; 109

DR   ENCODE; ENCBS695UGH

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=25262759;

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z743 ! ML-DmD20

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD20-c4

AC   CVCL_Z775

DR   DGRC; 111

CC   Group: Insect cell line.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z743 ! ML-DmD20

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD20-c5

AC   CVCL_Z776

SY   D20-c5; D20c5

DR   EFO; EFO_0005828

DR   DGRC; 112

DR   ENCODE; ENCBS752KGT

DR   GEO; GSM609217

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=24985917;

RX   PubMed=25262759;

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

HI   CVCL_Z743 ! ML-DmD20

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   ML-DmD21

AC   CVCL_Z744

SY   D21

DR   EFO; EFO_0005829

DR   DGRC; 86

DR   ENCODE; ENCBS360NKZ

DR   GEO; GSM609220

DR   GEO; GSM609249

RX   PubMed=21177962;

RX   PubMed=24434506;

RX   PubMed=24985917;

CC   Group: Insect cell line.

CC   Omics: Deep RNAseq analysis.

OX   NCBI_TaxID=7227; ! Drosophila melanogaster

SX   Sex undetermined

CA   Spontaneously immortalized cell line



您正在向 biovector.net  发送关于产品 细胞株Cell Lines 53-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。